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Abstract 
Healthcare is a large, extensive, and complex system that aims to help restore 
peoples’ health and assist patients where possible. A number of health services 
make this possible through the delivery of care by medical professionals. 
However, the constant pressures facing the healthcare systems around the 
globe are making the delivery of healthcare services a challenge. The growing 
number of aging population, the rising number of chronic diseases, the number 
of cases of medical harm leading to quality issues in healthcare, and the 
constant rise in healthcare costs, are making the delivery of care a challenge.  
To address this challenge, technologies such as Mobile Health (mHealth) are 
grabbing the attention of academics and medical professionals, to try and 
establish methods of delivering healthcare services using this technology. 
However, technologies do have some challenges that can become a barrier in 
making mHealth a possibility. One area this research focuses on, is the Data 
Quality of Information Systems, specifically in the context of mHealth, and the 
Integrity of the information produced as a result of this data. This study involves 
the use of a qualitative research method that examines diabetes data, a case 
that represents one of the solutions mHealth is being deployed for. The 
qualitative study searches for themes in the data to understand ways inaccurate 
data can be captured and how Machine Learning techniques, can be deployed 
to prevent erroneous data from being used in mHealth.   
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Chapter 1 : Introduction 
Health, according to the World Health Organization (WHO) is ‘a state of which 
complete physical, mental and social well-being and not merely the absence of 
disease or infirmity’ (WHO, 2018). Healthcare systems focus on meeting the 
health needs of a particular population (Glowik & Smyczek, 2015). These 
essential systems are continuously exposed to pressures which lead to making 
the delivery of healthcare services challenging.  
 
Several factors inside and outside the healthcare systems, are creating those 
challenges. Rising number of aging population, the ever-increasing costs of 
health services, injuries due to quality and safety issues within the delivery of 
healthcare, and chronic diseases, are making the delivery of healthcare a 
challenge (Armstrong, Gillespie, Leeder, Rubin, & Russell, 2007). The aging 
population is at an ever-increasing rate as people live longer and maintain a 
healthier routine (Foscolou et al., 2018). 
 
An instance of this increasing rate in aging population is felt in Australia as the 
life expectancy at birth for people born in 2014 is 84.4 years for girls and 80.3 
for boys, compared to 1890’s where life expectancy was 50.8 years for girls, 
and 47.2 for boys (Australian Institute of Health and Welfare (AIHW), 2018). 
The aging population in Australia, people that are aged 65 and over, is 3.7 
million, that makes 15% of the total Australian population which stands at 24.4 
million (AIHW, 2018). At a global level, statistics from the WHO indicate that the 
aging population is continuing to rise as people are living longer with an 
expectation of living beyond the age of 60 (WHO, 2018). This aging population 
of people aged 65 or older will account for 1.5 billion worldwide by 2050 (WHO, 
2018). The United Nations (UN) also demonstrate this rate of increase in Figure 
1.1, where aging population around the world is increasing and the forecast for 
the aging population continues to rise in proportion to population growth  (UN, 
2018). The effect of such increase is felt at the social, political and economic 
levels (Peter, Stefan, & Markus, 1999).   
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Figure 1.1: UN Statistics on Aging Population. Adapted from (UN, World Population Ageing, 
2015) 
 
With aging comes the problem of people developing diseases as they get older 
(Niccoli & Partridge, 2012). Common health problems that are developed with 
aging are hearing loss, cataracts and refractive errors, back and neck pain and 
osteoarthritis, chronic obstructive diseases, diabetes, depression and dementia 
(WHO, 2018).  
 
As life expectancy increases, the likelihood of people developing chronic 
diseases increases as well. Chronic diseases, also referred to as 
noncommunicable (NCD) diseases, is ‘a disease that cannot be cured and 
never disappears’ as defined by Healey and Evans (2015, p. 299). Chronic 
diseases according to WHO (2018), are the top four diseases that range from 
cardiovascular diseases, cancers, respiratory diseases and diabetes. Reports 
from the WHO indicate that chronic diseases are the leading cause of mortality 
worldwide, where the number of deaths from 2012 are projected to increase 
from 38 to 52 million by 2030 (WHO, 2018). People suffering from a chronic 
disease might develop a certain limitation (Boccolini, Duarte, Marcelino, & 
Boccolini, 2017). At the social level, people develop a limited capacity of 
performing certain tasks and live life within a certain routine (Boccolini et al., 
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2017). In Australia, at the economic level, people would become limited to 
certain working conditions, and in 2002, there were more than 5 people of 
working age to support every person aged over 65 (Australian Government, 
2018). By 2042, there will be only 2.5 people of working age supporting each 
person aged over 65 (Australian Government, 2018). 
 
Despite people living longer, the chances of developing a chronic disease leads 
to premature deaths and can reduce the quality of life while suffering from a 
chronic disease (Malvey & Slovensky, 2014). Statistics from AIHW between 
2011 and 2012 have shown similar figures presented by the WHO as about 5% 
the of Australian adult population (accounting for approx. 917,000 people) have 
self-reported diabetes, including sources from biomedical data (AIHW, 2018). 
In the period between 2013 and 2014, diabetes was a factor in 9% of all 
hospitalization (approx. 900,000 people) in Australia (AIHW, 2018). Figure 1.2 
illustrates the causes of premature deaths and the contributing percentage of 
each chronic disease to premature deaths.  
 
Figure 1.2: Causes of premature deaths due to chronic diseases. Adapted from (WHO, 2018) 
AIHW have reported that four major disease groups (chronic – cardiovascular, 
oral health, mental disorders, and musculoskeletal) have cost the Australian 
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healthcare system an estimated $27 billion in 2008-09 (AIHW, 2018). In the US, 
the healthcare expenditure has risen from 5% in 1960 to 19% (2015 figure) and 
is expected to reach 40% of GDP by 2040 (Hosseini, 2015).  
All modern healthcare systems are facing common challenges caused by 
globalization, medical and technological progress, and demographic change 
(Smith, 2011). This requires healthcare systems to adjust and change their 
ways of how provisioning of a service is organized (Smith, 2011). The presence 
of mobile phone technology presents an opportunity for the healthcare 
challenges to be met through innovative solutions. The number of mobile phone 
subscriptions as per the 2015 statistics released by the International 
Telecommunication Union (ITU) (See Figure 1.3), is estimated to be 7 billion 
worldwide (ITU, 2018) and it is expected to reach 24 billion devices by 2020 
(Serhani, Harous, Navaz, Menshawy, & Benharref, 2017). The growing number 
of mobile phone subscriptions is driven by peoples’ needs and habits, and it is 
not imposed (Taruna, 2014).  
 
Figure 1.3: Statistics on mobile subscriptions trend around the globe. Adapted from (ITU, 
2018) 
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This presents an opportunity for mobile phone devices to be used for the 
management of health and as an intervention in the rising number of chronic 
diseases, as half of the smartphone owners frequently browse for health 
information online and monitor their health using mobile health applications 
(Fox & Duggan, 2012). As such, the new role for mobile phones is mobile health 
(mHealth). The definition of mHealth is the use of portable devices such as 
smartphones and tablets to improve health (Hamel, Cortez, Cohen, & 
Kesselheim, 2014). mHealth has enabled people to play an active role in 
managing their health rather than being the passive object when seeking 
treatment during traditional methods (Niilo, Ilkka, & Elina, 2006). 
 
This technology does not only enable self-management but can also reduce 
healthcare costs (LeRouge & Wickramasinghe, 2013). For instance, one of the 
methods of reducing healthcare costs is through self-care (Wickramasinghe & 
Gururajan, 2016). Home self-care for example, can reduce the healthcare costs 
by allowing follow-up care by nurses via telephone calls and home visits that 
significantly decrease hospital readmissions (Schatz & Berlin, 2011). The 
advances in sensor technology such as heart rate, respiratory and blood 
pressure sensors, along with mobile phone devices, have allowed patients to 
self-monitor their health before conditions deteriorate and risk being readmitted 
to hospital (Tarassenko & Clifton, 2011). 
 
Table 1.1 Classification of devices and sensors. Adapted from (Ade, 2012). 
Form Description Examples 
Traditional Medical devices connected to a mobile 
phone via Bluetooth and which use the 
phone as a data gateway 
Blood pressure monitors, 
Precision weight scales, 
Spirometers 
Implantable Implantable medical devices embedded 
just below the surface of the skin and 
which use a small transmitter to send 
data to a gateway attached to the 
patient or located in their vicinity. 
Implantable devices are typically used 
to monitor disease conditions such as 
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chronic diabetes where 24 hour a day 
constant monitoring is required 
Wearable Body sensors and wearable devices 
contain one or more small, embedded 
sensors capable of monitoring different 
physiological and physical parameters. 
BodyMedia Armband and 
monitoring system 
Ingestible Small micro-transmitters in chemical 
agents, which react with the contents of 
the stomach to generate electrical 
signals which are then transmitted via a 
data hub to a medical station 
Proteus ingestible 
sensors and monitoring 
system 
Mobile 
Peripherals 
Devices that can be plugged directly 
into a mobile phone and which turns the 
mobile phone into a medical instrument 
AgaMatrix device 
manufactured by Sanofi 
Aventis and which is used 
to monitor diabetes 
Mobile 
Apps 
Applications that are developed to 
replicate functionality that is normally 
provided by a dedicated medical device 
iPhone Stethoscope app 
that records a heart 
rhythm and plays back a 
cardiogram 
 
Individuals can self-monitor the status of their health using any form of mHealth 
technology as presented in Table 1.1 which allow for different uses and 
applications. The variety of mHealth solutions does not only introduce 
innovative solutions but can also cater for patients with different needs and 
diseases (See Figure 1.4) that make battling chronic diseases much more 
powerful by allowing patients to be proactive in managing their health. The 
different forms of mhealth solutions also play an important role in extending 
healthcare to be delivered at the right time by bypassing all the geographical 
barriers that patients might have when trying to access healthcare services.  
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Figure 1.4: Battling chronic disease using any form of mHealth technology. Outer circle 
adapted from (WHO, 2016) and inner circle shows ways of battling those diseases 
This technology is changing the dynamics of healthcare by allowing for 
evidence to be collected at the population scale in different time scales, track 
activities and outcomes in real time, and even extend the patient to be involved 
in their own treatment (O'Riordan & Elton, 2016). 
 
While smartphones have a new role to play in the effective management of 
health and diseases, the technology must be clear of medical errors. Errors 
have been defined as active and latent (Kalra, 2011). Active errors are those 
that produce immediate events and involve operators of complex systems such 
as errors by healthcare professionals in medicine (Kalra, 2011). Latent errors 
are those that result from factors that are inherent in the system, such as 
excessive workload, insufficient training, and inadequate maintenance of 
equipment (Kalra, 2011).  
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Errors in the medical field belong to a number of domains such as development 
and use of technologies, ergonomics, administration, management, politics and 
economics (Vincent, 2010). A common root cause is human error, where errors 
are of omission (forgetting to do something) and commission (intentionally 
doing something that is not meant to be done) (Health informatics: improving 
patient care, 2012). The famous report from the Institute of Medicine (IOM) titled 
“To Err Is Human” that was published in 1999, estimated that approximately 
98,000 people die each year in hospital due to preventable medical errors 
(Kohn, Corrigan, & Donaldson, 2000). In 2016, the Johns Hopkins (2016) report 
of medical errors showed that the number of medical errors has doubled, as it 
estimated that 250,000 people die each year due to medical errors.  
 
Examples of medical errors from recent literature include when patients both 
with and without a chronic disease have suffered a medication error (Nuovo, 
2010), errors in discharge prescriptions due to incomplete and inadequate 
prescriptions (Murray, Belanger, Devine, Lane, & Condren, 2017), and data 
entry errors resulting in hospital staff being incorrectly tested for Hepatitis B, yet 
when the correct test was carried, it was found the staff lacked immunity 
(Vecellio, Maley, Toouli, Georgiou, & Westbrook, 2015). These examples 
demonstrate few instances of how and when medical errors occur, and the 
impact medical errors have on both healthcare and people.  
 
With the introduction of technology in the healthcare domain, a new and 
emerging contributor to medical errors is technology, whilst human errors are 
still occurring (Jenicek, 2010). Jenicek (2010) defines technology errors in 
medicine as errors that relate to data and information recording, processing, 
and retrieval caused by information technology and its uses (information 
technology inadequacy and failure). Modern healthcare patients are becoming 
more of consumers than a patient due to the great control over the decisions 
that affect their healthcare (Konschak & Jarrell, 2010). Safe clinical care 
requires quality data and documentation (Medhanyie et al., 2017). Patient 
safety as defined by Zacher (2014, p.7), and one that’s based on World Alliance 
for Patient Safety is “the reduction of risk of unnecessary harm associated with 
healthcare to an acceptable minimum”.  
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The use of mobile phone technology for managing health has its own set of 
challenges and complexities, such as accuracy, integrity, privacy, security and 
confidentiality. The technology can be a great tool that can benefit healthcare, 
people and society. To keep the momentum of continuous mhealth 
developments and innovation in healthcare, this research addresses the key 
areas of mHealth that are the foundational features of the technology.  
 
First, is an overview of Healthcare delivery along with the challenges in 
healthcare delivery. Second is a review of Internet of Things (Iot) followed by 
mHealth and Rise of mHealth. Third, is a review of the challenges in the delivery 
of healthcare. Third is how mHealth is used for chronic diseases, with focus on 
mHealth for diabetes. Fourth, is a review of human interaction with technology 
and how errors might occur during the interaction stage. Fifth is a look at Big 
Data and how Big Data occurs in the health domain. Sixth is data quality and 
the accuracy dimension of data is reviewed with definitions underlying the key 
components of accurate data. Seventh, a review of Information Integrity, and 
what constitutes Information Integrity after data is processed, along with the use 
of Omaha Care Plan to assist in understanding the generation of information. 
Last, is a review of Machine Learning and how data is solely the underlying 
source of insight and knowledge that is extracted using Algorithms, with a view 
of Machine Learning in healthcare. 
 
Chapter Summary 
Constant pressures in the healthcare domain are making the delivery of 
healthcare services more challenging. Some of these challenges are being 
solved using technologies such as mHealth, that have the potential of lowering 
healthcare costs while delivering more care to patients simultaneously 
empowering patients to self-manage their health. While the opportunity is there, 
the technology must be free of any errors that can potentially contribute back to 
medical errors. 
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Chapter 2 : Literature Review 
The literature review includes a review of healthcare delivery, the challenges in 
healthcare delivery, IoT, rise of mHealth, mHealth technology, chronic disease 
challenges and success factors, mHealth for chronic diseases, mHealth for 
Diabetes, Patient – Clinician Interaction, Big data for Health, Data Accuracy, 
Information Integrity, and Machine Learning. 
 
2.1 Healthcare Delivery 
Healthcare is a system involving inputs (finance, workforce), processes, outputs 
and outcomes (Willcox et al., 2015), that is delivered by trained an licensed 
professionals in medicine, nursing, dentistry, pharmacy, and other allied health 
providers (Griffin et al., 2016). The quality and accessibility of healthcare is 
different from one country to another, and it is shaped by health policies that 
are in place (Griffin et al., 2016). The outputs and outcomes of the healthcare 
system include individual or person-level outputs (patients treated) and 
outcomes (improved quality of life) and wider outputs/outcomes (research 
outputs, strong communities, changed environments) (Willcox et al., 2015). 
Health outputs and health outcomes may not be distributed evenly across all 
members of society (Willcox et al., 2015). The healthcare system can be 
evaluated in terms of its impact on equity, quality, efficiency and acceptability 
(Willcox et al., 2015). 
 
Healthcare systems are  generally of two types, welfare-based, a public system 
by the government that provides healthcare to all citizens, and a market-driven, 
a private system that is run by private providers and is paid for by citizens 
(Willis, Reynolds, & Keleher, 2016). The Australian healthcare system for 
example, provides population health prevention inclusive of general practice 
and community health, emergency health services and hospital care, and 
rehabilitation and palliative care (healthdirect, 2018). The funding of such 
system is through the government such as the Australian Medicare, or through 
the private health system (Australian Government, 2018).  
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The 3 fundamental objectives of a Healthcare System according to the WHO, 
are (Coady, Clements, Gupta, & International Monetary, 2012, p. 3): 
• Improving the health of the population it serves 
• Providing financial protection against the costs of ill-health; and 
• Responding to people’s expectations.  
 
The delivery of healthcare services is dependent on the conditions or need of 
care. Table 2.1.1 highlights the different types of care, the delivery method, how 
it is provided, and the condition that instigates the type of care. Table 2.1.1 also 
highlights the complexity and the components of healthcare delivery. 
 
Table 2.1.1: Delivery of Healthcare Services. Adapted from (Griffin et al., 2016). 
Type Delivery Focus Providers Conditions/Needs 
Primary 
Care 
• Day-to-Day 
healthcare 
• Often the first 
point of 
consultation for 
patients 
• Primary care 
physician, general 
practitioner, or 
family or internal 
medicine physician 
• Pediatrician 
• Dentist 
• Physician assistant 
• Nurse practitioner 
• Physiotherapist 
• Registered nurse 
• Clinical officer 
• Ayurvedic 
• Routine 
checkups 
• Immunizations 
• Preventive care  
• Health 
education 
• Asthma 
• Chronic 
obstructive 
pulmonary 
disease 
• Diabetes 
• Arthritis 
• Thyroid 
dysfunction 
• Hypertension 
Vaccinations 
• Oral health 
• Basic maternal 
and child care 
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Urgent 
Care 
• Treatment of 
acute and 
chronic illness 
and injury 
provided in a 
dedicated walk-
in clinic 
• For injuries or 
illnesses 
requiring 
immediate or 
urgent care but 
not serious 
enough to 
warrant an ER 
visit 
• Typically do not 
offer surgical 
services 
• Family medicine 
physician 
• Emergency 
medicine physician 
• Physician assistant 
• Registered nurse 
• Nurse practitioner 
• Broken bones 
• Back pain 
• Heat exhaustion 
• Insect bites and 
stings 
• Burns 
• Sunburns 
• Ear infection 
• Physicals 
Ambulatory 
or 
outpatient 
care 
• Consultation, 
treatment, or 
intervention on 
an outpatient 
basis (medical 
office, 
outpatient 
surgery center, 
or ambulance) 
• Typically does 
not require an 
overnight stay 
• Internal medicine 
physician 
• Endoscopy nurse 
• Medical technician 
• Paramedic 
• Urinary tract 
infection 
• Colonscopy 
• Carpal tunnel 
syndrome 
• Stabilize patient 
for transport 
Secondary 
or acute 
care 
• Medical 
specialties 
typically needed 
for advanced or 
acute conditions 
• Emergency 
medicine physician 
• Cardiologist 
• Urologist 
• Dermatologist 
• Emergency 
medical care 
• Acute coronary 
syndrome 
• Cardiomyopathy 
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including 
hospital 
emergency 
room visits 
• Typically not the 
first contact with 
patients; usually 
referred by 
primary care 
physicians 
• Psychiatrist 
• Clinical psychologist 
• Gynecologist and 
obstetrician 
• Rehabilitative 
therapist (physical, 
occupational, and 
speech) 
• Bladder stones 
• Prostate Cancer 
• Women’s health 
Tertiary 
care 
• Specialized 
highly technical 
healthcare 
usually for 
inpatients 
• Usually patients 
are referred to 
this level of care 
from primary or 
secondary care 
personnel 
• Surgeon (cardiac, 
orthopedic, brain, 
plastic, transplant, 
etc.) 
• Anesthesiologist 
• Neonatal nurse 
practitioner 
• Ventricular assist 
device coordinator 
• Cancer 
management 
• Cardiac surgery 
• Orthopedic 
surgery 
• Neurosurgery 
• Plastic surgery 
• Transplant 
surgery 
• Premature birth 
• Palliative care 
• Severe burn 
treatment  
Quaternary 
care 
• Advanced levels 
of medicine that 
are highly 
specialized and 
not widely 
accessed 
• Experimental 
medicine 
• Typically 
available only in 
a limited 
number of 
• Neurologist 
• Ophthalmologist 
• Hematologist 
• Immunologist 
• Oncologist 
• Virologist 
• Multi-drug 
resistant 
tuberculosis 
• Liver cirrhosis 
• Psoriasis 
• Lupus 
• Myocarditis 
• Gastric cancer 
• Multiple 
myeloma 
• Ulcerative colitis 
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academic health 
centers 
Home and 
community 
care 
• Professional 
care in 
residential and 
community 
settings 
• End-of-life care 
(hospice and 
palliative) 
• Medical director 
(physician) 
• Registered nurse 
• Licensed practical 
nurse 
• Certified nursing 
assistant 
• Social worker 
• Dietitian or 
nutritionist 
• Physical, 
occupational, and 
speech therapists 
• Post-acute care 
• Disease 
management 
teaching 
• Long-term care 
• Skilled nursing 
facility/assisted 
living 
• Behavioural 
and/or 
substance use 
disorders 
• Rehabilitation 
using 
prosthesis, 
orthotics, or 
wheelchairs 
 
Healthcare, as a system, is complicated, and the complexity in the system 
arises from six interconnected levels— the patient, the population, the team, 
the organization, the network, and the political and economic environments 
(PPTONE) (Griffin et al., 2016). Aspalter, Pribadi, and Gauld (2017) 
demonstrate this complexity in healthcare by illustrating the process of care 
when an individual seeks health services through their general practitioner. The 
example is that individual practitioners, such as primary care physicians 
working in solo practice and their individual patients, are inevitably a part of a 
broad system of care. The patient with a condition that the solo primary medical 
practitioner is unable to diagnose, and treat will be referred on to a provider with 
a higher level of training, qualification and specialization. That provider may 
then require additional input from others, such as those with specific technology 
required to diagnose and to deliver effective treatment. Of course, prescribing 
is central to most patient consultations, and the drugs themselves are often 
dispensed by independent pharmacists to ensure there is a separation between 
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prescribing and dispensing. Where such separation does not exist (as is the 
case in some Asian countries), this provides a potential incentive for the 
prescribing doctor to indicate medicines that generate a higher personal profit; 
it can also mean that patients do not necessarily obtain the expert advice and 
second opinion often provided by pharmacists. Many patients require 
hospitalization, either through referral from a primary care physician or due to 
an accident or emergency that requires treatment or ongoing observation. At 
any of these points, information on the patient is critical including medical 
history, current treatment regime and any test or other diagnostic results. For 
this reason alone, information systems are a fundamental foundation for 
healthcare systems (Aspalter, Pribadi, & Gauld, 2017). 
 
Healthcare systems around the world operate differently and face different 
challenges (Baldwin, 2011). The US healthcare system for instance, is 
fragmented and currently designed to support billing rather than care 
coordination and continuity (Gupta & Sharda, 2013). Part of this complexity in 
the US healthcare system is due to low efficiencies, poor technology interfaces, 
communication gaps, and high costs (Gupta & Sharda, 2013). Healthcare 
systems also differ between developing and developed countries. In developing 
countries, access to universal healthcare is deemed urgent while in developed 
countries, governments focus on increasing access to additional private 
healthcare coverage to supplement government-run universal coverage 
(Newswire, 2018).  
 
WHO (2018) explains that a “good health system delivers quality services to all 
people, when and where they need them. The exact configuration of services 
varies from country to country, but in all cases, it requires a robust financing 
mechanism; a well-trained and adequately paid workforce; reliable information 
on which to base decisions and policies; well-maintained facilities and logistics 
to deliver quality medicines and technology”. 
 
Ensuring life is the core goal of the health system as explained by Knickman, 
Kovner, and Jonas (2015). WHO (2018) describes a well-functioning health 
system as “A health system working in harmony is built on having trained and 
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motivated health workers, a well-maintained infrastructure, and a reliable 
supply of medicines and technologies, backed by adequate funding, strong 
health plans and evidence-based policies”. The healthcare systems comprise 
of multiple components that allow people access to health services and care. 
Healthcare systems are fragmented, disorganized and unaccountably variable 
as explained by Yih (2014). 
 
Healthcare systems are also experiencing a shift in the way care is delivered. 
New models such as Patient-centered and Patient Direct healthcare, are an 
example of a shift in healthcare system that moves from provider focused to 
more patient first model (Konschak, Nayyar, Morris, & Levin, 2013). The 
redesign of the care delivery towards patient centered model (PC) according to 
Verzillo, Fioro, and Gorli (2018, p. 3) is an “attempt to redesign the care delivery 
process by shaping the structures and processes involved in delivering hospital 
care according to the needs of the patients. In the traditional hospital models, 
patients are admitted under individual specialist clinicians, who keep them or 
transfer them to the care of another clinician.”.  
 
Table 2.1.2: Comparison of the differences between traditional and PC hospital. Adapted from 
(Verzillo et al., 2018). 
 Functional hospital 
configuration 
More recent 
innovations: 
converging patterns 
towards PC hospitals 
Organizational 
model/care delivery 
model 
Functional/divisional 
model 
Lean organization 
/process-oriented model 
Organizational unit: 
patients’ care needs and 
the relationship among 
specialties 
Specialty-based units. 
Practitioners (doctors and 
nurses) are grouped into 
semi-autonomous units 
depending on their 
specialty of belonging 
Multi-specialty units. Units 
are aggregated in 
accordance with patients’ 
clinical and assistential 
needs. Doctors might 
treat patients located in 
different units and nurses 
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might assist patients with 
different pathologies 
Model of care Functional nursing 
(nurses’ task-oriented job: 
each nurse is specialized 
in a single care activity) 
Modular nursing (nurses 
are responsible for 
the overall assistential 
practices required 
by small groups of 
patients within the 
ward) 
Use of resources Separated resources 
(beds, operating rooms, 
equipment, nursing staff, 
other staff) devoted to the 
individual specialties 
Resource pooling: 
resources are shared by 
all the functional 
specialties regrouped 
Managerial roles Head physicians in 
charge of their 
departments 
Bed manager/case 
manager (as 
distinguished by the 
clinical activity) for 
centralized operation 
management 
Physical environment Hospitals are built around 
fixed and focused spaces, 
with often isolated wings 
Newly built hospitals are 
designed to maximize 
resource pooling and 
patient grouping, flexibility 
and modularity of spaces 
 
Table 2.1.2 is a comparison of the differences between traditional and PC 
Hospital. Situations where providers talk to patients, than with them; blame 
patients when treatments fail; have little expectation or trust that patient will 
participate in their own care; and exhibit little patience with patients who 
question the provider’s approach, research their own conditions, or ask for more 
time or information (Konschak et al., 2013). 
 
The strategic imperative behind PC is based on patient centeredness with a 
focus on individual responsibility and the promotion of prevention and self-
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management of diseases (Moretta Tartaglione, Cavacece, Russo, & Cassia, 
2018). PC models engage patients in care-related decisions, being involved in 
and adhering to their plan of care, that enhances the level of satisfaction with 
care and improves outcomes (Sidani et al., 2018). The new PC models have 
been trialed and implemented in some instances. A study that focused on low 
back pain, conducted a pilot randomized controlled trial that combined primary 
care and chiropractic care to produce a patient-centered model, resulted in 
better perceived improvement and patient satisfaction (Goertz et al., 2017). 
Good health is closely linked to economic growth through higher labor 
productivity, demographic growth, and higher educational attainment 
(Ngwainmbi, 2014). 
 
While healthcare systems aim to maintain or restore the human body through 
treatments and other means of disease prevention (Griffin et al., 2016), yet 
there are a number of challenges that make delivery of healthcare difficult. The 
Australian healthcare system, like many other healthcare systems around the 
world, is under pressure as the demand for more health services increases as 
a result of aging population, rising number of chronic diseases and high 
consumer expectation (Carlisle, Fleming, & Berrigan, 2016). These issues 
create challenges in delivering healthcare services to people and for population 
at large.  
 
2.2 Challenges in Healthcare Delivery 
Healthcare systems are facing many challenges as a result of aging 
populations, chronic diseases, quality of care, patient safety and rising 
healthcare costs (Armstrong et al., 2007). 
 
Population aging is defined by (Rowland, 2012) as “an increase in the 
proportion of the population in older ages”. The aging population is currently 
progressing faster than previously predicted as the number of older population 
is bypassing the number of birth rates (Rowland, 2012), which results in 
changes in demography (Komp & Johansson, 2015). In Western Europe, 
fertility rate is low hence the aging population is increasing in Europe, compared 
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to developing countries (Bengtsson, 2010).  The increase in aging population 
is leading to elderly people requiring more care compared to the younger 
generation. An example of this is In the United Kingdom, where many of those 
admitted to the hospital in 2016 were aged 65 and over (Gabriel, 2017). The 
length of stay for patients between the age of 65-74 was 6.5 days, 8.3 for people 
between 75-84, and 10.1 days for individuals over the age of 85 (Gabriel, 2017). 
These numbers indicate the duration of care required for older people, which 
leads to adding pressure on healthcare systems to deliver more care and strain 
the funding of healthcare. Australia’s healthcare expenditure is expected to rise 
as a result of the aging population requiring more services and care (Duckett & 
Willcox, 2015).  
 
Aging does not only pose a financial threat to healthcare systems but is also 
changing and reforming policies. Superannuation in Australia has been 
redesigned over the last 20 years, with ongoing debate about retirement 
incomes policy, the establishment of a Commissioner on Age Discrimination 
and the ‘rights’ approach, and consumer-led directions in the Living Longer 
Living Better reforms of aged care, as Kendig, McDonald, and Piggott (2016) 
explain the reform.  
 
With aging comes the problem of people developing diseases as they get older 
(Kennedy et al., 2014), as chronic diseases are common amongst older 
persons where 65% of U.S. men and 72% of U.S. women above the age of 65 
had two or more chronic illnesses in 2010 (Gaugler, 2015). Caring for patients 
with chronic diseases and delivering care is an ongoing challenge (O'Loughlin, 
Mills, McDermott, & Harriss, 2017) as it results in expensive bills, long term-
care and may involve multiple medical specialties (Klein & Neumann, 2008).  In 
England, 15.4 million people live with a chronic condition, which consumes 50% 
of all the general practitioner appointments, 65% of all outpatient appointments, 
and over 70% of all inpatient bed days (Saxton, 2011). The average number of 
times a person sees a primary care provider is 2 and number of specialists is 5 
per year, compared to a patient with chronic diseases who is likely to see 16 
health professionals (Grossmann et al., 2011).  
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The human rights and health section from WHO (2018) state that Quality is a 
key component of Universal Health Coverage and includes the experience as 
well as the prescription of healthcare. Quality health services according to WHO 
(2018) should be: 
 
• Safe – avoiding injuries to people for whom the care is intended 
• Effective – providing evidence-based healthcare services to those who need 
them; 
• People-centred – providing care that responds to individual preferences, 
needs and values; 
• Timely – reducing waiting times and sometimes harmful delays. 
• Equitable – providing care that does not vary in quality on account of gender, 
ethnicity, geographic location, and socio-economic status; 
• Integrated – providing care that makes available the full range of health 
services throughout the life course; 
• Efficient – maximizing the benefit of available resources and avoiding waste 
 
However, medicine is a field that is practiced by humans and the risk of humans 
making an error is likely to occur (Kelsey, 2016). Patient safety according to 
Jara, Zamora, and Skarmeta (2014) “is one of the most important issues in 
worldwide healthcare”. Patient safety according to the WHO, is the 14th leading 
cause of global disease burden (WHO, 2018). It is estimated that out of the 421 
million annual hospitalisations worldwide, around 42.7 million bad outcomes are 
a result of poor care (WHO, 2018). Noncompliance is an example of how 
patients’ safety can be compromised and it occurs when a patient neglects to 
take the prescribed dosage at the recommended times or decides to stop the 
treatment without consulting their physician (Jara et al., 2014). A primary 
responsibility of healthcare providers, facilities and systems is to do no harm 
and do everything to ensure that the benefits of an intervention outweigh its 
risks and deleterious effects as explained by Organisation for Economic Co-
operation and Development (2018). Drug compliance, Adverse Drug Reaction, 
and the elimination of medical errors are important for improving patient care 
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(Jara et al., 2014). Harm in healthcare comes at a cost and it is one of the 
reasons for the increase in healthcare costs (Van Den Bos et al., 2011). 
 
The cost of healthcare delivery is rising and there are several factors 
contributing to this increase (Dyas, Lovell et al. 2018). The relationship between 
economic growth and health, have an effect on the economic and human 
growth, such that malaria and Human immunodeficiency virus/ acquired 
immune deficiency syndrome (HIV/AIDS) and other infectious diseases cause 
a slow growth in the economy and human development (Ngwainmbi, 2014). 
Patient safety for instance, costs around 42 billion annually, and this figure is 
without the inclusion of lost wages, productivity, or healthcare costs 
(WHO,2018). In 2014, the National Health Service (NHS) in England paid more 
than 1 billion in legal claims (Kelsey, 2016). The aging population is another 
variable that contributes to the increasing costs of healthcare as people grow 
older, they require more care that results in increased costs (Howdon & Rice, 
2018). Chronic diseases also account for a large portion of healthcare cost as 
they result in significant economic burden because of the combined effects of 
health-care costs and lost productivity from illness and death (AIHW, 2018). 
Estimates based on allocated health-care expenditure indicate that the 4 most 
expensive disease groups are chronic—cardiovascular diseases, oral health, 
mental disorders, and musculoskeletal—incurring direct health-care costs of 
$27 billion in 2008–09, which equates to 36% of all allocated health expenditure 
(AIHW). Patient hospitalisation, also contributes to the increasing costs of 
healthcare expenditure (Stey et al., 2015).  
 
With the aforementioned challenges of healthcare, issues such as accessibility 
and efficiency also create challenges in healthcare. According to Barjis, 
Kolfschoten, and Maritz (2013, p. 1) “efficiency is becoming a buzzword in 
discussion with both healthcare managers and decision makers. Behind the 
term there is enormous complexity; from healthcare processes management to 
decision making, policy, supporting technology, innovation, and socio-cultural 
and economic realities — all are interwoven and interrelated into the equation 
of efficiency”.  
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Access to healthcare is another challenge in healthcare systems for individuals 
wanting to obtain health services. In Australia, many people find it difficult to 
access health services for a variety of reasons (healthdirect, 2018). Groups that 
are affected by such access barrier are those with specific needs, such as those 
with complex and chronic health conditions who use health services frequently, 
those in regional and rural areas, and Aboriginal and Torres Strait Islander 
peoples (healthdirect, 2018).  
 
One factor is the availability of health services and health professionals. There 
are clear differences in access to services depending on where you live. 
According to AIHW, there are lower rates of doctor consultation and generally 
higher rates of hospital admission in regional and remote areas compared to 
major cities. 70% of callers to the Australian after-hours GP helpline service do 
not have access to a doctor after hours (evenings, weekends and public 
holidays) (healthdirect, 2018). The barriers to access healthcare (healthdirect, 
2018) are: 
 
• Geographic locations: Health call centres are an effective way for people to 
access healthcare information and advice, without time or geographic 
restrictions. Otherwise, they would have little option but to visit their nearest 
hospital, which could be hours away.  
• Language: To achieve the best health outcomes, people need to find a 
health provider they can communicate with and trust. There may be a lack 
of services and information available in languages other than English, or a 
lack of culturally appropriate services and information. 
 
Another example of accessibility issue in healthcare is oral healthcare. Access 
to oral healthcare is essential to promoting and maintaining overall health and 
well-being (Committee on Oral Health Access to et al., 2011). When individuals 
are able to access oral healthcare, they are more likely to receive basic 
preventive services and education on personal behaviours (Committee on Oral 
Health Access to et al., 2011). They are also more likely to have oral diseases 
detected in the earlier stages and obtain restorative care as needed (Committee 
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on Oral Health Access to et al., 2011). In contrast, lack of access to oral 
healthcare can result in delayed diagnosis, untreated oral diseases and 
conditions, compromised health status, and, occasionally, even death. 
Unfortunately, access to oral healthcare eludes many Americans.  
 
A significant proportion of the U.S. population is not adequately served by the 
current oral healthcare system, and millions of Americans have unmet oral 
healthcare. This is especially true for the nation’s vulnerable and underserved 
populations. Commonly studied populations include but are not limited to 
(Committee on Oral Health Access to et al., 2011) : 
• Racial and ethnic minorities, including immigrants and non– English 
speakers  
• Children, especially those who are very young  
• Pregnant women  
• People with special healthcare needs 
• Older adults; Individuals living in rural and urban underserved areas 
• Uninsured and publicly insured individuals  
• Homeless individuals  
• Populations of lower socioeconomic status 
 
For example, in 2009, 4.6 million children did not obtain needed dental care 
because their families stated that they could not afford it and people with 
disabilities are less likely to have seen a dentist in the past year than people 
without disabilities (Committee on Oral Health Access to et al., 2011). 
 
Limited access to healthcare impacts quality of life and can lead to poorer health 
outcomes (healthdirect, 2018). Charness, Demiris, and Krupinski (2011) 
explain that the increase in the aging population, coupled with chronic diseases, 
mean that there will be a great need for cost effective healthcare provisioning 
in many countries. A way of overcoming these challenges is via the use of 
technology that enables accessibility to healthcare, improves quality of care, 
can reduce costs and ensure patient safety. Well-designed technology and 
good decision making models can improve safety, efficiency and reduced costs 
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(Gupta & Sharda, 2013). The Internet of Things (IoT) is a technology that is 
enabling communications between devices, connect people with devices and 
services that can enhance and simplify daily lives and work.  
 
2.3 IoT 
Traditionally, modern Information and communication technologies (ICT) were 
adopted in healthcare systems for the purpose of promising solutions for 
efficiently delivering all kinds of medical healthcare services to patients, known 
as e-health, such as Electronic Health Records (EHR), telemedicine systems, 
and personalized devices for diagnosis (Qi et al., 2017). The use of  consumer 
health informatics technology (CHIT) for self-managing chronic diseases is 
expected to help healthcare consumers assume greater responsibility for 
managing their health; support the exchange of information among patients, 
caregivers, and healthcare providers; and facilitate the patient–provider 
partnership (LeRouge & Wickramasinghe, 2013). 
 
Today’s technology is far more advanced than what it was a century ago. 
Supercomputers, tiny sensors, mobile phones, wearable and implantable, and 
Internet of Things (IoT), are all providing solutions to numerous challenges in 
different industries, including healthcare. A technology that is enabling 
connectivity amongst devices is IoT. IoT as defined by Hussain (2017, p. 1) is 
“interconnection of things”, that is used to sense and report real world 
information. IoT allows for people and objects in the physical world as well as 
data and virtual environments to interact with each other (Verma & Sood, 2018).  
 
The development of IoT was proposed by Ashton and Brock of Massachusetts 
Institute of Technology (MIT) and later the term IoT was coined in 2005 by the 
ITU (Y. Yin, Zeng, Chen, & Fan, 2016). IoT has since seen a strong trend in 
adoption and solutions being developed using the technology. This great 
intersection of small devices and healthcare presents an opportunity for the 
technology to be introduced in healthcare and be used to break some of the 
challenges in healthcare. IoT is a field that combines systems that may include 
but not limited to embedded systems, electronics, wireless sensor networks, 
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communication networks, and computing paradigms (Baloch, Shaikh, & Unar, 
2018). IoT serves as an umbrella above these technologies, which diversifies 
its applications area. IoT applications include smart cities, smart homes/smart 
buildings, environment monitoring, smart business and product management, 
emergency response systems, intelligent transportation, security and 
surveillance, energy and industrial automation, and healthcare (Baloch et al., 
2018). 
 
IoT consists of four elements (Patil, 2017): 
1. Things: Any physical thing, such as line-of-business assets, including 
industry devices or sensors. 
2. Connectivity: Those things that have connectivity to the internet. 
3. Data: Those things that can collect and communicate information – this 
information may include data collected from the environment. 
4. Analytics: The analytics that come with the data produce insight and enable 
people or machines to take actions that drive business outcomes. 
 
The advances in IoT technology have resulted in the development of several 
IoT applications in different domains, including the healthcare domain. These 
advances in IoT technology are leading to the design of smart systems that 
support and improve healthcare and biomedical-related processes (Catarinucci 
et al., 2015). Automatic identification and tracking of people and biomedical 
devices in hospitals, correct drug–patient associations, real-time monitoring of 
patients’ physiological parameters for early detection of clinical deterioration are 
a few examples of the possible solutions that can be created using IoT 
(Catarinucci et al., 2015). Table 2.3.1 illustrates different examples of IoT in 
healthcare, the application of IoT, how the sensors work, and how information 
is collected as described by (Laplante & Laplante, 2016). 
Table 2.3.1: Applications for Healthcare in the IoT. Adapted from (Laplante & Laplante, 2016). 
Application Solutions using IoT 
Bulimia 
(Eating 
Disorder) 
Sensors can be used for people suffering from bulimia at both 
hospital and home. In a patient’s room (hospital settings), sensors 
can be used to detect increased body temperature or blood pressure, 
or even the odour of vomit. Outside of hospital, the sensors can be 
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used to detect exercise abuse such as excessive cardio training or 
accelerated walking activity as compared to walking at a normal pace. 
All the information collected from these sensors can provide valuable 
information in the diagnosis and management of the illness. 
Alzheimer’s 
Disease 
IoT sensors can be deployed for people suffering from Alzheimer’s 
disease. The IoT sensors can be used to track people’s geolocation 
to prevent them from wandering or prohibit unwanted mobility 
behaviours. Often, patients with Alzheimer’s suffer from comorbidities 
with other diseases, such as hypertension (high blood pressure), 
macular degeneration, or diabetes. Therefore, appropriate 
interconnected devices could capture data for monitoring the unique 
signs and symptoms of these conditions. 
Safety and 
Violence 
Safety and violence are real issues in healthcare today. There are 
numerous accounts of horizontal violence—for example, nurse 
against nurse—but also of violence from visitors or family toward 
healthcare providers or patients. Despite healthcare institutions 
equipped with video surveillance systems, IoT could be deployed as 
another measure of detecting violence and implement a zero-
tolerance policy. For example, tracking the movement of staff, 
patients, and visitors could provide warnings of aberrant or 
threatening behaviour. Biometric sensors could be used to detect 
signs of aggression or stress in people who are entering or reside in 
these settings. 
Monitoring 
inside the 
hospital 
IoT can also be used to track equipments inside the hospital. IoT can 
be used by staff to try to keep certain equipment, such as an IV pump 
or oxygen tanks, in their unit for future use. In a hospital, scarce 
shared equipment such as EKG machines, IV pumps, and patient-
controlled analgesia (PCA) medication pumps could be tracked via 
an IoT. In addition, the use of such equipment would be of interest to 
individual units and administration—as well as insurance companies, 
including Medicare—in documenting the need for additional 
equipment. An IoT could also be used to monitor equipment that 
needs to be refilled or calibrated, such as oxygen tanks, and to alert 
staff of such situations. 
Acute/Long 
term care 
IoT can be used for tracking supplies that can be scanned using low-
cost RFID or bar code tags for acute or long-term care setting, making 
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it easy to make charges to a patient’s account. Such supplies can 
also be tracked using an IoT as they are either checked out from a 
repository or administered to a patient. In some cases, where an 
RFID tag is used, an item could be located more quickly, for example. 
Likely trackable items include one-time use supplies, such as 
dressings, catheters of different types, and personal care items. In a 
home setting, medical supplies could be marked with RFID tags to 
monitor use and alert the home care team when an item is being 
overused or supply is too low. 
 
The rising cost of healthcare and the number of diseases worldwide are 
transforming the delivery of healthcare from a hospital-centric system to a 
person-centric environment (Verma & Sood, 2018). IoT technology provides a 
number of personalized solutions that make person-centric healthcare delivery 
possible.  
 
IoT technology has the potential of creating many medical applications that 
range from remote health monitoring, fitness programs, chronic diseases, and 
elderly care (Islam, Kwak, Kabir, Hossain, & Kwak, 2015), help patient monitor 
their chronic conditions, recover from injuries or in designing Ambient Assisted 
Living (AAL) (Mora, Gil, Azorín, Terol, & Szymanski, 2017). Another area of 
healthcare that IoT can potentially address, is compliance with treatment and 
medication at home and by healthcare providers (Islam et al., 2015), including 
adhering to treatments and medications. Proteus Digital Health, is developing 
a pill-size ingestible sensor, that can detect when and how often patients take 
their pills (Minteer, 2017). For chronic diseases, an application was designed 
for real-time non-invasive glucose level measurements in Diabetes patients 
(Istepanian, Hu, Philip, & Sungoor, 2011). 
 
IoT can also capture physiological signs that relate to the human body. Wireless 
Body Area Networks (WBAN) allow for the collection and transmission of vital 
signs data (such as temperature, blood pressure etc) to enable preventative 
care and monitor ones’ well-being (Watts, 2016). Other capabilities of WBAN 
include hear pulse, respiration, pulse oximeter (SpO2), electroencephalogram, 
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electrocardiography (ECG, electromyography, motion detection, cochlear 
implant, artificial retina, audio and video) (Adibi, 2012).  Another instance of IoT 
in Healthcare is an IoT solution for examining human vision for proactive 
tackling of vision impairment (Jebadurai & Dinesh Peter, 2018).  
 
Various medical devices, sensors, and diagnostic and imaging devices can be 
viewed as smart devices or objects constituting a core part of the IoT (Islam et 
al., 2015). The IoT technology also enables interconnection, where for instance, 
in healthcare, it can connect health-monitoring devices with emergency 
notification systems in real time (Rossman, 2016). With IoT, doctors can play 
an active role in their patient’s care by monitoring their health status after being 
discharged from the hospital (Rossman, 2016). People are realizing the 
importance of healthcare and they seek to obtain medical services 
conveniently, making smart healthcare one of the applications of IoT in 
healthcare (Wei Li, Cheolwoo Jung, & Jongtae Park, 2018). Lack of timely and 
adequate medical information and problems in the management of the care-
giving process are challenges to the effective and efficient implementation of 
healthcare services (Kim & Kim, 2018). The features of IoT such as the 
seamless connection of sensors and devices can overcome these challenges 
by improving information delivery and the care-giving process in healthcare 
services (Kim & Kim, 2018). 
 
Table 2.3.2 : IoT Applications. Adapted from (Farahani et al., 2018). 
Application Benefits 
mHealth Anywhere, anytime access to healthcare 
for patients. Doctors can manage and 
guide patients when needed 
IoT in ambient assisted living Real time monitoring of patients with 
chronic diseases and other diseases. 
IoT medication Help in detecting adherence to 
medication and prevent Adverse Drugs 
Reaction. 
IoT for individuals with disabilities and 
special needs 
People with disabilities can access 
services to assist and enhance their life. 
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IoT for smart medical implants Monitor implantable sensors that can 
enhance one’s health and treat 
diseases. 
IoT-based Early Warning Score (EWS) Detect and forecast early signs of 
deterioration. 
IoT-based anomaly detection Detect early signs of anomalies for faster 
treatment. 
 
Table 2.3.2 lists the multiple applications of IoT in healthcare and the benefits 
the technology brings to people, healthcare professionals, and the healthcare 
domain itself.  
 
IoT technology is successful partly due to the Cloud technology that enables 
people to connect, securely, and manage IoT devices, while also generating 
insights from data analytics (Patil, 2017). Big Cloud Computing companies like 
Amazon (2018), IBM (2018) and Microsoft (2018), all provide IoT services and 
solutions for different industries using their cloud offering. Another factor that 
made IoT gain popularity is the decrease in the cost of sensors, bandwidth, the 
spread of cellular coverage, and the rise of cloud computing that easily 
connects devices over the internet (Minteer, 2017). A variety of small 
embedded electronic devices in IoT collect and exchange data over the internet 
(Wei Li et al., 2018). The IoT market is expanding, such that in Healthcare, IoT 
delivering medical devices, systems, software, and services are expected to 
grow to a market size of $300 billion by 2022 (Firouzi et al., 2018). 
 
Issues such as aging population mean finding economically viable solutions 
that deliver high quality patient centred healthcare services (Qi et al., 2017). IoT 
does not only benefit the patients but can potentially assist in easing pressure 
off the healthcare systems. IoT enabled technology is changing healthcare from 
a conventional hub-based system to a more personalized healthcare system 
(Qi et al., 2017). Applications such as remote health monitoring can reduce 
costs of healthcare by monitoring non-critical patients at home rather than at 
hospital, which reduces the pressure on hospital resources such as doctors and 
beds (Baker, Xiang, & Atkinson, 2017). Qi (et al., 2017., ) elaborates that 
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“Successful utilisation of IoT enabled technology in PHS will enable faster and 
safer preventive care, lower overall cost, improved patient-centred practice and 
enhanced sustainability. Future IoT enabled PHS will be realised by providing 
highly customised access to rich medical information and efficient clinical 
decision making to each individual with unobtrusive and successive sensing 
and monitoring. (Qi et al., 2017)”. 
 
Reduction in healthcare costs due to IoT is of 2 types. The first is achieved due 
to the technological fusion and there is no need to pay separately for the use of 
a particular technology (Farahani et al., 2018). Second, patients can monitor 
their health status which makes them consult doctors when it is only below the 
recommendation (Farahani et al., 2018). From the perspective of healthcare 
providers, the IoT has the potential to reduce device downtime through remote 
provision. In addition, the IoT can correctly identify optimum times for 
replenishing supplies for various devices for their smooth and continuous 
operation. Furthermore, IoT provides for the efficient scheduling of limited 
resources by ensuring their best use and service of more patients (Islam et al., 
2015).  
 
IoT presents an opportunity to drive change in behaviours that can lead to 
healthier lifestyles by connecting pedometers and scales with other tracking 
devices (Hoffer, 2016). With the simplicity and versatility IoT provides, and the 
technologies involved in tackling diseases, mHealth is another technology that 
is readily available using mobile phones that make creating healthcare solutions 
possible. Telemedicine is the utilization of medical information transferred 
remotely via digital communication to improve or promote the health of patients 
and is progressively becoming common practice of medicine in many areas of 
the world. The usual model of care for people with cardiovascular diseases 
includes regular visits to the doctor and emergency services, involving high 
healthcare costs. However, new methods to deliver healthcare using mobile 
digital communication devices, mobile health (mHealth), may increase the 
number of patients treated while facilitating patient self-management and 
saving costs (Supervía & López-Jimenez, 2018). 
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2.4 mHealth 
Mobile technology has changed and will continue to change the life of millions 
of people around the globe (Jusoh, 2017). Mobile networks were implemented 
as early as 1956 in France, where mobile telephone network devices were 
carried in the boot of a car (Le Bodic, 2005). Since then, Mobile technology has 
come a long way and the technology has evolved from big bulky devices to 
mobile devices, devices that are not physically plugged into a socket or a link 
(Jusoh, 2017). The term mobile envisages a number of devices like 
smartphones, laptops, tablets, e-book readers, and cameras (Jusoh, 2017). 
The most powerful and attractive one is smartphones. It incorporates all 
aspects of computing application and wireless communications (Jusoh, 2017). 
 
A number of different emerging and interrelated mobile communication systems 
have been adopted and adapted for delivering mHealth, including the 
increasing use of (Kreps, 2017): 
• Audio and Video Enabled Telemedicine Applications: These applications 
include closed circuit telephone and/or televised conferencing systems, with 
both data collection tools (often collecting images, or measuring body 
temperature, heart rate, and brain activity for diagnostic and monitoring 
purposes) and delivery tools (that can remotely control surgical equipment, 
and provide treatment instructions) which can be set up in different sites to 
provide mediated (virtual) care to patients who may not have easy access to 
healthcare delivery systems. 
• Telephonic and Internet-based Message Systems: These systems can 
provide individuals with health information via SMS text messages, phone 
calls, or e-mail via mobile phones. 
• Websites and Web-based Portals (intranets): Web portals are available to 
healthcare consumers via portable lap-top computers, tablets, and smart 
phones. 
• Wearable (sometimes implantable) devices: These include devices such as 
fitness tracking wristbands and other digital monitoring devices. 
• Specialized Application Software Programs (apps): Apps are typically 
downloaded onto smart phones, tablets, or laptop computers that provide 
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health information and support, and are often linked to Internet delivered 
resources and services. 
 
Technologies such as mobile and web applications, are becoming an 
alternative for people wanting to self-manage their health, generate health data 
and gain social support (Arslan, 2016). Benefits of consumer online health-
information seeking (Henriquez-Camacho, Losa, Miranda, & Cheyne, 2014) 
are: 
• Widespread access to health information in remote areas and vulnerable 
populations. 
• Equity in access to health information. 
• Interactivity with the web contents, in the world of web 2.0 and social 
media. Interactivity facilitates interpersonal interaction. 
• Tailoring information: interactive health communication offers the potential 
for more personalized service and users can select sites, links and specific 
messages based on knowledge, educational or language level, need, and 
preferences. 
 
The evolution of mobile technology has had an impact on peoples’ lives and the 
way we interact with the technology and the people around us (Goggin, 2008). 
The technology has allowed people to interact with anyone, anywhere, and at 
any time while being reachable (Klemettinen, 2007). This level of interaction 
has changed how people stay informed, agreeing on how to do things by 
scheduling things, adapting to changes, and maintaining a general feel of each 
other’s’ situation (Klemettinen, 2007). Mobile phones have transformed 
industries like banking, airlines, transportation, and shopping, by changing the 
level of business and customer interaction, and making it mobile living 
(Konschak et al., 2013). 
 
Today’s smartphones are a lot more personalized as they store and exchange 
personal information, and are more customizable, fitting users’ needs (Boulos, 
Brewer, Karimkhani, Buller, & Dellavalle, 2014). The portability and versatility 
of mobile phone devices has allowed it to be part of solving different healthcare 
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challenges in different parts of the world due to low costs, and availability of 
mobile devices. The treatment of chronic obstructive pulmonary disease 
(COPD) at home, is an example where hospital at home schemes have reduced 
the costs of healthcare while maintaining similar effectiveness of care at 
hospital and patient safety (Bitsaki et al., 2017).  
 
Mobile technology creates connections between people, information, and 
places that allow for designing of health services that link and enable 
collaboration among different actors of the healthcare system (Arslan, 2016). 
mHealth and the technology known as mhealth technology are extending the 
healthcare services beyond physical wardens and doctors. These technologies 
are breaking a number of barriers, such as physical barriers (Taylor, 2013), by 
extending the services beyond physical places and through remote services 
using the technology. Table 2.4.1 illustrates different examples of mHealth for 
both clinical and nonclinical applications. 
 
Table 2.4.1: Applications of mHealth. Adapted from (Mirza, Norris, & Stockdale, 2008). 
Clinical 
mHealth 
Applications 
Web access to evidence-based databases  
Medication alerts using mobile phones  
E-prescribing for repeat prescriptions via mobile phones 
Telemonitoring to transmit patient results to clinicians Transmission 
of test results to patients via SMS messages Online electronic health 
records via computer or phone Community nursing contact with 
clinical expert advice  
Public health and lifestyle messages over mobile phones  
Care of at-risk people, e.g. airline pilots, military personnel 
Emergency care for accidents, natural disasters 
Non-clinical 
mHealth 
Applications 
Efficient workflow via wireless communication  
Rapid collection/sharing of current data via mobile phones Optimal 
asset utilization, e.g. hospital bed rostering  
Patient or asset (e.g. clinical equipment) location using RFID Patient 
appointment booking and alerts via wireless e-mail Mobile phone 
support for patients and carers  
Safety of staff checks with RFID or mobile phones/networks 
pg. 42 
 
These technologies have opened the door for new opportunities for people to 
use. Chiarini, Ray, Akter, Masella, and Ganz (2013) systematic review of 
literature, have identified 4 different solutions that use mHealth systems. Self-
healthcare management, Assisted healthcare, Supervised healthcare, and 
continuous monitoring (Chiarini et al., 2013). These solutions are being 
delivered via mHealth using the capabilities available on the mobile phone 
devices. O'Shea, McGavigan, Clark, Chew, and Ganesan (2017) have 
categorized mHealth as follows:  
 
• Video Conferencing 
• Text Messaging 
• Applications 
• Remote Device Monitoring 
 
In Australia, several solutions are available for people wanting to access 
healthcare services. An example of a telemedicine in Australia are digital health 
services that are becoming more widely available and in many cases are 
increasing people’s access to health information (healthdirect, 2018). For 
example, the Pregnancy, Birth and Baby service provides video call access to 
maternal child health nurses, thus allowing parents to have care delivered to 
them without having to leave their home (healthdirect, 2018). In a report 
published by PwC (2018), patients expect mHealth to change their healthcare 
experience (See Figure 2.4.1). These expectations can result in not only more 
health services, but also a reduction in costs. 
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Figure 2.4.1: Source PwC Report, based on data from Economist Intelligence Unit 2012 
Patients expect mhealth application/services to be more convenient for them, 
improve the quality of care they receive, and reduce costs associated with 
healthcare (costs such as travel to and from the clinic) (PwC, 2018).  
 
The benefits mhealth brings to healthcare include (Gleason, 2015): 
• Low cost of equipment 
• Patient familiarity with the devices 
• Generic interfaces that can be customized for handicapped persons 
• Seamless data upload with accurate timestamps and GPS markers built-in 
• Existing security systems 
• Use of individual equipment identifiers such as the MAC address 
• Facilitates record keeping for personalized healthcare 
• Automatic user feedback 
 
According to the systematic review by Coorey et al.,4 several risk factors and 
lifestyle habits might be modifiable with the utilization of mobile apps, like high 
blood pressure, obesity, smoking, dyslipidaemia, and sedentarism, with 
improvement of medication adherence, quality of life and psychosocial well-
being (Supervía & López-Jimenez, 2018). 
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In India, a survey on the use of mHealth for the prevention of CVDs in the Kerala 
district has shown that out of 262 participants involved in the survey (Feinberg 
et al., 2017): 
• 92% of respondents were willing to receive mHealth advice 
• 94% favored mobile medication reminders 
• 70.3% and 73% preferred voice calls over short messaging services (SMS) 
for delivering health information and medication reminders, respectively 
• 85.9% would send home recorded information on their blood pressure, 
weight, medication use and lifestyle to a doctor or to an accredited social 
health activities (AHSA) 
• 75.2% trusted the confidentiality of mHealth data, while 77.1% had no 
concerns about the privacy of their information. 
 
Among the younger generation, mHealth has been perceived as supporting 
young people's self-management for a range of NCDs including asthma, 
diabetes, and cancer (Slater, Campbell, Stinson, Burley, & Briggs, 2017). The 
self-management is the result of functionalities offered by mHealth technologies 
that assist young people in managing their conditions in a number of different 
ways, including (Slater et al., 2017): 
• Monitoring their health status and symptom triggers via graphical charting 
and sign or symptom awareness using self-checks 
• Improving their comprehension and understanding of their health condition 
• Providing reminders about medication adherence 
• Providing ready access to automated tailoring of personal health information 
related to the management of their condition(s)  
• providing relevant information, support, and reassurance about planning for 
emergencies and safety issues through prompting timely communication 
with health professionals 
 
Mobile health applications (also knowns as Apps), are becoming more apparent 
on Application stores such as Google Play and Apple Store. The range of 
applications vary from Apps for medical providers, specialty or disease-specific 
apps, medical education and teaching, Apps for patients and the general public 
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(including health and fitness apps), Text messaging, Telemedicine and 
telehealthcare, and smartphone attachments (Boulos et al., 2014). Their 
potential means better access to healthcare and more resources for the 
management of different diseases. 
 
2.5 Rise of mHealth 
The advances in smartphones have made the provisioning of health services 
using mobile devices a reality (Adibi, 2013). mHealth, also known as medical 
and public health practice supported by mobile devices, such as mobile phone, 
patient monitoring devices, personal digital assistants and other wireless 
devices (Chow, Ariyarathna, Islam, Thiagalingam, & Redfern, 2016). In a report 
published by PwC, mHealth being a disruptive technology is attracting early 
adopters who are ill-served by the existing provision or not served at all (PwC, 
2018). The two types of patients attracted to such adoption are those with poorly 
managed chronic diseases and those who pay more than 30% of their 
household income towards healthcare (PwC, 2018). The potential of mobile 
phones being used as health devices extends to countries, specifically those 
with low-resource settings of low- and middle-income countries where 
healthcare infrastructure and services are often insufficient (Chib, van 
Velthoven, & Car, 2015).The rise of mHealth is led by existing factors such as 
the adoption of mHealth for the aging population, accessibility to health services 
self-management, using it for interventions, adherence, health promotion, 
seeking information online, and mhealth Apps. These factors are illustrated 
below in greater depth. 
2.5.1 Aging Population: 
The number of aging population is increasing, as WHO (2018) predicts that the 
number of people aged 65 or over will be 1.5 billion by 2050,  an increase of 
8% from 524 million in 2010. An example of this already happening is China as 
the country is facing a major challenge caused by the increasing number of the 
aging population (Sun, Guo, Wang, & Zeng, 2016). China’s aging population is 
estimated to increase at a rate of 5.96 million per year from 2001 to 2020 and 
then 6.2 million per year from 2021 to 2050, and is expected to exceed 400 
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million by 2050, accounting for 30% of its total population (Sun et al., 2016). 
One way for mHealth to be used for the aging population is:  
• Electronic health records 
• e-Prescribing 
• Telemedicine 
• Consumer health informatics 
• Health knowledge management 
• mHealth 
• Healthcare information systems 
• Social media 
 
Mobile technologies such as phones and wireless monitoring devices are 
increasingly being used in healthcare and public health practice for 
communication, data collection, patient monitoring, and education, and to 
facilitate adherence to chronic disease management (Hamine, Gerth-Guyette, 
Faulx, Green, & Ginsburg, 2015). mHealth devices can be used in healthcare 
to improve service delivery and impact patient outcomes (Hamine et al., 2015). 
The Sensors and context-awareness features allow for individualization and 
real-time information submission delivery (Hamine et al., 2015). mHealth is 
appropriate for the delivery of healthcare services due to the strong attachment 
people have to mobile phones as they tend to carry them everywhere, which 
opens up opportunities for continuous symptom monitoring and connecting 
patients with providers outside of healthcare facilities (Hamine et al., 2015). A 
technology also delivering such solutions outside of healthcare facilities is 
telemedicine. Telemedicine is the utilization of medical information transferred 
remotely via digital communication to improve or promote the health of patients 
and is progressively becoming common practice in medicine in many areas of 
the world (Supervía & López-Jimenez, 2018). This technology is changing the 
way patients interact with doctors. For instance, the usual model of care for 
people with cardiovascular diseases includes regular visits to the doctor and 
emergency services, which ends up involving high healthcare costs. 
technologies such as telemedicine and mHealth, may be able to increase the 
number of patients treated while facilitating patient self-management and 
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saving costs, thus attending to more elderly patients (Supervía & López-
Jimenez, 2018). 
 
2.5.2 Accessibility: 
WHO (2018) states that “Understanding health as a human right creates a legal 
obligation on states to ensure access to timely, acceptable, and affordable 
healthcare of appropriate quality as well as to providing for the underlying 
determinants of health, such as safe and potable water, sanitation, food, 
housing, health-related information and education, and gender equality”. The 
mobility of healthcare services has increased reachability, accessibility and has 
the ability to reach more individuals, especially in rural areas (Sezgin, Özkan-
Yildirim, & Yildirim, 2018). The developments of new technologies and web 
applications are allowing medical doctors to practice medicine over long 
distances and patients have faster access to healthcare services (Bert, 
Giacometti, Gualano, & Siliquini, 2013). Technologies like telemedicine and 
mHealth are growing and their practical applications can potentiality offer 
healthcare services in terms of accessibility of service, cost saving, efficiency, 
quality and continuity of care and in clinical practice (Bert et al., 2013). The use 
of mHealth in the healthcare domain has made some unique and important 
contributions to the delivery of care and the promotion of health as mHealth 
applications are used as supplements to traditional channels of health 
communication, according to (Kreps, 2017). For example, in the context of 
access to healthcare services, mHealth applications have resulted in a timely 
delivery of healthcare services and the ability to provide relevant health 
information to key audiences wherever they may be via their mobile phones 
that they carry with them (Kreps, 2017). 
 
2.5.3 Self-management: 
Results from a recent poll in the US showed that the majority of US adults owns 
a smartphone, and the interest in mHealth technologies was also reported 
amongst the adults, who were keen to adopt mobile fitness technologies 
(Dugas et al., 2018). The advantages offered by mHealth technologies are such 
that they can be used as interventions due to their widespread accessibility, 
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cost-effective delivery, and flexibility to content tailoring (Dugas et al., 2018). 
The benefits of mHealth provision, have resulted in an increase in the use of 
mHealth as a self-management tool for chronic diseases (Dugas et al., 2018). 
For instance, CVD diseases result in deaths and disabilities worldwide, with the 
number of deaths resulting from CVD expected to reach 22.2 million by 2030 
(Baek et al., 2018). 80% of what causes CVD diseases are related to smoking, 
drinking, and other unhealthy lifestyle (Baek et al., 2018). To prevent and 
reduce these risk factors amongst CVD, mHealth can be used as a self-
managing tool to prevent and manage such chronic diseases (Baek et al., 
2018). 
 
2.5.4 Intervention: 
Mobile devices offer unique opportunities for health promotion professionals to 
design tailored interventions that make use of innovative technology to reach 
populations according to White, Burns, Giglia, and Scott (2016). With the built-
in sensors inside smartphones, physical activity interventions can be delivered 
using the built-in pedometers and accelerometers to accurately record exercise 
and movement, while nutrition interventions can be delivered using food diaries 
and can benefit from non-textual data entry, including the use of photos (White 
et al., 2016). Other mHealth apps incorporate strategies such as gamification, 
social connectivity and push notifications to reach people as they go about their 
daily lives (White et al., 2016). The most common mobile health (mHealth) 
approach is a variety of daily and weekly one- or two-way SMS (Short Message 
Service) communication interventions that encourage patients to take their 
medication (Bardosh, Murray, Khaemba, Smillie, & Lester, 2017). The use of 
SMS for interventions offers the opportunity for dissemination of automated, 
timely, and target-specific messages, which can be designed to complement or 
mirror in-person counselling (Bardosh et al., 2017). For example, messages 
offer the opportunity to provide tailored advice, behaviour tracking, goal setting, 
encouragement, or personal feedback in different stages of behaviour change 
(Bardosh et al., 2017).  
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2.5.5 Adherence: 
Levensky and O’Donohue (2006, p. 3) state that “advancements in healthcare 
have yielded numerous effective medical and behavioural health treatments 
which, if administered correctly, can help patients live healthier, happier, and 
longer. However, all too often the benefits of these treatments are not fully 
realized because of patient nonadherence”. The management of chronic 
diseases usually require long term care plan, and adherence to chronic disease 
management is critical for achieving improved health outcomes, quality of life, 
and cost-effective healthcare (Hamine et al., 2015). Poor adherence is a 
complex problem that can be divided into intentional (consciously deciding) and 
unintentional (forgetting or not being able to use medicines) non-adherence 
behaviours (Nousias et al., 2018). People seeking medical care are expected 
to change their behaviour (ie: coming to appointments, picking up medications, 
agreeing to have assessments and procedures performed) and change in 
behaviour in regard to medications (ie: following demanding and complex 
medication regimens; making dietary, activity or other lifestyle changes; 
enduring sometimes aversive behavioural interventions such as self-monitoring 
or exposure) (Levensky & O'Donohue, 2006). However, adherence can be 
achieved using mHealth. Asthma and COPD are chronic inflammatory 
conditions of the airways affecting over 235 million people worldwide with more 
than 30 million living in Europe (Nousias et al., 2018). Inflammatory lung 
diseases significantly deteriorate the quality of life for patients and their families 
while affecting the overall efficiency of the healthcare system (Nousias et al., 
2018). The adherence of patients to their medication, both in terms of following 
the doctor prescription and using the inhaler device correctly, is one of the most 
important factors for the effective management of their condition (Nousias et 
al., 2018). To assist with the issue of adherence in such disease, a mHealth 
system was designed for monitoring medication adherence for obstructive 
respiratory diseases that included audio recording of exhalation, inhalation drug 
usage, and ambient sound events (Nousias et al., 2018). Several emerging 
behaviour theories suggest that SMS- or email-based interventions can provide 
timely health messages that can match the level of an individual's motivation 
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and his or her ability to act, and therefore facilitate behaviour change (Bardosh 
et al., 2017).  
 
2.5.6 Health promotion: 
Lupton (2012) explains “the use of mhealth in health promotion extends the 
temporal nature of health surveillance and allows for further refinements of the 
categorising and identifying of ‘risk factors’ and ‘at-risk groups’ that are then 
deemed eligible for targeting”. This may be achieved by using the health-related 
data that is easily and frequently collected from users’ mobile devices each time 
they log on to the relevant app, which becomes a way of monitoring and 
measuring individuals’ health-related habits (Lupton, 2012). Promoting health 
programs using technologies such as SMS- or email-based have several 
advantages over traditional mass media for health promotion and disease 
prevention, as they provide opportunities for interactive 2-way communication 
and target specific, tailored behaviour change communication (Yepes, Maurer, 
Viswanathan, Gedeon, & Bovet, 2016).  
 
2.5.7 Seeking health information online: 
Mobile technologies such as phones and wireless monitoring devices are 
increasingly being used in healthcare and public health practice for 
communication, data collection, patient monitoring, and education, and to 
facilitate adherence to chronic disease management (Hamine et al., 2015). 
mHealth devices can improve service delivery and impact patient outcomes. 
Sensors and context-awareness features allow for individualization and real-
time information submission delivery. Moreover, the strong attachment people 
have to mobile phones and the tendency to carry them everywhere, opens up 
opportunities for continuous symptom monitoring and connecting patients with 
providers outside of healthcare facilities (Hamine et al., 2015). 
 
2.5.8 mHealth Applications (Apps): 
The capabilities of smartphones, tablets and other devices have created an 
opportunity for a growth in the number of mHealth apps to be developed and 
deployed (Wildenbos, Peute, & Jaspers, 2018). In April 2015, according to the 
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American Heart Association, there were 12,991 apps on iTunes and 1420 apps 
on Google Play about weight management, exercise, smoking cessation, 
diabetes control, blood pressure management, cholesterol management, and 
medication management through mHealth for CVD prevention (Baek et al., 
2018). Nowadays, it is estimated there are 259,000 mHealth apps in the major 
app stores from 2016 onwards, which boost innovative mHealth apps to be 
used for assisting patients in self-management of diseases and independent 
living (Baek et al., 2018). This is particularly important for the older adult patient 
population, as risks for functional decline and loss of independence increase 
with normal aging and accumulation of chronic diseases, approximately from 
the age of 50 onwards (Wildenbos et al., 2018). mHealth apps may offer 
medication assistance by prompting alerts, provide self-care advice to patients, 
facilitate self-monitoring of various biometrics or educate patients on disease 
outcomes (Wildenbos et al., 2018). These mHealth advances align well with the 
upcoming interest of older adults to integrate technologies into their own 
healthcare (Wildenbos et al., 2018).  
 
These opportunities provided by mHealth technologies, are a gateway for using 
mHealth for chronic diseases. However, Chronic diseases do come with their 
own challenges and have success factors where mHealth can be introduced as 
a solution to help patients with chronic diseases.  
 
2.6 Chronic diseases, challenges and success factors 
Chronic diseases have a long painful and suffering period that causes disability 
and deaths (Morewitz, 2006). Chronic diseases present enormous challenges 
to many patients, their families, many providers, and to the healthcare systems 
(Nuovo & Nuovo, 2007). The challenges are due to a number of factors 
associated with chronic diseases such as smoking, overweight, obesity, poor 
nutrition, sedentary lifestyles, and genetics (Morewitz, 2006). Other factors that 
contribute to chronic diseases are race, ethnicity, gender, age, and 
socioeconomic inequality (Morewitz, 2006).  
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According to AIHW (2018), “in 2003, smoking was considered to be responsible 
for the greatest disease burden in Australia (7.8% of total burden)”. Chronic 
diseases are common amongst Australians as 77% of Australians reported 
having one or more long-term health problems with people aged 65 and over 
having five or more conditions (Harris & Zwar, 2007). In Europe, chronic 
diseases are also a leading cause of deaths as it accounts for 2/3 of all deaths 
and consume about 75% of the healthcare costs (Brunner-La Rocca et al., 
2016). In low and middle-income countries, chronic diseases are also leading 
to deaths as 80% of deaths are a result of cardiovascular disease and diabetes 
mellitus while 90% of deaths attributable to chronic obstructive pulmonary 
disease (Beratarrechea et al., 2014).  It is estimated that by 2030, 23 million 
people will die annually from cardiovascular disease, with the majority of people 
(representing 85% of the total figure) residing in low to middle-income countries 
(Beratarrechea et al., 2014).  Table 2.6.1 lists the different factors associated 
with a chronic disease and their definitions. The risk factors include both 
behavioural and biomedical health determinants. Some of the NCDs are 
preventable and they tend to share the same risk factors (Adeyi, Smith, & 
Robles, 2007). 
Table 2.6.1: Definition of Risk Factors according to AIHW, 2018 
Risk Factor Definition 
Daily smoking The smoking of tobacco products on 
daily basis 
Risky/high risk alcohol consumption: An average daily consumption of more 
than 50 mLs for males and more than 25 
mLs for females 
Physical inactivity Not achieving the recommended 
amounts of physical activity of 150 
minutes per week over at least five days 
Insufficient amounts of fruit Usual consumption of two serves of fruit 
per day (few than three servers for those 
aged 15-17) 
Insufficient amounts of vegetables Usual consumption of fewer than five 
servers of vegetables per day (few than 
four servers for those aged 15-17) 
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Fat intake Defined as the usual consumption of 
whole milk 
Obese Defined as having a body mass index 
(BMI) of 30 or more 
Large waist circumference A measure of, or greater, than 94 
centimetres for men and 80 centimetres 
for women 
High waist-hip ratio A measure of 1.0 or more for men, and 
0.85 or more for women 
High blood pressure Based on respondent’s self-reports of 
having high blood pressure as a current 
and long-term conditions, or currently 
taking medication for high blood 
pressure 
 
 
 
Figure 2.6.1: Number of deaths by risk factors (Source: Our ln World In Data, 2018). 
 
These risk factors are associated with the number of deaths worldwide, which 
saw an increase. Some of these risk factors are developed at an early stage of 
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life (gestation), with some becoming chronic in nature, that results in people 
needing more care over a long period of time (Adeyi et al., 2007). The growing 
number of the older population, along with health inequalities and poor health 
behaviours, mean that the issue of chronic diseases is becoming more 
apparent and an escalating problem (Saxton, 2011). The trend in the rising 
number of chronic diseases is due to aging, a decline in communicable 
diseases and conditions related to childbirth and nutrition, including changing 
lifestyles that relate to smoking, drinking, diet and exercise (Adeyi et al., 2007). 
Table 2.6.2 lists some of the barriers, current initiatives and possible 
enhancements to general practice care for people with chronic disease. 
Table 2.6.2: Some barriers, current initiatives and possible enhancements to general practice 
care for people with chronic disease. Adapted from (Harris & Zwar, 2007). 
Barriers and problems Current Initiatives Possible enhancements 
Lack of effective 
multidisciplinary 
team care in general 
practice 
• Practice nurse 
involvement in 
chronic disease 
management 
• Team care 
arrangements with 
allied health providers 
• Access to allied 
health through 
Medicare or More 
Allied Health Services 
programs in rural 
divisions 
• Systems to support 
better communication 
between general 
practice and allied 
health  
• Infrastructure funding 
to provide space and 
equipment or other 
health professionals 
within general 
practice 
Patient understanding of 
self-management and 
adherence to 
management plan 
• Sharing Health Care 
Initiative 
• More available local 
self-management 
programs 
• Involvement of 
practice staff in 
delivering self-
management 
education 
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•  Better feedback from 
self-management 
programs to general 
practitioners 
Care that does not meet 
evidence-based 
guidelines 
• Guidelines 
disseminated by = 
National Health and 
Medical Research 
Council., Royal 
Australian College of 
General Practitioners, 
Diabetes Australia, 
National Heart 
Foundation 
• Better integration of 
guidelines into 
structure of practice 
information systems 
Inability of most clinical 
information systems to 
provide effective clinical 
audit of quality of care 
• Templates for Care 
Plans 
• Support for disease 
registers through 
Practice Incentives 
Program. 
•  Division and National 
Primary Care 
Collaboratives 
collaborative 
programs 
• Greater capacity for 
audit incorporated 
into practice systems 
 
People who suffer from a chronic disease need to adjust to the requirements of 
the illness, and adhere to the treatments (Morewitz, 2006). A number of 
strategies exist for managing chronic diseases, and prevention is one of the 
methods of reducing cases of chronic diseases (Estrin & Sim, 2010). Smoking 
is one of the contributing factors of chronic diseases. Reduction in tobacco 
smoking rates has reduced the number of males dying from lung cancers 
(AIHW, 2018). Similarly, the screening for cervical cancers has reduced the 
number of deaths that were caused by cancer (AIHW, 2018).  
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“Doctors alone cannot solve chronic diseases, but have to work with patients to 
manage chronic diseases together so that the disease does not lead to painful 
complications like amputations or blindness” as stated by Stuckler and Siegle 
(2011, p.  124). A chronic disease care model for preventing chronic diseases 
and working with patients, is one that focuses on (Stuckler & Siegel, 2011): 
1. Continuity of care 
2. Preventing unnecessary hospitalisation 
3. Coordinating and integrating care services 
4. Empowering patients to know about and manage their conditions 
5. Joint decision-making between doctors and patients 
 
A number of methods exist for managing chronic diseases and preventing 
incidents of chronic diseases such education, prevention, and support. Chronic 
diseases can be treated and managed in different ways. An example of this is 
diabetes, as change in lifestyle is seen as a medication for the treatment of 
diabetes (Nuovo & Nuovo, 2007). Physical activity also leads to the prevention 
and delay in contracting NCD diseases (Phillips, Cadmus-Bertram, Rosenberg, 
Buman, & Lynch, 2018). A way of enabling these prevention programs is using 
technology. 
 
Technology can have a great impact on chronic diseases and may reduce the 
pressure on healthcare systems. In an Australian telehealth study, telehealth 
technology monitored patients and the results show (Jayasena et al., 2016):  
• Reduction of health services utilization observed towards the later part of 
the trial (after 8-9 months) by reduced number of GP visits, specialist 
consultations, laboratory tests and procedures performed 
• Reduction in primary healthcare costs were demonstrated by the reduction 
of Medicare benefit costs by more than AUD600/year/patient and 
medication dispensing costs by more than $300/year/patient at end of trial 
• Reduction in hospital length of stay by more than 7 days 
• Reduction in rate of hospitalisations by 1 less event 
• There were improved Quality of life metrics/Human factors/Usability and 
acceptability to patients and clinicians 
pg. 57 
 
 
This can be achieved through self-empowerment of patients, which is by 
emphasizing the role patients play in the active management of their own 
healthcare (Nuovo & Nuovo, 2007). Self-empowerment is an example of the 
shift happening in the healthcare model which regards patients as passive 
recipients of care, to a model which empowers patients with knowledge and 
skills to manage their health (Saxton, 2011). Self-management can be achieved 
through mHealth and other technologies that empower patients (Baek et al., 
2018).  
 
With the capabilities and functionalities mHealth has, the technology can be 
used for dealing with a variety of chronic diseases.  
 
2.7 mHealth for chronic diseases 
According to Ardies (2014, p. 1) “Chronic diseases comprise a major source of 
mortality from disease for the world and are by far the greatest source of 
mortality among the high-income countries. In the United States, chronic 
diseases account for about 70% of all deaths and 75% of healthcare costs and 
their prevention is extremely important in terms of alleviating personal suffering 
and reducing economic impact, for individuals and for the nation”. 
 
Chronic diseases can range from mild conditions such as short- or long-
sightedness, dental decay and minor hearing loss, to debilitating arthritis and 
low back pain, and to life-threatening heart disease and cancers (AIHW, 2018). 
Chronic diseases are often long-term conditions that cannot be cured, which 
result in people needing long term management of the diseases (AIHW, 2018). 
Once present, chronic diseases often persist throughout life, although they are 
not always the cause of death. Examples of chronic diseases include: 
• Cardiovascular conditions (such as coronary heart disease and stroke) 
• Cancers (such as lung and colorectal cancer) 
• Many mental disorders (such as depression) 
• Diabetes 
• Many respiratory diseases (including asthma and COPD) 
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• Musculoskeletal diseases (arthritis and osteoporosis) 
• Chronic kidney disease 
• Oral diseases 
 
The most noticeable forms of chronic conditions are Cardiovascular Diseases 
(CVD), cancer, chronic respiratory disease (CRD), and diabetes (Bovell-
Benjamin, 2016). WHO (2018) has defined the chronic diseases and illustrated 
the burden chronic diseases have on healthcare systems and on world 
economies. The following elaborates on chronic diseases:  
 
• Cardiovascular Diseases (CVDs): Are a group of disorders of the heart and 
blood vessels including: coronary diseases, cerebrovascular diseases, 
peripheral arterial diseases, rheumatic heart diseases, congenital heart 
disease and deep vein thrombosis and pulmonary embolism. CVDs have a 
huge impact on morbidity as they are ranked as the number 1 cause of 
death. In 2015, 17.7 million people died from CVDs, representing 31% of all 
global deaths. Some of the risk factors associated with CVDs are unhealthy 
diet, physical inactivity, tobacco use and harmful use of alcohol. 
 
• Cancer: Cancer is a generic term for a large group of diseases that can 
affect any part of the body. Other similar terms of cancer are malignant 
tumors and neoplasms. Cancer is known for the fast creation of abnormal 
cells that grow beyond their usual boundaries, and which are able to 
penetrate adjoining parts of the body and spread to other organs, which is 
known as metastasizing. Metastases are a major cause of death. Cancer is 
a leading cause of deaths worldwide accounting for 8.8 million deaths in 
2015. The various types of cancers include lung (accounting for 1.68 million 
deaths), liver (accounting for 788,00 deaths), Colorectal (accounting for 744 
000 deaths), Stomach (accounting for 754 000 deaths), and Breast 
(accounting for 571 000 deaths). Risk factors associated with cancer are 
tobacco use, alcohol use, unhealthy diet, and physical inactivity.  
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• Chronic Respiratory Diseases (CRD): Chronic Respiratory Disease (CRD) 
also known as Chronic Obstructive Pulmonary Disease (COPD) is a lung 
disease that is known by the persistent reduction of airflow. The primary 
cause of COPD is tobacco (including secondhand or passive exposure). 
Others include indoor air pollution, outdoor air pollution, occupational dusts 
and chemicals, and frequent lower respiratory infections during childhood. 
It is estimated that 3.17 million deaths worldwide were caused by COPD in 
2015. In 2016, a study by The Global Burden of Disease has reported the 
widespread of COPD to be 251 million cases worldwide. 
 
• Diabetes:  Diabetes is a chronic disease that occurs when the pancreas 
does not produce enough insulin or when the body cannot effectively use 
the insulin it produces. Insulin is a hormone that regulates blood sugar. 
Diabetes include Type 1, Type 2 and Gestational diabetes.  
 
Other diseases such as mental illness, vision and hearing loss, and digestive 
diseases such as cirrhosis are also considered chronic diseases (Bovell-
Benjamin, 2016). With the listed risk factors associated with the chronic 
diseases, diet and physical activity can potentially reduce their burden by 
developing preventive methods that focus on diet and physical activity (Ardies, 
2014). Health inequalities are stemming from chronic conditions in low-middle 
income countries, resulting in the urgent need to implement more effective and 
cost-effective interventions (Beratarrechea et al., 2014).  Interventions to 
promote and improve patient empowerment are important components for 
effective self-care behaviour, risk factor control for chronic diseases, can 
increase adherence to medical treatments and preventive strategies (Supervía 
& López-Jimenez, 2018). Deaths caused by chronic diseases can be prevented 
through counselling, risk factor modification, and medication adherence 
(Beratarrechea et al., 2014). An example of risk factor modification using 
mHealth is from a trial in New Zealand aimed at ceasing smoking, where text 
messaging was used as an intervention method for CVDs (Chow et al., 2016). 
The study showed that those receiving text-message intervention were almost 
twice as likely to quit smoking (Chow et al., 2016). Table 2.7.1 is an example of 
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tailored text-messages developed for the self-management of chronic diseases 
(Dobson et al., 2015). 
Table 2.7.1: SMS4BG Modules. Relevant Sections Adapted from (Dobson et al., 2015) 
Module Description Participants Example text 
message 
Smoking cessation 1 message per 
month 
encouraging 
participants to 
consider quitting 
smoking and 
providing details of 
services for 
support. 
All participants 
who register as 
smokers. 
“SMS4BG: Good 
management of 
your diabetes and 
your future health 
includes not 
smoking, call 
Quitline on 0800 
778 778 for 
support.” 
Lifestyle behaviour Up to 4 messages 
per week 
encouraging 
participants to set 
a lifestyle goal and 
supporting them to 
work toward this 
goal. Participants 
can receive one of 
these modules for 
3 months. 
The three lifestyle 
modules are: (1) 
exercise, (2) 
healthy eating, 
and (3) stress and 
mood. 
Available to all 
participants. 
(1) “SMS4BG: Hi 
[name]. If you are 
finding it tough to 
keep up your 
exercise think 
about why good 
management of 
your diabetes is 
important to you.” 
(2) “SMS4BG: 
Healthy eating is 
an important part 
of your diabetes 
treatment and it 
will help you in 
controlling your 
blood glucose 
levels.” 
(3) “SMS4BG: 
Make sure you 
have fun activities 
scheduled 
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regularly. Doing 
something 
enjoyable helps 
reduce stress & 
improves mood.” 
Blood glucose 
monitoring 
Reminders to test 
blood glucose, 
sent at a 
frequency selected 
by the participant 
(up to 4 per day), 
for which they are 
encouraged to 
reply by text 
message with their 
blood sugar 
readings. 
Available to all 
participants 
required to monitor 
their blood 
glucose. 
“SMS4BG: Hi 
[name]. Just a 
reminder it is time 
to check your 
blood glucose. 
Reply with the 
result.” 
If valid response 
received, 
“SMS4BG: Thank 
you for sending 
your result.” 
 
The effectiveness of mobile phone text messaging was also related to weight 
loss, physical activity, lowering of blood pressure and management of diabetes 
(Chow et al., 2016). mHealth has the functionalities that can deliver health 
services to people and patients with chronic diseases. An application of this is 
mHealth for diabetes.  
 
2.8 mHealth for Diabetes 
Diabetes is a long term, non-curable serious diseases that is based on 
hormonal conditions where the body is unable to use the energy from the food 
(Leslie, Lansang, & Coppack, 2012). Shaw (2012) states that there are 2 main 
types of diabetes: 
1. Type 1, where the autoimmune system destroys the insulin-producing cells 
in the pancreas 
2. Type 2, which is a common form and is caused by the reduced production 
of insulin and an inability of the body tissues to respond fully to insulin 
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Hyperglycaemia, also known as high level of blood sugar, is a common effect 
of uncontrolled diabetes and it can affect body parts over a period of time, 
including the nerve and blood vessels (WHO, 2018). 
 
Diabetes causes complications that affect different parts of the human body that 
include feet, eyes, kidneys, and cardiovascular health (Shaw, 2012). The 
number of deaths according to WHO (2018), show that in 2014, 8.5% of adults 
aged 18 years and old had diabetes, 1.6 million deaths in 2015 from diabetes 
being the direct cause, and 2.2 million deaths in 2012 due to high blood glucose. 
Diabetes is predicted to be the seventh leading cause of deaths in 2030 (WHO, 
2018). Diabetes does not only cause deaths but is a financial burden on families 
and individuals suffering from it (Patel, Resnicow, Lang, Kraus, & Heisler, 
2018). 
 
WHO (2018) explains that “diabetes affects economy on a global scale as a 
result of direct medical costs, indirect costs associated with productivity loss, 
premature mortality, and the negative impact of diabetes on nation’s gross 
domestic product (GDP)”. The costs of diabetes are associated directly with the 
expenditure for preventing and treating it and its complications, including 
outpatient and emergency care, inpatient hospital care, medications and 
medical supplies such as injection devices and self-monitoring consumables 
and long-term care (WHO,2018). The cost of diabetes in Australia is $6 billion 
for type 2 diabetes, and $570 million for type 1 diabetes, which includes 
healthcare costs, the cost of carers and Commonwealth government subsidies 
(Shaw, 2012). 
 
Managing diabetes can be quite complex and requires a lot of effort to ensure 
the blood glucose level remains within the desirable threshold of healthy levels. 
Although diabetes is classified as a non-communicable disease and it is not 
curable, it can be controlled using medications (Saxton, 2011). The prevention 
of diabetes can be achieved by changing the lifestyles and through the early 
diagnosis and treatment of the disease (WHO, 2018). The changes in lifestyles 
include healthy diet, regular physical activity, maintaining a normal body weight 
and avoiding tobacco use (WHO, 2018).  
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Whettem (2012, p. 8) illustrate that “Good diabetes management involves 
partnership between healthcare providers and individuals with diabetes actively 
managing their condition themselves on a day-to-day basis, a role which may 
extend to family, friends and carers/ support workers in the case of children and 
young people, older people and people with learning disabilities or mental 
health problems”. Good management of diabetes involves people obtaining and 
developing knowledge, skills and confidence required to ensure the conditions 
are managed effectively (Whettem, 2012). With the global burden of diabetes, 
access to technology can enable a better management of diabetes that includes 
all activities aforementioned that are delivered using mHealth technology 
(Wickramasinghe, Troshani, & Goldberg, 2010). mHealth for diabetes has 
shown a positive impact on the management of diabetes. It has improved 
glucose management for people and assisted in maintaining lifestyle changes 
(Georgsson & Staggers, 2016).  
 
The nature of diabetes management makes technology an appealing solution 
for providing patients with support as patients routinely use glucometers, 
continuous glucose monitoring (CGM) devices, and insulin pumps 
(Modzelewski, Stockman, & Steenkamp, 2018). Dulce Digital is an example of 
where SMS based intervention was designed to support middle aged females 
born in Mexico (Fortmann et al., 2017). In a systematic review (See Table 2.8.1) 
done by Youfa et al. (2017), a number of interventions exist in the literature that 
highlight the role of different mHealth technologies for the treatment of diabetes. 
 
Table 2.8.1: Details of mobile application intervention for chronic disease management. 
Adapted from (Youfa et al., 2017) 
Intervention Control 
Treatment 
Key Outcome(s) Conclusions 
Daily tailored 
text messages 
to enhance 
diabetic self-
care behaviour 
Standard 
diabetes self-
management  
1) HbA1c levels changed 
but not significantly (P = 
0.1534). 2) Self-efficacy 
scores improved 
significantly (P = 0.008).  
Text messages may 
have a positive 
impact on some 
clinical outcomes and 
self-efficacy in 
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patients with type 2 
diabetes.  
Personalized 
messaging in 
response to 
blood glucose 
values, 
diabetes 
medications, 
and lifestyle 
behaviours by 
mobile phone  
Usual care  1) HbA1c decreased 
over 12 mo (P < 
0.001). 2) Appreciable 
differences in 
depression, diabetes 
symptoms, BP, and lipid 
concentrations were not 
observed between 
groups (P > 0.05).  
 
Telephone 
monitoring of 
PA and a low-
calorie, low–
glycemic index 
diet 
Conventional 
low-fat diet 
and standard 
care 
Weight loss, glucose, 
HbA1c, and antidiabetic 
drug intake were 
reduced (P < 0.001).  
Telephone 
monitoring can 
effectively lower body 
weight, HbA1c, and 
antidiabetic drug use 
in patients with type 2 
diabetes.  
Self-care 
video 
messages by 
cell phone  
Standard 
diabetes care  
Decline in HbA1C over 
12 mo (P < 0.002).  
One-way, mobile 
phone–based video 
messages about 
diabetes self-care 
can improve HbA1C.  
A short 
message 
every week on 
diet, exercise, 
taking diabetic 
medication, 
self-monitoring 
of blood 
glucose, and 
stress 
management  
Counseling 
appointments 
via telephone  
Between control and 
intervention groups, 
there was no significant 
difference in HbA1C (P = 
0.489), diet adherence 
(P = 0.438), or physical 
exercise (P = 0.327), but 
medication adherence 
improved in the control 
group (P = 0.034).  
SMSs of cellular 
phones may improve 
adherence to 
diabetes therapeutic 
regimen in patients 
with type 2 diabetes.  
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Remote 
patient 
reporting and 
an automated 
telephone 
feedback 
system  
Standard of 
care  
Significant reduction in 
HbA1c (P < 0.03) and 
body weight (P < 0.03).  
Automated feedback 
improves patient 
outcomes in patients 
with type 2 diabetes.  
Telemetry 
device at 
home to 
transmit 
glucose levels, 
BP readings, 
and weight 
measurements 
to the diabetes 
care manager 
weekly  
Standard 
care  
1) Self-efficacy (P = 
0.319), fructosamine (P = 
0.881), and HbA1c (P = 
0.310) had no significant 
changes between 
groups. 2) LDL tended to 
decrease more in the 
intervention group (P = 
0.045).  
The use of a 
telemetric device to 
download information 
for care management 
was associated with 
improved control of 
LDL-C.  
 
For the treatment of a health issue to be successful, an active participation by 
an informed patient is required (LeRouge & Wickramasinghe, 2013). An 
instance where this is valid, is in the case of lifestyle issues related to chronic 
diseases, such as diabetes, which cannot be successfully treated without 
changing the patient’s personal behaviour and habits (LeRouge & 
Wickramasinghe, 2013). In the past, a number of information and 
communication technologies (eg, Internet, telephone, mobile phone, and 
Bluetooth-connected blood glucose meters)  were used to track and transmit 
blood glucose results (Cafazzo, Casselman, Hamming, Katzman, & Palmert, 
2012). Many of these interventions were seen as electronic logbook 
applications to collect, store, and display blood glucose readings (Cafazzo et 
al., 2012). Some of these technologies included prompts to cue patients with 
diabetes about taking actions and modifying the treatment protocolCafazzo et 
al., 2012). 
 
pg. 66 
 
In a systematic review conducted by Kitsiou, Paré, Jaana, and Gerber (2017), 
it was found that a variety of mHealth interventions were included in the 
systematic reviews which used a variety of technological innovations, including 
text messaging (SMS), mobile applications, Bluetooth-enabled glucose meters, 
as well as secure websites/web-portals that could be accessed through the 
participants’ mobile device for data entry and patient support (Kitsiou et al., 
2017). The review looked at how technology is used for diabetes and it found 
that (Kitsiou et al., 2017): 
• The most prevalent method for sending blood glucose measurements 
and/or receiving self-management support (e.g. encouragement, education, 
reminders, and recommendations) involved the use of text messages (SMS) 
via mobile phones (34 out of 53 studies).  
• Twelve studies involved the use of web-portals that patients accessed 
through their cell phones to enter diabetes self-care data and receive 
feedback.  
• In 19 studies, data entry and transmission of glucose data were performed 
automatically via Bluetooth-enabled devices or other connectivity methods 
(e.g. infrared transmission or attachment of the glucose device to the mobile 
phone). In the remaining studies data entry was performed manually.  
• The majority of studies included in the systematic reviews (38 out of 53) 
encouraged self-monitoring of blood glucose combined with other 
intervention components, such as support of medication adjustment and 
reinforcement of lifestyle changes.  
• Half of the studies (26 out of 53) provided educational support to patients 
via SMS (15 studies) and/or the Internet (11 studies). In 28 of 53 trials 
patient data were transmitted daily or more often. 
 
Table 2.8.2: Examples of tailored text-messaging for self-management support for Blood 
Glucose (SMS4BG) (Dobson et al., 2015) 
Module Description Participants Example text message 
Core 2 messages per week 
providing general 
motivation and support 
for diabetes 
All (1) “SMS4BG: Kia ora. 
Control of your glucose levels 
involves eating the right kai, 
exercise & taking your 
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management. 
Available in two 
versions: (1) Māori, and 
(2) non-Māori. 
medication. Your whanau, 
doctor & nurse can help you.” 
(2) “SMS4BG: There is no 
quick fix to diabetes but with 
good management it will have 
less impact on your life and 
leave you more time to do the 
things you enjoy.” 
Insulin 1 educational text 
message per week on 
insulin management for 
patients receiving 
insulin. 
Available to 
participants 
prescribed 
insulin. 
“SMS4BG: Unopened insulin 
should be kept in the fridge. 
Don’t use insulin that has 
changed color, lumpy, 
expired, cracked or leaking, 
has been frozen or too hot.” 
Young 
adult 
1 message per week 
around managing 
diabetes in the context 
of work/school and 
social situations. 
Available to 
participants 
aged 16-24. 
“SMS4BG: It’s important not 
to ignore a hypo. No one likes 
to be embarrassed, but 
ignoring a hypo can make you 
feel worse & can be more 
embarrassing.” 
Another study developed tailored text messages (See Table 2.8.2) for assisting 
people with self-management of blood glucose (Dobson et al., 2015). This 
illustrates how mHealth can be used to assist people in managing their 
diabetes.  
 
The introduction of technologies in healthcare has changed the interaction 
between patients and clinicians. Patients using mHealth technologies for the 
management of their chronic conditions, have taken the patient-clinician 
interaction to a new level with the aid of smartphones.  
 
2.9 Patient – Clinician Interaction 
People in need of care often interact with different stakeholders of the 
healthcare system. This interaction is often referred to as patient-clinician 
interaction. The interaction, also known as patient-practitioner interaction, is 
“the relationship between practitioner and patient in the context of the 
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consultation” (Dambha-Miller, Silarova, Kinmonth, & Griffin, 2017, p. 1) Kelly-
Irving et al. (2009, p. 1) explains that “the interaction between patients and their 
general practitioner is important for the efficiency and usage of health services, 
and the nature and quality of the relationship affect communication, medical 
advice, satisfaction and diagnosis”.  
 
The interactions often include communication, empathy, interpersonal skills, 
listening, and mutual decision-making (Dambha-Miller et al., 2017). When 
dealing with a chronic disease, these interactions provide an opportunity for 
health professionals to influence patients’ behaviour (Dambha-Miller et al., 
2017). Health professionals can positively influence healthcare decisions, 
encourage self-management or enablement, and support patients with long-
term health changes during the long course of diabetes (Dambha-Miller et al., 
2017). These interactions can be decisive and have a positive outcome on 
patients’ behaviour as early evidence suggests that better patient experiences 
with practitioners are associated with lower cardiovascular (CV) risk factors 
such as blood pressure, glycated haemoglobin (HbA1c), and cholesterol, which 
in turn could lead to a delay in diabetes progression (Dambha-Miller et al., 
2017). Clinicians relationships with patients can be as healing as the treatment 
they recommend, as the therapeutic effect from the interaction can have greater 
effect than the pharmacological effects (Halpert, 2018). Patients interacting with 
medical professionals often have perceptions about the care they receive. 
Halpert (2018, p. 1) describes the effects of the patient-provider interaction on 
placebo (inert substance that provokes perceived benefits) or nocebo (inert 
substance that causes perceived harm) provide strong evidence that the 
context of the patient-provider encounter impacts clinical outcomes.  
 
People who do not participate in diagnosing or preventing diseases belong to 
key groups unaware of the risk of severe or life-threatening diseases and do 
not perceive the benefits of behaviour change outweighing potential barriers or 
other negative aspects of recommended actions. (Schiavo, 2013). A Health 
belief model (HBM) was established for the purpose of explaining why people 
do not participate or undertake proactive measures in managing their health. 
HBM has the following components (Schiavo, 2013): 
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• Perceived susceptibility: The individual’s perception of whether he or she is 
at risk for contracting a specific illness or health problem  
• Perceived severity: The subjective feeling whether the specific illness or 
health problem can be severe (for example, permanently impairing physical 
or mental functions) or is life threatening, and therefore worthy of one’s 
attention  
• Perceived benefits: The individual’s perceptions of the advantages of 
adopting recommended actions that would eventually reduce the risk of 
disease severity, morbidity, and mortality 
• Perceived barriers: The individual’s perceptions of the costs of and 
obstacles to adopting recommended actions (includes economic costs as 
well as other kinds of lifestyle sacrifices) 
• Cues to action: Public or social events that can signal the importance of 
taking action (for example, a neighbour who is diagnosed with the same 
disease or a mass media campaign) 
• Self-efficacy: The individual’s confidence in his or her ability to perform and 
sustain the recommended behaviour with little or no help from others 
 
Complying with instructions provided by doctors is crucial to the process of 
treatment, and effective therapy (Heszen-Klemens & Lapińska, 1984). Patients 
who do not follow the instructions, often do not understand or remember the 
insutrctions due to emotional reactions to sickness or incapable of 
understanding the instructions (Heszen-Klemens & Lapińska, 1984). Table 
2.9.1 presents the essential elements of effective patient-clinician 
communication inside hospitals.  
 
Table 2.9.1: Patient-clinician communication in hospitals (Source: safetiyandquality.gov.au, 
2018) 
Element Purpose Outcome 
Fostering 
relationships 
• To build rapport, trust 
and good relationships 
• Improved satisfaction and 
experience with the health 
service 
• Trust in the health service 
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• A decrease in healthcare 
provider stress and burnout 
Two-way 
exchange of 
information 
• To ensure accurate 
diagnosis and 
interpretation of 
symptoms 
• To engage with a person 
to gather relevant 
information  
• To share meaningful 
information in a 
comprehensive way  
• To check that a person 
understands the 
information provided 
• Increased diagnostic 
effectiveness and improved 
health outcomes 
• Less medical errors  
• Increased and shared 
understanding of a person’s 
care needs and preferences 
• Decision making based on 
complete and accurate 
information 
• Improved partnerships 
between people and their 
healthcare providers 
Conveying 
empathy 
• To build rapport, trust 
and good relationships 
• To deliver quality 
healthcare 
• To acknowledge and 
treat the patient as a 
person 
• Improved satisfaction and 
experience with the health 
service 
• Improved partnerships 
between people and their 
healthcare providers 
Engaging 
patients in 
decision-
making and 
care planning 
• To reach agreement on 
problems and plans 
• To facilitate self-
management 
• To recognise that the 
person receiving care as 
an important role in co-
producing their care 
• To ensure that decisions 
are appropriate, realistic 
and reflects the person’s 
preferences and goals 
for their care 
• Improved health outcomes 
• People having a better 
understanding of their care 
plan and treatment 
• Improved adherence to care 
and treatment 
• Increased ability for a person 
to self-manage their care 
• Improved satisfaction by a 
person of the decisions made 
about their care 
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Managing 
uncertainty 
and complexity 
• To manage a person’s 
expectations 
• To keep the person 
informed 
• To ensure that care is 
appropriate to the 
changing needs of a 
person receiving care 
• To ensure that critical 
information is not lost 
when care is transferred 
between teams 
• To ensure new 
information is 
communicated and 
considered 
• A reduction in the potential 
distress, anxiety or confusion 
arising from changes to care 
• Improved satisfaction and 
experience with the health 
service 
• Treatment and care matching 
the care needs of the person 
• Improved health outcomes 
 
In chronic disease, clinicians need to support patients as they engage in self-
management and adhere to medications. In diabetes care, clinician empathy 
has been associated with objective measures of disease management such as 
blood sugar control and fewer complications of diabetes (Flickinger, Saha et al. 
2016). Empathic communication has also been shown to increase patients’ 
cancer-related self-efficacy and sense of control (De Vries et al., 2014). 
Flickinger et al. (2016, p. 221) states that “when primary care patients rate their 
clinicians as having higher empathy, they demonstrate better adherence to 
recommended treatment. Showing empathy plays a role in patient adherence 
as it is develops interpersonal trust and a therapeutic partnership between 
clinicians and patients (Flickinger, Saha et al. 2016). Flickinger et al. (2016, p. 
221) also states that “it may also be that clinicians who exhibit more empathic 
communication are able to create more effective partnerships with patients, 
providing patients with the understanding and confidence necessary to take 
active roles in disease management and thus, achieving more favourable 
disease outcomes”. 
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According to De Vries et al (2014, p. 1) “Effective communication allows the 
clinician to assess, inform, and support the patient and has been associated 
with positive patient outcomes such as physical and emotional wellbeing, pain 
control, adherence to treatment, accuracy and completeness of assessment of 
symptoms and side-effects, patient satisfaction, information recall, and 
psychological adjustment. Studies investigating factors that influence”. 
 
Communication in healthcare between patients and clinicians are now being 
transformed using IT (Weiner, 2012). Such transformations include face-to-face 
patient/doctor contact becoming less desirable, and the exchanges between 
consumers and providers will increasingly be facilitated by electronic devices 
(Weiner, 2012). The presence of online information, such as Online Health 
Communities (OHC), is changing the way patients seek care (Atanasova, 
Kamin, & Petrič, 2018). Consulations done through OHCs provide patients with 
many benefits including a convenient, accessible, geographically independent 
and reliable source for information emotional support (Atanasova et al., 2018). 
 
As OHCs are internet-based platforms, they connect different groups of 
individuals with similar health-related interests, which in turn become important 
venues for connecting people with similar health conditions and sometimes 
access to health professionals (Atanasova et al., 2018). OHCs are divided into 
2 types (Atanasova et al., 2018): 
1. OHCs, which are mainly devoted to peer support groups and are usually 
referred to as online support groups.  
2. The second type, which are most commonly associated with the term of 
OHC, refers to online platforms that include both patients and health 
professional moderators who are usually healthcare professionals or 
doctors.  
 
With the information available online and through communities, they become a 
key enabler in decision making. The exchange of information is a pre-requisite 
of effective decision making and is in turn influenced by the quality of the 
relationship existing between doctor and patient as described by (Bigi, 2016). 
The exchange of information, data produced by electronic devices, and the data 
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generated during these interactions, produce a huge amount of data, and is 
often referred to as big data. Big data is another source of technology used in 
healthcare to assist in diagnosing patients and diseases, produce information 
from the analysis of large datasets and generate value from the collected data. 
 
2.10 Big data for Health 
Devices such as mobile phones, wearable technology, tiny sensors, social 
media, and other modern technologies, are producing large amount of data that 
led to the phenomenon of big data (Runciman & Gordon, 2014). The huge 
volume of data available in different industries and domains, is one of the 
characteristics of big data. De Mauro, Greco, and Grimaldi (2015) state that, 
“Big Data represents the Information assets characterized by such High 
Volume, Velocity and Variety to require specific Technology and Analytical 
Methods for its transforming into Value”. This definition took into consideration 
the 4 themes of Information, Technology, Methods, and Impact, which are 
always found when big data is defined (De Mauro et al., 2015).  
 
At the time big data emerged, the 3 V’s of big data were Volume, Velocity and 
Variety (Trifu & Ivan, 2014). However, these have been expanded and now 
include Veracity, Variability, and Value (Sebaa, Chikh, Nouicer, & Tari, 2018). 
The definition of the 6 V’s are (Sebaa et al., 2018): 
• Volume: High volume of data 
• Velocity: Rate of data generation and speed of processing 
• Variety: The diversity of types of data 
• Veracity: The degree of reliability and quality of sources of data 
• Variability: The variation in rate of data flow 
• Value: Value generated based on the analysis of data  
 
Examples of some of the V’s in healthcare are (Lin, Ye, Wang, & Wu, 2018): 
• Volume: A common statistic from EMC (now known as Dell EMC) is that 4.4 
zettabytes of data existed globally in 2013, which is predicted to increase to 
44 zettabytes by 2020.  
• Velocity: Health monitoring data is being generated every second 
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• Variety: The medical domain contains a number of big data sources such 
as the digital medical record, MRI, CT, health monitoring data, and genome 
data. 
• Veracity: Medical data might be incomplete, biased, or even filled with noise 
 
Big data differs from Business Intelligence (BI) as its features are different from 
Traditional BI as shown in Table 2.10.1 (Trifu & Ivan, 2014). 
 
Table 2.10.1: Business Intelligence vs Big Data, Adapted from (Trifu & Ivan, 2014). 
Traditional BI Reporting Big Data Analysis 
Reporting tool like cognos, SAS, SSIS, 
SSAS 
Visualization tool like QlikView or 
Tableau 
Sample data or specific historical data Huge volume of data 
Data from the enterprise Data from external sources like social 
media apart from enterprise data 
Based on statistics Based on statistics and social sentiment 
analysis or other data sources 
Data warehouse and data mart OLTP, real-time as well as offline data 
Sequential Computing Parallel Computing using multiple 
machines 
Query languages SQL, TSQL Scripting Languages Java script, 
Python, Ruby and SQL 
Specific type of data : txt, xml, xls, etc Multiple kinds of data : pictures, sounds, 
text, map coordinates 
 
 The Healthcare domain contains a big volume of data and information 
(Koumpouros, 2014). One of the many sources of big volume of data in 
healthcare is data that is generated by patients during their interaction with 
healthcare, such as hospital visits (Koumpouros, 2014). Medical professionals 
also collect data while interacting with patients and use them to achieve a 
desired outcome (Koumpouros, 2014). Other sources of big data in healthcare 
include data generated by the use of the Electronic Health Records (EHR), 
personalized medicine, and administrative data (van Loggerenberg, 
Vorovchenko, & Amirian, 2017).  
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Preventative care is understood to be better than cure, as information from the 
analysis of big data is put into practice (Marr, 2015). The collections of cancer 
data from patients have resulted in large datasets requiring method from big 
data to discover new knowledge and aid in the analysis of data (Hinkson et al., 
2017). Big data is changing healthcare as it delivers new insights through the 
analysis of data. Search engines and social media can provide insights into 
people’s reaction and monitor their conditions of epidemic diseases (Huang et 
al., 2015). Decision support systems, are another example where information 
from big data can be used to help individuals choose their medicine and assist 
health professionals in selecting the treatment for patients (González-Ferrer, 
Seara, Cháfer, & Mayol, 2018). 
 
The information relating to patients’ care and conditions is derived from the 
analysis of big data. A single patient can ultimately produce around 1.2 
Gigabytes of structured data consisting of patient record (Marconi & Lehmann, 
2014). Data from a variety of different sources such as hospital information, 
medical sensors, medical devices, websites and medical applications consume 
storage capacity in the masses of terabytes and petabytes of storage (Sebaa 
et al., 2018). Big data has the promise of answering some of the challenging 
questions in disciplines such as science, technology, healthcare, and business, 
that are yet to be addressed (Tomar, Chaudhari, Bhadoria, & Deka, 2016).  
 
Big data can address many of the problems in health sciences such as 
recommendation system in healthcare, Internet based epidemic surveillance, 
sensor based health conditions and food safety monitoring, Genome-Wide 
Association Studies (GWAS) and expression Quantitative Trait Loci (eQTL), 
inferring air quality using big data and metabolomics and ionomics for 
nutritionists (Gao, Chen, Tang, Zhang, & Li, 2016).   
 
Some of the companies delivering big data in healthcare are IBM. IBM Watson 
technology uses big data for healthcare solutions. IBM Watson be used in 
multiple areas of healthcare (IBM, 2018): 
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• Drug Discovery: Used for helping researchers identify novel drug targets 
and new indications for existing drugs and uncovering new connections and 
developing new treatments ahead of the competition. 
• Social Program Management: Supporting agencies in their work to deliver 
health and human services that enable citizens to meet their maximum 
potential while protecting the most vulnerable populations. 
• Oncology: Spend less time searching literature and more time caring for 
patients. For example, IBM Watson can provide clinicians with evidence-
based treatment options based on expert training by Memorial Sloan 
Kettering physicians. 
• Care Management: Use personalized care plans, automated care 
management workflows, and integrated patient engagement capabilities to 
help create more informed action plans. 
 
The role of Big Data in healthcare has already been seen in various 
applications. Precision Public Health, is a term defined as “improving the ability 
to prevent disease, promote health, and reduce health disparities in populations 
by applying emerging methods and technologies for measuring disease, 
pathogens, exposures, behaviours, and susceptibility in populations; and 
developing policies and targeted implementation programs to improve health” 
(Dolley, 2018). Precision public health uses big data and its enabling 
technologies to accomplish a previously impossible level of targeting or speed 
(Dolley, 2018). Big data has been used in Precision Public Health for (Dolley, 
2018): 
• Disease Surveillance and signal detection: Precision signal detection or 
disease surveillance using big data has shown efficacy in air pollution, 
antibiotic resistance, cholera, dengue, drowning, drug safety, 
electromagnetic field exposure, Influenza A (H1N1), Lyme disease, 
monitoring food intake, and whooping cough. Disease surveillance includes 
the tracking of individuals i.e., human carriers, patients, or victims through 
the human movement to understand how disease transmission occurs. This 
sort of surveillance results in a large volume from the stream of real-time 
data generated by humans. As a result of human fast movement and the 
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spread of diseases, the real time data analysis offered by big data makes 
the tracking of diseases possible. 
 
• Predicting risk: The prediction of public health risk improves the modes of 
implementing preventative measures. This prediction can be accomplished 
by using big data models. An example of this prediction is Google Flu trends, 
which provided info regarding flu trends in different countries. However, 
Google later stopped this service. 
 
 
• Target interventions: Target interventions have been applied in the 
treatment of small populations within a larger population who suffer from a 
certain disease. An example of this includes the treatment of gonorrhoea in 
the 1980s, HIV in the 1990s, breast cancer in the 2000s, and malaria in the 
2010s. However, Big data is now being used for targeted intervention that 
is specific to an individual rather than the public in general. Examples of this 
finer-grain treatment intervention include interventions in childhood asthma, 
childhood obesity, diarrhea, Hepatitis C, HIV, injectable drug use, malaria, 
opioid medication misuse, use of smokeless tobacco, and the Zika virus. 
Nowadays, this extends to vaccines, where it is no longer ‘one size fits all’ 
but rather personalized treatment for individual outcomes.  
 
• Understanding Disease: Data volume and variety in epidemiology have 
grown consistently over time well before the age of big data. Contemporary 
exponential increases in data sizes, and perhaps more importantly 
increases in variety of data sources, make big data a valuable addition to 
the epidemiologist’s toolkit.  
 
Big data can play a critical role in achieving economic and efficiency targets in 
healthcare (Murdoch & Detsky, 2013). There are 4 ways big data can help 
achieve this in healthcare (Murdoch & Detsky, 2013): 
 
1. Big data may greatly expand the capacity to generate new knowledge as 
the cost of answering many clinical questions prospectively, and even 
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retrospectively, by collecting structured data is prohibitive. Analyzing the 
unstructured data contained within EHRs using computational techniques 
(eg, natural language processing to extract medical concepts from free-text 
documents) permits finer data acquisition in an automated fashion. 
 
2. Big data may help with knowledge dissemination. Most physicians struggle 
to stay current with the latest evidence guiding clinical practice. The 
digitization of medical literature has greatly improved access; however, the 
sheer number of studies makes knowledge translation difficult. Even if a 
clinician had access to all the relevant evidence and guidelines, sorting 
through that information to develop a reasonable treatment approach for 
patients with multiple chronic illnesses is exceedingly complex. This 
problem could be addressed by analyzing existing EHRs to produce a 
dashboard that guides clinical decisions. For example, this approach is 
being used in the collaboration between IBM's Watson supercomputer and 
Memorial Sloan-Kettering Cancer Center to help diagnose and propose 
treatment options for patients with cancer. The big data approach differs 
from traditional decision support tools in that suggestions are drawn from 
real-time patient data analysis, rather than solely using rule-based decision 
trees. For example, longitudinal diagnostic data have been shown to predict 
a patient's risk of a future diagnosis of domestic abuse. Data-driven clinical 
decision support tools could also lead to cost savings and help with 
appropriate standardization of care. Just as purchasers receive messages 
from Amazon (eg, customers like you also bought this book), clinicians may 
receive messages that inform them about the diagnostic and therapeutic 
choices made by respected colleagues facing similar patient profiles. 
 
3. The capabilities of big data may assist in translating personalized medicine 
initiatives into clinical practice by offering the opportunity to use analytical 
capabilities that can integrate systems biology (eg, genomics) with EHR 
data. The Electronic Medical Records and Genomics Network does so by 
using natural language processing to phenotype patients, in an effort to 
streamline genomics research. 
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4. The transformation of healthcare information by big data can allow the 
delivery of information directly to the patient, which can empower them to 
play a more active role. The model that’s currently in place stores patients' 
records with healthcare professionals, putting the patient in a passive 
position. However, this may change in the future, where medical records 
may reside with patients. Big data offers the chance to improve the medical 
record by linking traditional health-related data (eg, medication list and 
family history) to other personal data found on other sites (eg, income, 
education, neighbourhood, military service, diet habits, exercise regimens, 
and forms of entertainment), all of which can be accessed without having to 
interview the patient with an exhaustive list of questions. By doing so, big 
data offers a chance to integrate the traditional medical model with the social 
determinants of health in a patient-directed fashion. Public health initiatives 
to reduce smoking and obesity could perhaps be delivered more efficiently 
in this way by targeting their messages to the most appropriate people 
based on their social media profiles. 
 
Using data efficiently has the potential to improve the care of patients and lower 
costs (Jones, Pulk, Gionfriddo, Evans, & Parry, 2018). The use of Big data does 
not only provide more solutions but can play an important role in decreasing 
healthcare costs. A 2013 report by McKinsey & Company estimated that using 
big data could reduce healthcare spending by $300-450 billion annually, or 12-
17% of the $2.6 trillion baseline in annual U.S. healthcare spending (Marconi & 
Lehmann, 2014). 
 
In healthcare, big data can provide a number of benefits and initiatives that can 
have a positive influence on the delivery of care. Table 2.10.2 highlights the 
different lessons from Big Data in healthcare and how it is impacting healthcare. 
Table 2.10.2: Lessons Learned in Applying Data to Drive Care. Adapted from (Jones, Pulk, 
Gionfriddo, Evans, & Parry, 2018). 
Lesson Explanation 
Data can inform care Continual synthesis of data can 
influence treatment best practices and 
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help to individualize care and treatment 
approaches. 
Stakeholders should be engaged early Successful implementation of 
organizational initiatives and clinical 
best practices occurs when 
stakeholders across the organization 
are engaged in identifying opportunities 
for improvement from the beginning, at 
the point of decision-making, and at 
final best practice. 
Collaboration is necessary for complete 
data 
Organizations may not have access to 
all the data they need to improve care 
processes; thus, utilization of external 
data may be necessary 
but is not always complete. 
Communications with stakeholders 
must be open and continuous 
Open and constant dialogue between all 
stakeholders is necessary to ensure 
uniform understanding and utilization of 
data. 
Data can create efficiencies Processes can be improved by creating 
discrete data elements for previously 
nondiscrete data fields that allow data to 
be accurately and 
constantly retrieved and quantified. 
 
With big data becoming more apparent in healthcare, it is producing in new 
insights and changing some of the ways care is delivered. Data used in 
healthcare must display the right properties and be accurate to prevent medical 
errors.  
 
2.11 Data Accuracy 
Data itself, is defined as information in the form of facts or figures obtained from 
experiments or surveys, used as a basis for making calculations or drawing 
conclusions as defined by (Dumas, 2013). Nowadays, data in the Information 
Technology (IT) domain is often referred to as facts stored and shared 
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electronically in databases or computer applications (Sebastian-Coleman, 
2013). Data in healthcare is viewed as the lifeblood of a continuous learning 
health system, and the flow of such data is necessary to coordinate and monitor 
patient care, analyze and improve systems of care, conduct research to 
develop new products and approaches, assess the effectiveness of medical 
interventions, and advance population health (Sanders, Powers, Grossmann, 
& Institute of, 2013). 
 
The significant thing about data in modern society is that it is a representation 
of people, events or concepts in the real world (Sebastian-Coleman, 2013). The 
representation allows for an event to be captured in digital format and stored in 
databases for later representation. In the case of mHealth, the collected data is 
simply patients describing their symptoms, side effects and providing other 
information when suffering from an illness (Estrin & Sim, 2010).  
 
In a health context, the quality of the data helps evaluate health, assess 
effectiveness of interventions, monitor trends, inform health policy and set 
priorities (van Velthoven, Car, Zhang, & Marušić, 2013). Accuracy is an element 
of data quality that is intended to achieve desirable objectives using legitimate 
means, and its accuracy is the original source of the data (WHO, 2014). The 
international Organization for Standardization (ISO) ISO 8000 section 130 
states that accuracy is a measure of how closely data represent the data of the 
real world at any given time (Talburt & Zhou, 2015). In healthcare, the traditional 
and standard method of collecting data from patients is through the direct 
observation, also known as Gold Standard, which is a direct observation of 
patients at the clinic (Eisele et al., 2013). 
 
The data consists of multiple elements, referred to as Data Quality. Table 2.11.1 
presents the different elements of Data Quality according to two definitions 
collected from WHO (2014) and Batini & Scannapieco (2016). 
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Table 2.11.1: Definitions of Data Quality Elements. Adapted from ((WHO, 2014) and (Batini & 
Scannapieco (2016)). 
Data Quality Element WHO Definition Batini and Scannapieco 
(2016) Definition 
Accuracy and Validity The original data must be 
accurate in order to be 
useful. 
Accuracy is the closeness 
between a value v and a 
value v’, considered as 
the correct representation 
of the real-life 
phenomenon that v aims 
to represent. 
Reliability Data should yield the same 
results on repeated 
collection, processing, 
storing and displaying of 
information. 
Whether data can be 
counted on to convey the 
right information, it can be 
viewed as correctness of 
data. 
Completeness All required data should be 
present and the 
medical/health record 
should contain all pertinent 
documents with complete 
and appropriate 
documentation. 
The extent to which data 
are of sufficient breadth, 
depth, and scope for the 
test at hand. 
Legibility All data whether written, 
transcribed and/or printed 
should be readable. 
N/A 
Currency and 
Timeliness 
Information, especially, 
clinical information, should 
be documented as an event 
occurs, treatment is 
performed, or results noted. 
Currency: how promptly 
data are updated. 
Timeliness: how current 
data are for the task at 
hand. 
Volatility: frequency with 
which data vary in time.  
Consistency N/A Consistency, cohesion, 
and coherence refer to 
the capability of the 
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information to comply 
without contradictions to 
all properties of the reality 
of interest, as specified in 
terms of integrity 
constraints, data edits, 
business rules, and other 
formalisms.  
Accessibility All necessary data are 
available when needed for 
patient care and for all other 
official purposes. 
Accessibility measures 
the ability of the user to 
access the data from his 
or her own culture, 
physical status/functions, 
and technologies 
available.  
Meaning or 
usefulness 
Information is pertinent and 
useful. 
N/A 
Confidentiality and 
Security 
Both important to the patient 
and in legal matters. 
N/A 
 
The Elements of Data Quality have been further elaborated on and put in a 
context to understand how each element works. This has been done by Wang 
& Strong (1996) who classified the elements of Data Quality in a framework 
(See Table 2.11.2): 
 
Table2.11.2: Data Quality Dimension Framework. Adapted from (Talburt, 2010). 
Intrinsic Contextual Representational Accessibility 
Accuracy Value-added Interpretability Access 
Objectivity Relevancy Ease of 
understanding 
Security 
Believability Timeliness Representational 
Consistency 
 
Reputation Completeness Conciseness of 
Representation 
 
 Amount of Data Manipulability  
 
pg. 84 
 
When data lacks accuracy, currency or certainty, it can have catastrophic 
results (Sadiq, 2013). For an mHealth solution to be effective and safe, the data 
collected from mHealth devices, wearables and applications must be accurate 
and secure (Mottl, 2014). Data accuracy is a foundational feature or dimension 
that contributes to data quality (Gregori & Berchialla, 2012) and it is still a major 
part of mobile health developments, as some of the traditional ways of 
assessing the patients provide inaccurate data (Lin, 2013). In a study for using 
Multimedia Messaging Service for the emergency teleconsultation of 
orthopedia, it was found that the service demonstrated good reliability but 
provided poor diagnostic accuracy (Chandhanayingyong, Tangtrakulwanich, & 
Kiriratnikom, 2007). The elements of data quality can lead to serious problems 
that affect patient safety. Magrabi, Ong, and Coiera (2016) have demonstrated 
(See Table 2.11.3) how data can harm patients and risk their safety. 
Table 2.11.3: HIT errors can lead to adverse events and patient harm. Adapted from (Magrabi 
et al., 2016). 
Type of Error Example of error occurring in healthcare 
Data are wrong Example: Mismatch in the order of medicine 
Data are missing Example: Patient record missing critical information about 
allergies that might impact patients during treatment 
Data are partial Example: Lack of information during patient discharge, 
which could be as simple as missing the dosage while 
prescribing medicine 
Data are delayed Example: Delay in administering medicine for patients when 
instructed by a hospital physician using HIT system 
 
Data inaccuracy can occur as a result of many factors that affect the quality of 
the data. There are 4 different sources of data inaccuracy and they include (See 
Table 2.11.4) (Olson, 2003):  
Table 2.11.4: Source of Inaccurate Data. Adapted from (Olson, 2003). 
Source of Inaccurate Data 
1 Initial Data Entry Mistakes, Data Entry Processes, Deliberate, System 
Errors 
2 Data Decay Accuracy of data when originally created over time 
3 Moving and 
Restructuring 
Extract, Cleansing, Transformation, Loading, 
Integration 
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4 Usage Faulty Reporting, Lack of Understanding 
In addition to the 4 sources listed above, intentional and unintentional wrong 
data entry and speed of data collection that are misleading, can result in 
misallocating resources or interventions when needed for the patients (Patnaik, 
Brunskill, & Thies, 2009). Inaccurate readings, insufficient amount of data, 
movement and physical activities also contribute to inaccurate data provided 
through the mHealth devices (Mena et al., 2013). Another factor that affects the 
quality of data is security breaches, where unauthorized modification or 
alteration is made to patients’ data that compromise their confidentiality and 
privacy (Mena et al., 2013). Concerns associated with data accuracy and 
validity are persistent and can become a risk to patients’ safety (Linda, 2012). 
For data to be of value, it must always consist of completeness, consistency, 
currency, relevance and accuracy (Närman et al., 2011). In mHealth, these 
elements of data quality can be compromised as data goes through 5 different 
stages of collection, transmission, analysis, storage and presentation (Klonoff, 
2013) before being used. 
 
There are some measures implemented in mHealth technologies that assure 
data accuracy. The WE-CARE system, is a mHealth solution for the detection 
of cardiovascular diseases, in which 7 Electrocardiography (ECG) leads are 
used to guarantee that data is accurate (Anpeng et al., 2014). Similarly, in a 
direct observation, when the medical professional performs a certain diagnosis 
such as blood pressure reading (collecting data), there’s usually other 
observations made to help evaluate the patients. In a mHealth solution, a single 
reading of blood pressure does not convey the full picture and is often 
measured against thresholds (high and low limits) which trigger an alarm. Lack 
of data does not only present a difficulty in interpreting the results but also in 
making correlations and understanding deviations from certain activities 
(Tollmar, Bentley, & Viedma, 2012).  
 
The accuracy of the data contributes to data integrity that has been defined as 
maintaining and assuring the accuracy and consistency of data over its entire 
life-cycle (Cucoranu et al., 2013).  
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2.12 Information Integrity 
In the modern world, information is power, and organizations with the most 
accurate and readily available data make the fastest decisions with the least 
negative impact as explained by Tupper (2011). Information at the very basic 
level is raw data that is processed and transformed into information from which 
knowledge is then extracted (Dumas, 2013). The integrity element of 
information is about having the right properties of information including 
sensitivity in which information is used, as well as encompassing accuracy, 
consistency and reliability of the information content, process and system 
(Fadlalla & Wickramasinghe, 2004). A similar definition has been provided by 
Sinnett (2008) in which he states that information integrity has two definitions 
and are as follows: 
1. The dependability and trustworthiness of information 
2. The accuracy, consistency and reliability of information content, process 
and system.  
 
Information integrity may be viewed as one of three main components of 
“Information Value” that provides benefits specific to a consumer of the 
requested information (Sinnett, 2008). The three components of Information 
Value are (Sinnett, 2008): 
• Usefulness, or suitability to purpose 
• Usability, or its form and accessibility; and 
• Integrity, or accuracy, consistency and reliability. 
 
Integrity in a healthcare context means that an organization has the ability to 
prove that the information is authentic, timely, accurate, and complete and it is 
the fundamental expectation from patients, providers and other stakeholders 
such as regulatory agencies (Datskovsky, Hedges, Empel, & Washington, 
2015). As mHealth can be used in a number of ways, it is vital that the 
information generated is accurate in order to avoid misdiagnosis, delayed care 
seeking, incorrect self-treatment, conflict over appropriate care or non-
adherence to treatment plans and medication (Kahn, Yang, & Kahn, 2010). 
Claude Shannon developed a theory around Information where he 
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characterized information as a message transmitted from a sender to a receiver 
in a way such that the message is understood by the receiver and that the 
importance of this process is the integrity of the transmission (Talburt, 2010). In 
his model, Shannon differentiated between data and information, where data 
are assertions about the state of a system that become information when they 
are placed into a relationship to each other and interpreted by the receiver 
(Talburt, 2010).  
 
Self-management can prove critical in reducing healthcare costs while 
delivering optimal healthcare services (Monsen, Handler, Le, & Riemer, 2014) 
by delivering the right information to patients that do not only encourage self-
management but also empower and allow them to understand their medical 
conditions (Hayes & Aspray, 2010). The effect of poor and insufficient 
information can disengage people from using mHealth, causing inconsistent 
and incomplete data. For instance, physical inactivity according to statistics 
from WHO (2015) is the fourth leading cause of death accounting for 3.2 million 
deaths globally. Wearable devices such as fitness trackers, is an example of 
how doctors may promote and encourage better physical activity, yet they do 
not sufficiently satisfy the patient with the information provided and therefore 
can deter people from exercising (Product Design&Development, 2015). 
 
The integrity of information produced as a result of shift in the dynamics of 
technology has been getting more focus as the interaction experience has 
changed (Cunningham, 2012). The shift from clinician care towards patient 
centred model is encouraging patients to actively self-manage and make 
decisions concerning their health (David, Sara, & Erin, 2011), and to harness 
the power of mobile health in order to benefit from it, the technology must be 
error free and provide rich health information. 
 
In Health Information Management (HIT), wrong data, missing data, partial 
data, and delayed data, can affect the quality of the information and they result 
in information having errors that lead to medical errors (Magrabi, Ong, & Coiera, 
2016). Errors in healthcare system due to data loss, incorrect data entry, 
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displayed or transmitted data can lead to loss of information integrity (Bowman, 
2013). 
 
To overcome the challenge of correctly treating patients using mHealth and 
ensure information integrity, data governance, information workflow 
management, internal controls, confidentiality and data privacy processes must 
exist (Flowerday and Solms, 2008). These processes along with Information 
Technology can improve the quality of care by decreasing medical errors due 
to inaccurate and untimely information (Mahmood et al., 2012). Using a 
semantic tool when processing the data and transforming it into information, 
can prove crucial to detecting errors when inaccurate information is generated. 
Thus, stopping it from being turned into actions and preventing medical errors.  
 
Figure 2.12.1: The Omaha System 2005 version (Adapted from The Omaha System Chart, 
2018) 
 
The Omaha System (latest 2005 edition) is a semantic tool used in a number 
of domains including medical diagnosis which involves the aggregation and 
analysis of clinical data and better information management (The Omaha 
System, 2015). The Omaha system has three main components, each 
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designed for a specific use. These components are described in Table 2.12.1 
and the flow is shown in Figure 2.12.1. 
Table 2.12.1: Components of Omaha System 
The Omaha System Schemes Application 
Problem Classification Environmental Domain, Psychosocial 
Domain, Physiological Domain, Health-
related Behaviours Domain 
Intervention Scheme Teaching, Guidance and Counselling. 
Treatments and Procedures. Case 
Management. 
Problem Rating Scale for 
Outcomes 
A rating scale to assess client progress 
throughout the period of service. 
 
The introduction  of Omaha System in mHealth would increase the chance of 
capturing accurate data as its comprehensive problem classification stage 
would enforce and bring an understanding of which relevant health data need 
to be captured. The intervention component would mean empowering patients 
by providing information that are relevant to their condition. It can also have a 
role in detecting inaccurate data by examining the information fed back to the 
patient. The rating of the outcome would provide valuable feedback in designing 
the care plan. The learning from these 3 components can be incorporated into 
an algorithm that can detect the flow of data and flag any erroneous data. 
 
The detection of inaccurate data and information can be tested and done using 
Machine Learning Algorithms, a method where algorithms learn from data to 
produce high quality information.  
 
2.13 Machine Learning 
Smarter health is an example where big data allowed the discovery of a disease 
before it was apparent (Marr, 2015). The availability of such data has revived 
the field of Artificial Intelligence and Machine Learning (Kamath & Choppella, 
2017). Machine Learning is a branch of Artificial Intelligence (AI) and it 
combines multiple fields such as Statistics, Algorithms and Computation, 
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Database and Knowledge Discovery, Pattern Recognition and Artificial 
Intelligence (Kamath & Choppella, 2017). 
 
As a result of using smartphones for health management, this has enabled 
smarter use of data as we shift from curing to anticipating and preventing 
diseases before they occur through real time data analysis (Kumar et al., 2013). 
With Mobile health (mHealth), the technology is seen as a great opportunity and 
convenient way of tackling diseases and illness from child to chronic diseases 
(Curioso & Mechael, 2010). Such smart technology has been battling chronic 
diseases by using mobile phones and other devices that have multiple sensors, 
as well as data connectivity that provides around the clock support (Haddad et 
al., 2012). This technology is fast growing and can help solve complex problems 
and diagnosis of diseases (Lev-Ram, 2012). The ability to solve complex 
problems and perform diagnosis, is due to the new generation of smartphones 
having more advanced computing and communication (internet access, geo-
locations) capabilities compared to older versions of mobile phones, where they 
performed simple tasks and had limited capabilities (Boulos, Wheeler, Tavares, 
& Jones, 2011).  
 
Varshney (2009) describes common medical errors as those found during 
investigation, diagnosis, treatment, communication and office administration 
errors. Eliminating errors in mHealth can be achieved by learning about the 
collected data and applying analysis techniques to find new insights that help 
facilitate a better understanding of how the technology works. A common 
method is using machine learning algorithms. Machine learning is a knowledge 
extraction method used when there is great amount of data and it is achieved 
through well designed models or algorithms that can predict for new and unseen 
data (Lambin et al., 2013). The machine learning algorithms learn and improve 
the outcomes through experience and observations (Oquendo et al., 2012). 
This technique is different to rule based validations where rules are static and 
there’s no learning. Studies in fields of e-health and telemedicine included a 
pre-validation of the data during time of data collection and entry (Monda, 
Keipeer, & Were, 2012).  
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Table 2.13.1: Role of Machine Learning in mHealth. 
Machine Learning 
Algorithm 
Applications Uses Source 
Artificial Neural 
Networks 
Diabetes Diagnosing diabetes 
using neural networks 
on small mobile 
devices 
(Karan, 
Bayraktar, 
Gümüşkaya, 
& Karlık, 
2012) 
Support Vector 
machines, sparse 
multinomial logistic 
regression (SMLR), 
Naïve Bayes, 
Decision Trees, k-
nearest neighbor 
Fall Detection Fall Classification by 
Machine Learning 
Using Mobile Phones 
(Albert, 
Kording, 
Herrmann, & 
Jayaraman, 
2012) 
Bayesian Network Heart Rate Real-Time Robust 
Heart Rate Estimation 
based on Bayesian 
Framework and Grid 
Filters 
(Radoslav & 
Pavel, 2012) 
Classifiers Autism Use of Machine 
Learning to shorten 
observation-based 
screening and 
diagnosis of autism 
(Wall, 
Kosmicki, 
DeLuca, 
Harstad, & 
Fusaro, 2012) 
 
Table 2.13.1 illustrates the different algorithms used in mHealth developments 
that accurately detect the symptoms of a disease, perform diagnosis and 
monitor patients.  
 
The concept of Machine Learning is – learning that improves with experience 
in relation to some task. That is (Bell, 2014): 
• Improve over task, T 
• With respect to performance measures, P 
• Based on experience, E 
pg. 92 
 
 
Machine learning algorithms can play a pivotal role in acquiring accurate data 
through pre-trained algorithms that can be deployed in mHealth solutions. The 
Support Vector Machine (SVM) algorithm was deployed in a blood pressure 
measurement application on an android tablet that detected the patient’s arm 
and ensured stability, in order to acquire accurate reading of the data performed 
by the cuffs (Murthy & Kotz, 2014). In a fall detection scenario, recorded data 
were used from a database which contained 95 instances of recorded falls, from 
which then four types of machine learning algorithms were applied to accurately 
detect a fall (Sannino, De Falco, & De Pietro, 2014). 
 
Machine Learning techniques can close the ‘gap’ of incomplete or inaccurate 
data through the reasoning capabilities that they have (Martha & Bart, 2006). A 
simple method is the use of fuzzy logic algorithms. Fuzzy logic is a method that 
renders precise what is imprecise and is excellent in handling ambiguous, fuzzy 
data and imprecise information prevalent in medical diagnosis (Djam & Kimbi, 
2011). Fuzzy logic has been used in mimicking the regulation of glucose level 
of a patient (Zhu, Liu, & Xiao, 2014). This mimicking behaviour can be used in 
mHealth to enforce correct compliance and intelligently detect inaccurate data 
through calculations performed by the algorithms.   
 
This method along with other machine learning algorithms such as Artificial 
Neural Networks or Association Rules, can be applied at the stage of data 
collection where values captured are of exact or approximate reflection of the 
patient’s current condition. The role of machine learning in detecting inaccurate 
data through reasoning, could prove crucial in enhancing the quality of data 
collection stage of mobile health as the accuracy aspect of data is a major 
challenge in itself. Removing inaccuracy and assuring high data quality, would 
mean a plethora of solutions that can be developed to help manage diseases 
and lower the premature rate of deaths, as well as reduce healthcare costs. 
 
As Machine learning is becoming more apparent in industries and used in many 
applications, there were multiple frameworks created, one of which Reese, 
Reese, Kaluza, Kamath, and Choppella (2017) included in the process of 
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applying Machine Learning Algorithms to different problems and applications 
and that is by: 
1. Data and problem definition: Asking what the problem is, the importance 
of the problem and the end result of applying Machine Learning to a problem. 
2. Data collection: Collecting data that will be able to address the question. 
3. Data pre-processing: Cleaning data where data has missing values, 
smoothing noisy data, removing outliers, and resolving consistencies. 
4. Data analysis and modelling with unsupervised and supervised 
learning: Data analysis and the selection of supervised or unsupervised 
machine learning.  
5. Evaluation: Assessing the model and how it accurately predicts the new 
data. Overfitting and underfitting can occur at this stage, making the model 
less useful on new data. 
 
Machine learning has been used in a number of domains and in solving different 
problems. It has been used to (Lantz, 2013): 
• Predict the outcomes of elections 
• Identify and filter spam messages from e-mail 
• Foresee criminal activity 
• Automate traffic signals according to road conditions 
• Produce financial estimates of storms and natural disasters 
• Examine customer churn 
• Create auto-piloting planes and auto-driving cars 
• Identify individuals with the capacity to donate 
• Target advertising to specific types of consumers. 
 
The learning done by the machines comes from the training performed by the 
algorithms. There are several ways of training the algorithms (Reese et al., 
2017): 
• Supervised learning: The model is trained with annotated, labelled, data 
showing corresponding correct results. 
• Unsupervised learning: The data does not contain results, but the model is 
expected to find relationships on its own. 
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• Semi-supervised:  A small amount of labelled data is combined with a larger 
amount of unlabelled data. 
• Reinforcement learning: This is similar to supervised learning, but a reward 
is provided for good results. 
 
Healthcare can benefit from Machine Learning by applying it for different 
problems in healthcare. Such applications of Machine Learning in healthcare 
include Evidence-based medicine, epidemiological surveillance, drug events 
prediction, and claim fraud detection, using machine learning types such as 
supervised, unsupervised, graph models, time series, and stream learning 
(Reese et al., 2017). Machine learning has been employed by big companies 
like IBM, for building machines like Watson, where it can assist different 
industries such as Healthcare through its artificial intelligence using the 
powerful computing behind the machine (Mohammed, Khan, & Bashier, 2016). 
 
Table 2.13.2: Machine Learning for Healthcare: On the Verge of a Major Shift in Healthcare 
Epidemiology. Adapted from (Wiens & Shenoy, 2018). 
Application Role of Machine Learning in infectious diseases 
Predicting Risk of 
Nosocomial 
Clostridium difficile 
Infection  
Healthcare-associated infections remain at a large despite 
the efforts of reducing the number of such infections. This is 
in part due to a lack of an effective clinical tool that can 
accurately measure patient risk. Researchers have sought to 
develop models for predicting patient risk of Clostridium 
difficile infection (CDI). A way of making such prediction 
possible is by applying ML-driven approaches that can 
successfully leverage the entire contents of the EHR. Such 
clinical data contain information regarding medications, 
procedures, locations, healthcare staff, lab results, vital signs, 
demographics, patient history, and admission details. ML 
techniques learn to map these data to a value that estimates 
the patient’s probability of CDI. Although more complex than 
low-dimensional tools for calculating patient risk, models that 
leverage the richness of the EHR can be significantly more 
accurate. Such models, based on thousands of variables, 
have been extended to change over the course of an 
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admission, capturing how risk factors change over time. 
These time-varying models could be incorporated into an 
EHR system, using streaming data to generate daily risk 
estimates for each inpatient. 
Predicting 
Reservoirs of 
Zoonotic Diseases 
ML models have been used in to predicted hypperreservoir 
species for zoonotic diseases, as they account for billions of 
human infections and millions of deaths per year worldwide. 
The prediction included parameters such as lifespan, habitat 
etc, which resulted in high accuracy of in predicting such 
diseases. This in return can help in direct surveillance, vector 
control and research into vaccines and therapeutic treatment 
for such diseases.  
Predicting Clinical 
Outcomes in 
Ebola Virus 
Disease (EVD) 
Infection Using 
Initial Clinical 
Symptoms 
During the 2013-2016 West African Ebola Virus period, ML 
was used within a limited dataset in predicting the clinical 
outcomes for those infected with the disease. The data was 
publicly available de-identified dataset, where they accurately 
predicted outcome of infection with only a few clinical 
symptoms and laboratory results. 
Predicting Patients 
at Greatest Risk of 
Developing Septic 
Shock 
ML was applied in predicting septic shocks, which can help 
with early interventions prior to septic shocks. The prediction 
occurred at a median of more than a day prior to the septic 
shock occurring, providing clinicians sufficient time to 
potentially prevent disease or mitigate its severity. This 
prediction goes beyond the intervention and can assist in 
designing clinical trials. 
 
Table 2.13.2 is another example of how Machine Learning has been applied in 
the health domain, highlighting the role of the algorithms and the solutions it is 
providing healthcare professionals with. The applications of Machine Learning 
are endless and with proper training, they can be applied in a number of 
domains. 
Chapter Summary: 
Healthcare delivery is a big domain with multiple types of care for different 
conditions. The domain is complex, as it has a number of issues that affect the 
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delivery of healthcare services. Technologies like IoT present multiple 
opportunities and gateways for delivering health services and care using the 
technology that benefit the healthcare domain and lower the pressure on the 
healthcare systems. The cases of chronic diseases present a big pressure on 
healthcare systems. However, mHealth can reduce the pressures and deliver 
more personalized care for people with chronic diseases. This is all dependent 
on data and the different elements data have. Data and Information are keys to 
facilitating successful patient treatment and enabling self-management for 
reducing costs and pressure on the healthcare systems, yet they are prone to 
errors. Machine Learning is one of the options where technology can create 
successful solutions that can learn from data and detect errors when or before 
occurring, ensuring medical errors are reduced and prevented from happening. 
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Chapter 3 : Research Methodology 
Research design is ‘the logical sequence that connects empirical data to a 
study’s initial research questions and, ultimately to its conclusions’ as explained 
by Yin (2014). In addressing this study’s research question, a qualitative 
research method is applied, and it involves the use of an exploratory case study. 
The qualitative, exploratory case study focuses on examining empirical 
secondary data from an existing mHealth solution for diabetes, with the data 
being accessible for research purposes. The following describes the logical 
sequence for addressing this study’s research question. 
 
3.1 Single Case Study 
Case study is ‘an empirical inquiry that investigates a contemporary 
phenomenon (the “case”) in depth and within its real-world context, especially 
when the boundaries between the phenomenon and context may not be clearly 
evident’ (Yin, 2014). Case studies are not considered a methodology but rather 
a choice of what is to be studied (Denzin and Lincoln, 2011), and they are suited 
for studying a single group, event or person (Donley, 2012). Cases can be an 
individual (group, family, class), an institution (school, factory) or a community 
(town, industry) (Gillham, 2000). The selected case study for this research is a 
mHealth solution for the treatment of people with diabetes, with the case being 
patients’ data. It is a single case study and the selection of this case study is 
guided by two principles. First, the research question guides what case is to be 
selected and studied (Corbin and Strauss, 2008), with the research question 
posed in this study being: 
‘How Can Machine Learning be applied in mHealth Solutions to address Data 
Accuracy and Information Integrity?’ 
This research question is one that conforms to Yin’s (2014) criteria for selecting 
a case study, as the form of the question is ‘How’, requiring no control of 
behavioural events and focuses on contemporary events. As the study focuses 
on understanding how data inaccuracy can occur in mHealth and its effect on 
information integrity, the case (patients’ data) will be studied in its real-world 
context (using the data for the treatment of diabetic patients). The case under 
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study required no control of behaviour in order to produce the medical data, 
which permits the case to be studied and explored as it had occurred rather 
than controlling how it occurs.  
The second principle in selecting such case study is the single-case study 
rationale where the case is critical to the theory (Yin, 2014) and relevant to the 
research question. mHealth for diabetes is critical to the theory proposition as 
it allows for the theory to be tested. The accuracy of the data plays a major role 
in the delivery of healthcare services via mHealth.  
With chronic diseases projected to increase, patients’ data are critical for the 
delivery of effective mHealth services for the treatment of people with a chronic 
disease. Patients’ data can present a complexity in treating patients due to the 
shift in delivering healthcare services using mHealth. The change from being 
treated at the clinic to self-management of health using mHealth technology, 
could allow a gap for errors. Accessing such case study, enables the research 
question to be addressed by examining patients’ data and exploring the 
characteristics of the data, the intended meaning when data was produced and 
how it contributes towards the treatment of the patient.  
In health-related studies, using a case study to address a research question is 
due to the nature of complex and challenging environments in healthcare that 
require methods that do not only explore and understand the process, but also 
provide diverse and contradictory perspectives (Caronna, 2010). This 
complexity is dealt with through case studies as they allow for the exploration 
of processes, activities and events associated with a phenomenon (Creswell, 
2014) through detailed observation of information from records (Bowling, 2009). 
When studying a new emerging technology such as mHealth, in particular the 
core of the technology, data, where its value goes beyond the treatment of 
patients, is complex. Gaining new insights into a new phenomenon where little 
or no knowledge is available can be achieved through exploratory designs 
(Steinberg, 2015). Exploratory research designs begin with the research 
questions (Steinberg, 2015). Literature pertaining to data quality in information 
systems is extensive, including the standards that have been developed. With 
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mHealth still in its early stages, there’s little known literature about the accuracy 
of the solutions being developed and the accuracy once the solution is live, 
where it is out of the lab. Figure 3.1.1 shows the logical flow of the study and 
how it aims to answer the research question. 
 
Figure 3.1.1: Research Design 
In exploring this case study, the data collection method is based on secondary 
data accessible for research purposes. 
3.2 Data Collection 
Digital Data Collection allows for the research question to be addressed by 
tailoring the data to the research goal (Griffiths, 2009). With the case study 
defined as an mHealth solution for the treatment of people with diabetes, and 
the case being patients’ data, the collected data is purposefully selected to 
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complement the case study. Grbich (2013) states that data should come from 
the real world, situations or people who are closely tied to the research question 
or it is the reason the research question was framed in a particular form. Thus, 
the chosen method of data collection seeks data that present a chronic disease 
that is relevant to the case study, it is produced by people in real world and is 
authentic. The type of data collected for this study is qualitative secondary, de-
identified data of patients with diabetes. Secondary, de-identified data is data 
that is used for research purposes and do not identify or represent a person 
(McGraw, 2012). The de-identified data are records of patients who have 
diabetes and contain information such as time and date of the readings, glucose 
reading and a description of the reading. When the research design is an 
exploratory design, the collection of the data is to access information 
(Steinberg, 2015). Using such data, it allows the study to enter a real world 
situation where the data is used to treat a serious chronic disease and the 
method used to collect the data could be erroneous. It is also to understand 
how diabetes work, explore the different characteristics of the disease and data 
types with their meaning in terms of treatment, examining the accuracy of the 
data and understanding the effects data inaccuracy has on information Integrity. 
The adequacy of the data must be according to the research framework. The 
purpose of using the secondary data is to further interpret the data other than 
what it was originally intended for (Singleton, 1988) and to address this study’s 
research question through secondary analysis of data (Seale, et al., 2007). 
Analyzing the secondary data using a new research method and approach, 
establishes a new conclusion different to the one reached in the original 
analysis of the data (Boslaugh, 2007). 
 
A primary data collection method is not applicable as the aim of the study is to 
understand the contemporary phenomenon, that is the accuracy of data 
produced in mHealth. Accessing secondary data allows for understanding of a 
contemporary phenomenon by accessing data that has been produced. That is 
through natural interaction and not one that is produced under this study. This 
data then enables the research question to be tested and addressed. The 
secondary data is accessed using an archival data source (Yin, 2014) of 
patients with diabetes from a clinical solution for their treatment. Archived data 
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are considered a rich and unique source of data that is not often used (Seale, 
et al., 2007). Accessing such source provides an opportunity to test real data 
sets in which it was produced for dealing with serious chronic disease such as 
diabetes. The data present instances (cases) that are relevant to the research 
problem. 
 
3.3 Data Sampling 
With the type of data used in this study being secondary data, the sampling 
technique employed in this study is convenience sampling. Convenience 
sampling is a technique where the data is readily available and accessible for 
the study (Bowers et al., 2011) that can be conveniently recruited (Gideon, 
2012). The convenience sample is patients with diabetes where the treatment 
of patients is done through the use of technology. This type of sampling allows 
for the processes under study to be accessible by seeking events where they’re 
most likely to occur (Silverman, 2010), that is to access information and not 
generalization (Steinberg, 2015).  
 
The convenience sample is selected to fit the research question. The first 
sample of cases will be complete and accurate datasets. This is to match the 
data quality components to the dataset to test whether if all data quality 
components are present in the health data. The second sample of cases will be 
incomplete and inaccurate data where the values from the data are not 
complete. The intention of selecting the two cases is to explore the components 
of data quality and how they affect the meaning of the data if they are missing. 
This will then build an understanding on how inaccuracy can occur from which 
then a Machine Learning Algorithm can be modelled that best represents the 
case so that it can be tested.  
 
Convenience sampling is a non-probability-based sampling technique (Fawcett 
and Garity, 2009) as the data is purposefully selected to understand the 
phenomenon and it is not representative of the whole population. Purposive 
sampling is achieved by selecting typical cases, that is people with an illness 
pg. 102 
 
whose data is recorded in digital format for the treatment of their disease 
(Steinberg, 2014). 
Purposive sampling is “to purposefully select cases that are special, 
troublesome or enlightening” (Emmel, 2013, p. 37). That is to not randomly 
select cases but to access cases that provide information about the research 
question and the phenomenon. The datasets provide information that are 
critical to the treatment of patients and to the quality of care provided through 
mHealth. The purposefully selected cases provide rich information about the 
lived experiences of the patients. 
 
3.4 Data Triangulation 
The accuracy of the findings and interpretation of the data is further 
strengthened through the use of a triangulation method to enhance the 
credibility of the study (Yin, 2016). The triangulation method used for this study 
is triangulation of different data sources of information through the examination 
of different sources of evidence and building a coherent justification for themes 
(Creswell, 2009). The data is triangulated using two strategies. First, 
examination of different patients’ datasets allowing the study to explore the 
characteristics of the different datasets of patients. Second, different Machine 
Learning Algorithms are tested, and their results compared in order to find the 
best suitable and accurate algorithm that best detects the errors in data. 
 
3.5 Data Analysis 
Qualitative case studies search for the meaning and understanding of a 
phenomenon with a descriptive end product as Merriam explains it (2014). 
Accessing the secondary data does not have a meaning, as Kim (2013) states 
‘Texts do not mean, but we mean with text’. Understanding the meaning of the 
mHealth data and its intended use within the context of medical treatment, 
means taking the data and using it to seek a diverse interpretation of the texts 
using the right analysis strategy. It is important to distinguish between the 
analysis strategy and analysis technique. The analysis strategy for this study is 
pattern matching while the two analysis techniques are Thematic and 
Hermeneutics analysis. 
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3.5.1 Thematic Analysis 
Thematic analysis is the coding of data into organized segments of texts before 
bringing meaning to information (Creswell, 2009), and later underlining them for 
generating themes that describe passages in the data (Cohen et al., 2000). The 
secondary data is analyzed using Thematic analysis whereby the data is coded 
into categories that represent: 
1. Element of Data Quality as defined by the World Health Organization 
2. Sources of Data Inaccuracy 
3. Different parts of the research question (Data Accuracy, Information 
Integrity, Machine Learning and mHealth). 
4. New and emerging themes 
 
This pattern matching strategy addresses the whole of the research by 
understanding how the secondary data relates to each of the research 
components and the literature covered in this study. In generating themes, it 
forms the basis for applying a Hermeneutics technique to provide a detailed 
description of the text to capture and communicate the meaning of the lived 
experience for the sample being studied (Cohen et al., 2000). 
 
3.5.2 Hermeneutic Analysis 
We move from text to meaning through interpretation. Hermeneutics is 
extracting meaning from silent text, that is text which has been separated from 
the original authors as the authors were not present at the time text was access 
(example:The Hoy Bible) . The authors are not present and the only method to 
access the meaning of their experience is through interpretation. The 
interpretation process involves bracketing (Grbich, 2013) where it is removing 
one’s own meaning of preconceived ideas and concepts. The extraction of 
meaning from text is through the coding process, where data is coded and 
placed in the right category or concept that is relevant to the phenomena. 
 
Applying Hermeneutics when analyzing the themes is to understand the 
meaning of the texts rather than the cause and the effect of the text (White and 
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McBurney, 2013). Hermeneutics is comprised of three different layers; the Text, 
Translation, and Interpretation Layers (Kim, 2013). In this study, the text layer 
is the collected data of patients with diabetes where the data is authentic and 
credible, and one that represents an instance of the lived experience. In 
Translating the texts, The Omaha System and the Data Dictionaries enable the 
translation of the original data through the mapping of data using the Omaha 
System treatment plans and the definitions listed in the dictionaries. 
Interpretation of the texts starts when the data is translated, and that is 
explaining the texts from a wide array of perspectives (World Health 
Organization definition of Accuracy, Omaha System Treatment plans, Output 
produced by Machine Learning). 
The data is analyzed by first reviewing the secondary data of patients with 
diabetes. Accessing the secondary data allows for the first step of Thematic 
analysis (getting familiar with the data) and also the first step of Hermeneutics 
(turning to the nature of the lived experience) to be applied. The data is then 
revisited and it is aligned with codes from the literature review (Data Quality, 
Information Properties, mHealth, Machine Learning). The data is then mapped 
with the Client Care Plan from The Omaha System to confirm the accuracy of 
the data by matching the data with the treatment plan. Upon the completion of 
mapping the data to the care plan, a Machine Learning algorithm is identified 
that best matches the data. In order to test the Machine Learning Algorithms, 
the secondary data is divided into training and testing datasets. This then 
allowed for the Machine Learning algorithms to be trained using the training 
datasets. Once the training was completed, the Machine Learning Algorithms 
were tested using the testing datasets and the performance of the algorithms 
are both captured to compare the results and the accuracy of the algorithms. 
At each stage of the data analysis, Thematic analysis was applied to capture 
themes to understand the meaning of the data and accuracy of the values. This 
is completed by searching for themes, reviewing and defining them. These 
steps of Thematic analysis built the foundation for Hermeneutics analysis as 
the themes were used to reflect on what the themes meant, how they 
characterized the phenomenon and allowed for the writing of the results to be 
completed by maintaining a focus on the phenomenon through writing. Writing 
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of the results as the data is analyzed produces the report (last step of Thematic 
analysis) and the report included the different parts and entire research (last 
step of Hermeneutics analysis) including the literature review, the research 
question, the collected and the analyzed data. Figure 3.5.1 illustrates the 
process for analyzing the data by starting with the Text Layer that is primarily 
concentrated on the text (data) and wherever data existed or used in the 
research. The Translation layer is where Thematic Analysis was used to define 
and name the themes by reading the data to extract meaning of the data and 
initiate the steps required for the last step of Hermeneutics analysis, the 
Interpretation Layer. The interpretation layer was dependent on the themes that 
were generated through Thematic analysis as the data itself did not have a 
meaning. The interpretation of the themes brought out the meaning behind the 
data and explained what the data was used for and what the accuracy of the 
data meant in the context, treating the patients. 
Chapter Summary: 
The research question is based on Qualitative analysis and the case study 
selects a chronic disease where mHealth technology is delivering services and 
applications through the phone. Thematic and Hermeneutics analyses both aid 
in gaining an understanding of the domain and the results produced by them.  
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Figure 3.5.1 Analysis Design
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Chapter 4 : Data Analysis and Findings 
This chapter shows the process of analyzing the collected data and presents 
the findings. The collected data consisted of structured glucose readings data 
from patients suffering from diabetes. The data were collected using an 
automatic electronic recording device and paper records. The purpose of using 
such dataset is to see how Machine Learning can be applied to health data to 
achieve a certain level of data accuracy that can deliver information with 
integrity. 
4.1 Domain Description and understanding of Diabetes 
Understanding the health domain and how diabetes works, is important in the 
analysis of the data and in interpreting the results. The following describes the 
domain and how diabetes functions.  
 
Diabetes “is a complex chronic metabolic/endocrine disorder characterised by 
loss of normal blood glucose regulation and hyperglycaemia” (Whettem, 2012, 
p.1). Glucose extracted from diet becomes the body’s main source of energy 
(Whettem 2012). Beta cells in the pancreas produce the hormone insulin, which 
is then absorbed through the body’s tissues that use glucose for energy or 
stored as glycogen in the liver/muscles (Whettem, 2012). This is demonstrated 
in the secondary data as it contained a domain description of how insulin 
functions, how exercise affects insulin, diet, and glucose concentration (Dua & 
Karra Taniskidou, 2017). The following is an extract from the domain 
description included in the datasets (Dua & Karra Taniskidou, 2017): 
 
• INSULIN 
One of insulin's principal effects is to increase the uptake of glucose in many of 
the tissues (e.g. in adipose/fat tissue) and thereby control the concentration of 
glucose in the blood. Patients with Insulin Dependent Diabetes Mellitus (IDDM) 
administer insulin to themselves by subcutaneous injection. Insulin doses are 
given one or more times a day, typically before meals and sometimes also at 
bedtime. Many insulin regimens are devised to have the peak insulin action 
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coincide with the peak rise in BG during meals. In order to achieve this, a 
combination of several preparations of insulin may be administered. Each 
insulin formulation has its own characteristic time of onset of effect (O), time of 
peak action (P) and effective duration (D). These times can be significantly 
affected by many factors such as the site of injection (e.g. much more rapid 
absorption in the abdomen than in the thigh) or whether the insulin is a human 
insulin or an animal extract. The times I have listed below are rough 
approximations and I am sure that I could find an endocrinologist with different 
estimates. 
 
Regular Insulin: O 15-45 minutes P 1-3 hours D 4-6 hours 
NPH Insulin: O 1-3 hours P 4-6 hours D: 10-14 hours 
Ultralente: O: 2-5 hours. P (not much of a peak) D 24-30 hours. 
 
• EXERCISE 
Exercise appears to have multiple effects on BG control. Two important effects 
are: increased caloric expenditure and a possibly independent increase in the 
sensitivity of tissues to insulin action.  BG can fall during exercise but also quite 
a few hours afterwards. For instance, strenuous exercise in the mid-afternoon 
can be associated with low BG after dinner. Also, too strenuous of an exercise 
with associated mild dehydration can lead to a transient increase in BG. 
 
• DIET 
Another vast subject but (suffice it to say for the purposes of users of the data 
set) in brief: a larger meal will lead to a longer and possibly higher elevation of 
blood glucose. The actual effect depends on a host of variables, notably the 
kind of food ingested. For instance, fat causes delayed emptying of the stomach 
and therefore a slower rise in BG than a starchy meal without fat. Missing a 
meal or eating a meal of smaller than usual size will put the patient at risk for 
low BG in the hours that follow the meal. 
 
• GLUCOSE CONCENTRATIONS 
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BG concentration will vary even in individuals with normal pancreatic hormonal 
function.  A normal pre-meal BG ranges approximately 80-120 mg/dl. A normal 
post-meal BG ranges 80-140 mg/dl. The target range for an individual with 
diabetes mellitus is very controversial. Generally, it would be very desirable to 
keep 90% of all BG measurements < 200 mg/dl and that the average BG should 
be 150 mg/dl or less. Note that it takes a lot of work, attention and (painful) BG 
checks to reach this target range. Conversely, an average BG > 200 (over 
several years) is associated with a poor long-term outcome. That is, the risk of 
vascular complications of the high BG is significantly elevated. 
 
Hypoglycemic (low BG) symptoms fall into two classes. Between 40-80 mg/dl, 
the patient feels the effect off the adrenal hormone epinephrine as the BG 
regulation systems attempt to reverse the low BG.  These so-called adrenergic 
symptoms (headache, abdominal pain, sweating) are useful, if unpleasant, 
cues to the patient that their BG is falling dangerously. Below 40 mg/dl, the 
patient's brain is inadequately supplied with glucose and the symptoms become 
those of poor brain function (neuroglycopenic symptoms). These include: 
lethargy, weakness, disorientation, seizures and passing out. 
 
This description provides an understanding of how diabetes works, how the 
datasets are obtained and what the meaning of the actual datasets is. This 
description of the domain is taken into consideration when building the Machine 
Learning model and in describing the secondary data. 
 
4.2 Describing the secondary data 
The secondary data were obtained from a Machine Learning Data Repository 
provided by the University of California, where data is available for further 
analysis and testing (Dua & Karra Taniskidou, 2017). The data consisted of 70 
patients records (datasets) and each record presented an individual patient. 
The description of the data is as follows: 
 
Diabetes patient records were obtained from two sources: an automatic 
electronic recording device and paper records. The automatic device had an 
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internal clock to timestamp events, whereas the paper records only provided 
"logical time" slots (breakfast, lunch, dinner, bedtime). For paper records, fixed 
times were assigned to breakfast (08:00), lunch (12:00), dinner (18:00), and 
bedtime (22:00). Thus, paper records have fictitious uniform recording times 
whereas electronic records have more realistic time stamps.  
 
The data Diabetes files consist of four fields per record (See Figure 4.2.1). Each 
field is separated by a tab and each record is separated by a new line.  
File Names and format:  
(1) Date in MM-DD-YYYY format  
(2) Time in XX:YY format  
(3) Code  
(4) Value 
 
Figure 4.2.1: Example of the Secondary Data in its original format. Example is from Data1 
 
The secondary data also had an explanation for the code attached to each of 
the readings. The explanations are as per Table 4.2:1. 
Table 4.2.1: Codes and their explanations 
Code Explanation 
33 Regular insulin dose 
34 NPH insulin dose 
35 UltraLente insulin dose 
48 Unspecified blood glucose measurement 
57 Unspecified blood glucose measurement 
58 Pre-breakfast blood glucose measurement 
59 Post-breakfast blood glucose measurement 
60 Pre-lunch blood glucose measurement 
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61 Post-lunch blood glucose measurement  
62 Pre-supper blood glucose measurement 
63 Post-supper blood glucose measurement 
64 Pre-snack blood glucose measurement 
65 Hypoglycemic symptoms 
66 Typical meal ingestion 
67 More-than-usual meal ingestion 
68 Less-than-usual meal ingestion 
69 Typical exercise activity 
70 More-than-usual exercise activity 
71 Less-than-usual exercise activity 
72 Unspecified special event 
 
The data was chosen as: 
1. It presents a scenario where diabetes data is collected both using an 
electronic device and recorded manually, where the collection method is 
one similar to the ones discussed in the literature review. This method of 
entry makes data prone to error during the data entry stage of data 
collection. 
2. The data is part of Machine Learning data collection, which makes it 
appropriate for this research question and the techniques used in this study 
provides a fresh perspective on how Machine Learning can be applied in 
modern technologies that deal with chronic diseases. 
3. The data is diabetes, a chronic disease that is discussed in the literature 
review and a global burden to the healthcare systems around the world.  
The data is not based on a mHealth solution, but it is one that can closely 
simulate mHealth solution for diabetes. 
 
4.3 Review of secondary data of patients with diabetes 
The initial analysis of the data was reviewing the data in its original format and 
the aim of this is to gain information about the type of data being generated by 
patients with diabetes. The elements that were present in the datasets were: 
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• Completeness: This element of the data quality was present in the data as 
the element was tested during the analysis for when data showed complete 
datasets and where records were missing.  
 
• Currency and Timeliness: This element of the data quality was present in the 
data as the element was tested during the analysis by checking how current 
the data is and the time stamps when data was recorded. The data showed 
both currency (how promptly data are updated) and timeliness (how current 
data are for the task at hand). 
 
• Legibility: This element of the data quality was present in the data as the data 
was readable, except for instances where data was missing correct data 
format. Legilibty means the content of the data are sufficient for the data to be 
interpreted. 
 
• Consistent: This element of the data quality was present as the data showed 
both instances of consistent and inconsistent datasets. 
 
• Reliability: This element of data quality was present in the datasets as some 
of the datasets yielded the same results on repeated collection, processing, 
storing and displaying of information. 
 
• Meaning and usefulness: This element of the data quality was present in the 
datasets as the Information from the datasets were both useful, or in some 
instances lacked information.  
 
• Accuracy and Validity: The data demonstrated that not all elements of data 
quality were available in the datasets. The following elements of data quality 
were not applicable as they could not be tested during the analysis. 
 
• Accessibility element: This element of the data quality is of limitation in this 
study as the data was accessible at the time when the data was analysed. 
Therefore, accessibility can be evaluated when the researcher analyses data 
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that is observed when the patient sends/transmits the data to the medical 
professional, which is then when it can be tested for accessibility. 
 
• Confidentiality and security: This element of the data quality is of also a 
limitation in this study as the data cannot be tested for confidentiality as it was 
secondary data and it does not identify a person. It also could not be tested 
for security as the data was available for research purposes and it was not 
confidential. 
 
While some of the elements of data quality were missing, the structure of the 
data was simple and had very little information around the readings. The 
structure included date of the reading, time of the reading, a code explaining 
the reading and the actual reading. Figure 4.3.1 is an example of the raw data 
and this example is from Data20, one of the datasets.  
 
 
Figure 4.3.1: A snippet of the structure of the raw data from Data20 in its original format 
 
The structure of the data was transformed into a different format for multiple 
reasons: 
1. The structure of the data was too simple when algorithms were tested 
against the data as the results were simple and the data was easily 
classified, which defies the purpose of the study. 
2. The structure also shows the human behaviour and the management of the 
diseases through a sequence of data put together in a row that shows the 
researcher what is happening with the patient and what the symptoms 
mean, the treatment and the readings from the patient. This process allows 
the researcher to follow the history of the patient and understand how the 
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patient reacts to certain aspects of the disease and how they treat their 
symptoms, bringing the research question closer to being addressed. 
3. The new structure of the data allowed to introduced a new complexity in 
solving the issue of accuracy with data. The new structure (Figure 4.3:3) 
included more meta-data that enhanced the quality of the algorithms and 
made it more meaningful than before. The structure presented a simple 
checklist that checked for each element of data quality for each row of the 
datasets and calculate the accuracy.  
 
Figure 4.3.2 is the structure of the data prior to the change in the structure as 
per Figure 4.3.3.  
 
Figure 4.3.2: Example of old data structure from Data1 before it was transformed into new 
format 
 
 
Figure 4.3.3: Example of the new data structure from Data1 
 
The new structure of the data provides more information that assisted in 
deciding the algorithms and provide a closer view of the real world of health 
data, data generated by humans and not systems.  
 
4.4 The transformation of data before Machine Learning 
Part of preparing the data for machine learning, the structure of the data was 
transformed into a different structure in order to address the research question 
and make it ready for Machine Learning. The change in the structure of the data 
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is to include metadata that can yield more information and make sense of what 
the data means, thus making it relevant to the research question.  
The structure of the data included headings for each of the columns as the data 
must be unique prior to using Machine Learning Algorithms. The headings 
were: 
1. Date 
2. Time of the reading 
3. Code for reeading 
4. Reading 
5. Completeness 
6. Currency and Timeliness 
7. Legibility 
8. Consistency 
9. Reliability 
10. Meaning and Usefulness 
11. Accuracy and Validity 
 
The selection of these fields is based on the list of a priori codes generated from 
the literature review. Prior to the analysis of the data, a list of a priori codes was 
generated from the literature review which were used in the labelling of the data. 
The selection of these codes was (See Table 4.4.1) 
1. Relevant to the research question, such as elements of data quality and 
aspects of information integrity 
2. They would provide more information about the disease, the patients, and 
the management of the disease. 
Table 4.4.1: List of A priori codes generated from the literature review 
A priori codes generated using Elements of 
Data Quality 
A priori codes generated using causes 
of lack of Information Integrity 
Accuracy and Validity Inaccurate Data 
Reliability Incomplete Data 
Completeness Incorrect Data Entry 
Legibility Security 
Currency and Timeliness Untimely Data 
Consistency  
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Meaning or usefulness  
This list of a priori codes was used in the labelling of the data, which assisted 
in building a machine learning model in Weka. 
4.5 Labelling the data 
The data were labelled using the apiori codes from the literature review. The 
codes were chosen as they represented the elements of data quality, as they 
can help in identify which data can be classified as accurate or not.  
 
The order for the labelling was done by: 
1. Completeness: This field tags whether the data is complete or not. 
2. Currency and Timeliness: This field tag whether the data is current and 
timely or not. 
3. Legibility: This field tags whether the data is eligible for use or not. 
4. Consistent: This field tags whether the data is consistent or not. 
5. Reliability: This field tags whether the data can be relied in for making 
decisions or is of no use. 
6. Meaning and Usefulness: This fields tags whether the data is meaningful 
and is useful to be used in decision making. 
7. Accuracy and Validity: This field tags whether the data is accurate and valid 
once the data has been checked for earlier check or not. 
8. OverallAccuracy: This field tags whether the data overall accuracy is 
correct or not. This field is of important value to Machine Learning as it is 
the target variable the algorithms try to predict.  
 
After applying the codes to the data, the datasets were given either a ‘yes’, 
which marked the data as a valid dataset containing the correct data quality 
element, or a ‘no’, where data did not contain the valid data quality element. 
The labelling of the data follows a logic of which data is tested against each 
element of data quality (See Figure 4.5.1).  
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Figure 4.5.1: Labelling of the data 
By labelling the data, it became more relevant to addressing the research 
question in this study as the process of the labelling demonstrated how Machine 
Learning can be applied in mHealth solutions. This also assisted in defining the 
problem that was later applied in Machine Learning.  
4.6 Defining the problem and understanding the data 
Before analysing the data using an algorithm, a problem definition was 
described that assisted in the selection of the data. Applying an algorithm is not 
a simple process and it requires data to be of appropriate format and quality. 
The problem was defined as ‘Ways in which Machine Learning can detect data 
inaccuracy and/or improve the data quality in mHealth technology’. This moved 
the focus from finding the optimum algorithm that can detect the inaccurate data 
at 100% accuracy but rather focus on ways in which the technology can improve 
mHealth solutions by using the data and the advances in algorithm for a better 
solution.  
 
After the problem was defined, the early stages of the analysis, the datasets 
were then examined to form an understanding of the data structure, type of 
data, frequency of the readings and the length of the data (Figure 4.6.1 is a 
snapshot of what the data looked like). The data consisted of 70 patient records, 
and fields were Date Stamp, Time Stamp, Code to explain the condition, and a 
reading.  
 
 
Figure 4.6.1: Data Samples from Diabetic Dataset 
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The data were then re-written in a table format that simulated the patient dealing 
with diabetes on a daily basis. This improved the understanding of what the 
data meant, and the actions taken by the patient in different scenarios caused 
by glucose levels and activities carried by the patients. It also simulated the sort 
of behaviour/interaction patients have when self-managing their disease and 
health. It depicted how monitoring is done, the patient’s behaviour, and the 
quality of the data being generated by the patient and the disease. 
 
This led to the generating a machine learning model that could be applied to 
the datasets. 
4.7 Building the Model and Selection of Weka Machine 
Learning Tool 
With the data labelled with values and the target value, a machine learning 
model was built based on the new structure of the data (See Figure 4.4:3). The 
logic of the model is one that checks for the value of each of the elements of 
data quality and uses the target variable to predict whether the data is accurate 
or inaccurate. The model is illustrated in Figure 4.7.1 in which it 
1. Checks if data is complete or incomplete (Yes, No): Some of the data were 
complete and some incomplete, thus assigning either a ‘Yes’ or a ‘No’ to 
data. 
2. Checks if data is current and Timely (Yes, No): All the data were current and 
had a timestamp, thus assigning a ‘Yes’ to all records. 
3. Checks if the data is Legible (Yes, No): All the data were in readable format, 
thus assigning a ‘Yes’ to all records. 
4. Checks if the data is consistent or inconsistent (Yes, No): Some of the data 
were consistent and some inconsistent, thus assigning either a ‘Yes’ or a 
‘No’ to data. 
5. Checks if the data can be relied on for decision making (Yes, No): Some of 
the data were reliable and some weren’t, thus assigning either a ‘Yes’ or a 
‘No’ to data. 
6. Checks if the data is meaningful and useful (Yes, No). All the data had 
meaning and were useful, thus assigning a ‘Yes’ to all records. 
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7. Checks if the data is accurate and valid (Yes, No): Each instance of the data 
were accurate for the specific use and valid as well. The data were given a 
‘Yes’. However, the Overall Accuracy, is the last variable that took into 
consideration all the elements of data quality and produced either a ‘Yes’ or 
a ‘No’.  
 
 
Figure 4.7.1: Machine Learning Model 
Figure 4.7:2 illustrates the process in building the machine learning model. This 
model was built based on data accuracy, where accuracy takes into 
consideration the different elements of data quality in a decision. 
 
 
Figure 4.7.2: Process of building a Machine Learning Model 1.2 
Figure 4.7.2 and Figure 4.7.3 illustrate the behind the scene process for building 
the actual model in Weka Machine Learning Tool and the thinking behind it.  
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Figure 4.7.3: Process of building the model 1.2 
The Machine Learning model was built using Weka, an open source Machine 
Learning tool provided by the University of Waikato, New Zealand. It is an easy 
to use, yet powerful tool, that provides a graphical user interface for performing 
machine learning. It also contains the necessary tools for performing the ‘Pre-
processing’ of data prior to running the algorithm against the data.  
 
The algorithm used in this study is the J48 Classification Algorithm, a decision 
classification machine learning algorithm that produces an analysis of the input 
data and produce an output, modelling the output based on a decision tree. 
This algorithm is a common one used in many technologies, including 
commercial tools like music and entertainment industry. 
 
Once the model was built, the data was then ready for the ‘Pre-processing’ 
stage of Machine Learning algorithm.  
 
4.8 Data Pre-processing 
Prior to analysing the data using an algorithm, the data went through a pre-
processing stage, where the data were examined, organized in a sequence 
•Understand the 
diabetes data
•Review the fields of 
the datasets
•Tag the algorithms
Specification
•Model the data based 
on elements of data 
quality
Modelling
•Use J48 Algorithm to 
classify the data using 
the target variable 
‘Overall Accuracy’
Classification
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based on daily management of diabetes, removed missing and redundant data 
that might result in a biased output using the algorithms. The data was then 
split into a training and testing dataset following a 70:30 rule, where 70% of the 
data is used for training and 30% for testing (Zinoviev, 2016). This rule of 
splitting was also applied in a similar study for classifying diabetes data where 
70% of the data was used for training and the other 30% of the data for training 
(Nabi, Wahid, & Kumar, 2017). The data was split using the built in 
unsupervised filter (RemovePercentage) where 30% of the data was removed 
which produced the 70% of the training data. The rule was later removed after 
the training datasets were generated and invertSelection was set to true which 
generated the 30% of testing datasets.  
 
The pre-processing of the data ensured the data was ready for analysis and a 
list of outputs was produced through the algorithms.  
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4.9 Findings 
The following presents the findings from the Thematic analysis of the data and the outputs from the Machine Learning Algorithms. 
The Thematic analysis was conducted using Nvivo, where data was coded against the codes from the literature review (a priori 
codes). Thematic analysis also resulted in new themes emerging form the analysis that provided a new insight into what the data 
meant.  
 
The results from the Machine Learning training and testing were recorded based on the total number of records per dataset (patient 
records), and the 70% of data used for training and the 30% used for testing. 
 
4.9.1 Thematic Analysis 
 
Theme Area of mHealth Findings 
Expected Theme Data Quality Inconsistency 
• Some of the data were inconsistent on hourly basis (when data was recorded/collected) 
• The readings were sent at irregular intervals where some followed a consistent manner 
• Some of the readings were inconsistent in the number of readings that were sent (some instances of when data 
was recorded, it included 1 instance of a reading, other times 2 or more readings 
• Inconsistency between patient readings 
• Inconsistency between the readings for a patient on hourly and daily basis 
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Currency 
• All the data were current as the timestamps provided evidence that the data were current for the purpose the 
data were collected for 
• This element of data was consistent across the 70 datasets 
 
Incomplete 
• Some of the data included a code with no explanation as the code was not included in the code explanation 
• Some of the data were incomplete as there was a single reading, where most of the instances included multiple 
readings, showing the patients’ behaviour and the intended use of the data.  
 
Readability 
• Majority of the the 70 datasets were readable and the characters (data) were easily readable. This means that 
the data did not contain any invalid characters (ASCII characters or the format were not recongizable). 
• There were instances were data contained invalid codes which were not part of the codes supplied in the 
metadata 
 
Consistency 
• Consistency was a common theme amongst the data, as some of the readings were collected in a consistent 
manner, including timestamps, readings, and codes on a specific day. 
pg. 124 
 
 
Complete 
• There were instances of data were the collected data were complete and contained large amount of information 
that demonstrated the purpose of the readings and patients’ behaviour. 
Incorrect data 
• Instances of incorrect data were present in the data. An example is data64 where the data was repeated, it did 
not exactly reflect what was happening, and the data was duplicated. 
 
Timeliness 
• Frequency of the data: The data was transmitted hourly on a daily basis. 
• The readings were collected in minutes, that made them an hourly reading. . 
• The hourly readings were timely, which contributed to being daily readings. 
 
Accuracy 
There were different levels of accuracy that prevailed during the analysis, and accuracy is defined based on the 
context of the data. For instance, the accuracy of data meant that: 
1. Accuracy of the data at the hourly interval 
2. Accuracy of the data at the treatment level 
3. Accuracy of the data at the daily interval 
4. Accuracy of the treatment of the disease on the daily basis 
Emergent Theme Readings • The frequency of the data was on hourly and daily basis 
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• The readings varied at the times they were sent and the amount of data supplied was different too. The variability 
in the readings of the data makes it difficult for the algorithms to operate efficiently and the data had to be manually 
examined and reviewed. 
 
Lack of Information • Some data were missing information such as codes 
• Other data were a single data collected which lacked information about what was happening and why a single 
collection of data. 
Gap between readings • The data at times showed a gap between readings as at times data was collected at early morning (around 
9:00AM) and later collected again at 18:00PM 
Human Behaviour • The human behaviour demonstrated disease symptoms and the associated behaviour users go through when 
dealing with a symptom of diabetes 
• The collected data displayed human behaviour where a variability in the readings of data showed that the data 
was transmitted at different frequencies based on the activity the patients were undertaking. 
• Each record demonstrated that individuals manage their diseases differently and the decision for insulin dosage 
is not sufficiently demonstrated or elaborated on 
Duplicate Records • Some of the data contained duplicate records which were of no use as the data did not contain useful information. 
 
4.9.2 Machine Learning Outcomes  
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Dataset Total number of 
records per 
dataset 
Number of 
records for 
training 
Number of 
accurate 
classified 
data 
Number of 
inaccurate 
classified data 
Number of 
records for 
testing  
Number of 
accurate 
classified data 
Number of inaccurate 
classified data 
Data1 504 353 353 0 151 151 0 
Data2 380 266 264 2 114 114 0 
Data3 145 101 101 0 44 44 0 
Data4 151 106 106 0 45 45 0 
Data5 152 106 106 0 46 46 0 
Data6 65 45 45 0 20 19 1 
Data7 119 83 83 0 36 36 0 
Data8 133 93 93 0 40 40 0 
Data9 108 76 76 0 32 32 0 
Data10 107 75 75 0 32 32 0 
Data11 72 50 50 0 22 20 2 
Data12 91 64 62 2 27 27 0 
Data13 101 71 71 0 30 30 0 
Data14 58 41 40 1 17 17 0 
Data15 97 68 68 0 29 27 2 
Data16 97 68 68 0 29 29 0 
Data17 120 84 84 0 36 36 0 
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Data18 147 103 103 0 31 31 0 
Data19 140 98 98 0 42 42 0 
Data20 453 317 317 0 136 136 0 
Data21 245 171 171 0 74 74 0 
Data22 107 75 75 0 32 32 0 
Data23 106 74 74 0 32 30 2 
Data24 119 83 83 0 36 36 0 
Data25 91 64 64 0 27 26 1 
Data26 306 214 214 0 92 92 0 
Data27 463 324 324 0 139 139 0 
Data28 477 334 334 0 139 139 0 
Data29 617 432 432 0 185 185 0 
Data30 591 414 414 0 177 177 0 
Data31 336 235 235 0 101 101 0 
Data32 58 41 41 0 17 17 0 
Data33 126 88 88 0 38 38 0 
Data34 131 92 92 0 39 39 0 
Data35 131 92 92 0 39 39 0 
Data36 132 92 92 0 40 40 0 
Data37 152 106 106 0 46 46 0 
Data38 134 94 94 0 28 28 0 
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Data39 137 96 96 0 41 41 0 
Data40 Data could not be tested as the records were duplicate 
Data41 251 176 176 0 75 74 1 
Data42 261 183 183 0 78 76 2 
Data43 294 206 206 0 88 88 0 
Data44 144 101 101 0 43 43 0 
Data45 137 96 96 0 41 41 0 
Data46 142 99 99 0 43 43 0 
Data47 153 107 107 0 32 32 0 
Data48 157 110 110 0 47 47 0 
Data49 191 134 134 0 57 57 0 
Data50 249 174 174 0 75 75 0 
Data51 152 106 106 0 46 46 0 
Data52 173 121 121 0 52 52 0 
Data53 128 90 90 0 38 38 0 
Data54 407 285 285 0 122 122 0 
Data55 607 425 425 0 182 182 0 
Data56 510 357 357 0 153 153 0 
Data57 104 73 73 0 31 29 2 
Data58 126 88 88 0 38 38 0 
Data59 126 88 88 0 38 38 0 
pg. 129 
 
Data60 128 90 90 0 38 38 0 
Data61 124 87 87 0 37 37 0 
Data62 140 98 98 0 42 42 0 
Data63 156 109 109 0 47 47 0 
Data64 Data could not be tested as the records consisted of single readings and the format of the data was incorrect 
Data65 565 395 395 0 170 170 0 
Data66 Data could not be tested as the records were duplicate 
Data67 496 347 347 0 149 149 0 
Data68 528 370 370 0 158 158 0 
Data69 Data could not be tested as the records consisted of single readings 
Data70 151 106 106 0 45 45 0 
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Chapter 5 : Discussion 
This chapter discusses the findings from the study and some key points that 
relate to the research question, including emerging areas that relate to mHealth.  
The main goal of this study was finding a way in which machine learning could 
be applied in mHealth solutions that can detect inaccurate data and to deliver 
information with integrity. This was accomplished using the J48 Algorithm after 
the labelling the datasets, building, training, and testing the model, where data 
were classified as either accurate or inaccurate. The results from this study 
affect several areas that are integral components of mHealth and ones that 
must be taken into consideration in order to understand the interpretation of the 
research. These include: 
• The different levels of Data Accuracy 
• Understanding the human behaviour 
• The role of metadata in providing more information about the data 
• Contextual data and how it is providing background information about the 
patient 
• Using contextual data in building a machine learning model to detect 
inaccurate data 
• The privacy of the users and the security of the data when building an 
algorithm.  
 
5.1 The different levels of Data Accuracy 
Accuracy is a term that is context dependent and the term was used to discuss 
the accuracy of the diabetes data in the study. The accuracy in this study was 
defined on 2 levels: 
1. Accuracy of the elements of data quality, that took into consideration the 
accuracy of each element of data quality and how they contribute to the 
overall accuracy of the full dataset. This was then applied in building the 
Machine Learning Algorithm 
2. Accuracy of the information provided through the data, including the context 
(patients with diabetes), the human behaviour provided through the codes 
in the data and the purpose of the collected data. 
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Defining these 2 levels of data accuracy, provided an insight of where in the 
solutions data can be inaccurate and what signs or symptoms hint at 
problematic data. This then guided the study into understanding how data 
inaccuracy occurred, what inaccurate data readings looked like, and how they 
could be used as a benchmark for detecting accurate data. The inaccurate data 
provided an insight of how patient safety can be compromised, what triggers 
should be in place to flag when data is inaccurate and how it should be 
prevented from progressing into the next stage of becoming information. In 
terms of chronic diseases, the elements of data quality provided a check for 
each reading that came through and flagged whether the data met the 
necessary criteria to be qualified as accurate data. Once the elements of data 
quality were checked for each reading, the data then progressed to the next 
stage of being used as information. The integrity of the information was also 
impacted by the quality of the data as some instances of the data were 
inaccurate, which meant that the integrity of the information could not be 
accomplished and that it could lead to serious harm. Some of the data lacked 
consistency, accuracy and reliability, which are flags for information lacking 
integrity. 
 
With data and information integrity impacted by inaccurate data, the reasons 
and causes of inaccurate data can be better understood by understanding the 
human behaviour. 
 
5.2 Understanding the human behaviour 
During the analysis of the data, a theme that emerged was human behaviour 
as the data showed that the way humans manage their diabetes varies from 
one patient to another. Humans behave differently, and an interesting 
behaviour is a ‘lying patient’, a patient who does no adhere to treatment 
(Bardosh et al., 2017). Non-adherence is an example of how data can lack 
accuracy as data is missing the truth (complete data with context that shows 
what is happening). The changes in human behaviour can potentially impact 
the quality of the data as data is not consistent. This type of behaviour can be 
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tracked using Machine Learning where models can be built as new situations 
emerge. The tracking of human behaviour using Machine Learning might prove 
critical in detecting abnormalities in data that can enhance the quality of care 
through mHealth. The tracking of human behaviour can have both a positive 
and a negative impact on the algorithms. On a positive side, it means that once 
the human behaviour has been modelled, the algorithm can be used across 
multiple datasets to predict any data collected for a specific reason. On a 
negative side, the changes in human behaviour, mean that algorithms must be 
refined continuously as new data comes through, which results in overfitting. 
The modelling of human behaviour is not a new concept and it has been done 
in separate studies for different purposes. Human behaviour has been studied 
over a long time with such research including human movement in time and 
space that has spanned over at least over five decades (Weiner, 1999). The 
purpose of the study was to forecast future travel demand to better guide the 
investment of mega-scale transportation projects, where the prediction of the 
human behaviour would allow an understanding of how people travel (Weiner, 
1999).  
 
The concept of modelling human behaviour using a machine learning algorithm 
for a specific purpose or solution can be effective. The modelling of the human 
behaviour in this study meant that the algorithms can be applied in mHealth 
solutions to help continue the development of mHealth solutions and ensuring 
the quality of the data and information. With the patient-clinician interaction 
experience changing within the context of mHealth, the modelling of the human 
behaviour might become more common in delivering an effective solution to 
patients. The precision of modelling the human behaviour can be affected by 
the amount of metadata available that can add a greater meaning to the data. 
 
5.3 The role of metadata 
Metadata plays an important role in assisting people to understand data and 
the meaning of the data. The metadata accompanied with the datasets provided 
information that helped in establishing a Machine Learning model which created 
the classification algorithm. Metadata can provide more information around the 
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context of the data. In this study, the data contained 4 columns, data, time, 
reading, and the code for the data. These columns provided a context around 
what time of the day the reading came through, what instigated the treatment, 
the before and after glucose readings. However, if the date field contained the 
day of the week, it could provide more data as to the patients’ behaviour during 
the weekdays and the weekends, allowing for more information to be collected 
and used in the analysis of the data. The more data we have the better the 
prediction is. Metadata can be revealing as they capture large amount of data 
about individuals and their behaviour (Pomerantz, 2015). 
 
Metadata is becoming more common in modern technology such with likes of 
social media where metadata can reveal information about individuals and their 
social networks, connection between places, and organization (Pomerantz, 
2015). Metadata is becoming an inevitable section of technology to avoid as 
modern technologies keep adopting the technology. The collection of metadata 
can give a greater detail about the landscape of the data and the solution, thus 
building contextual data that mean something, specifically when the data is 
secondary data. 
 
5.4 Contextual data and the inclusion of other metadata 
The more data there is available about what is being studied, the more it can 
be understood about the content and the context of the data. This is where the 
more metadata we have about the data, the better we can train the algorithms 
to classify and predict results. In this research, metadata were generated apart 
from what was originally provided with the data. The metadata generated 
through the analysis included an insight into the life of a patient having diabetes 
on daily basis, and a mapping of the Omaha System Care Plan, which provided 
further insights of when a reading becomes problematic and when it can be 
safely acknowledged that if the condition is within the right limit. Both of these 
metadata information provided a better insight into how the data works and how 
to better train the data and push towards accurate results. Metadata can help 
build greater solutions using artificial intelligence such as the use of Machine 
Learning to better facilitate health IT solutions.  
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5.5 Machine Learning and Artificial Intelligence 
A separate perspective derived from the Artificial Intelligence world, and one 
that is related to this research is Machine Intelligence. The machines can be 
trained to do certain tasks and accomplish goals with rewards. Self-driving cars 
need to integrate pattern recognition, with other capabilities, including 
reasoning, planning and memory (Loukides & Lorica, 2016).  Loukides & Lorica, 
(2016). These different capabilities are to enable self-driving cars to detect 
hazards, reason to understand regulations, planning to plan routes, and 
memory to repeat and learn (Loukides & Lorica, 2016). In healthcare, it is a 
similar case to the AI solution as the algorithms must cater and be adequate for 
different diseases and patients. Figure 5.5.1 presented below is an illustration 
of this process and shows how algorithms can be applied to different areas of 
data in mHealth to achieve a higher level of data accuracy and information 
integrity. 
 
Figure 5.5.1: Application of Machine Learning in mHealth solutions 
The power of AI can provide ways to improve the functions and capabilities 
of mHealth devices. For example, the capabilities of AI techniques can assist 
in building smart solutions that can make mobile devices aware of the needs 
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and preferences of users by leveraging real-time situational data, such as 
location and mood of the users, that is collected via sensors and other data 
inputs (e.g., survey apps) (Luxton, June, Sano, & Bickmore, 2016). This similar 
method can be adopted in mHealth to help address the accuracy of data, 
particularly in solutions where evaluation of the data is limited or where 
automation takes precedence in providing feedback to users (Automated Apps, 
Text-messaging feedback etc).  
AI is a growing field and its use is expanding, particularly where sensor-based 
solutions existed. In a study Luxton et al. (2016), Ambient Intelligence (Aml) is 
a term that refers to smart technologies that are embedded within a space, such 
as in a home, hospital room, or a public area that interact with persons within 
the environment. Aml gathers information from sensors and other integration 
devices that provide contextual data to adapt environments to users’ needs in 
an interactive manner Luxton et al. (2016). The characteristics of Aml are 
Luxton et al. (2016): 
• Context Aware: It exploits the contextual and situational information. 
• Personalized: It is personalized and tailored to the needs of each individual. 
• Anticipatory: It can anticipate the needs of an individual without the 
conscious mediation of the individual. 
• Adaptive: It adapts to the changing needs of individuals. 
• Ubiquity: It is embedded and is integrated into our everyday environments. 
• Transparency: It recedes into the background of our daily life in an 
unobtrusive way. 
This technique can be applied to different mHealth devices where algorithms 
can be adapted to the specific solutions and check for data quality as it gets 
collected, analyzed and disseminated. This provides both accurate data and 
help improve the integrity of the data. With the technologies and advances in 
Artificial intelligence, earning the trust of the users to use the IT systems is of a 
concern and must be taken into consideration as it can deter patients from 
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adopting technologies. With the promising results of Machine Learning and 
Artificial intelligence, the privacy of people must be respected, and the data 
must be secure as health data is sensitive data. 
5.6 Privacy of users and data security 
With the introduction of ML and AI in the healthcare domain, user privacy needs 
to be respected and looked after while maintaining the security of their records. 
In a world where data is in abundance, it creates an opportunity for algorithms 
to be used in detecting a various number of activities for whatever the solution 
the data is required for. This level of intelligence can penetrate users’ privacy 
and breach their privacy as it generates information that can reveal information 
about the users or patients.  
 
The privacy of the users must be respected, and their health data secured to 
earn their trust. With data proving to containing more information about the 
patients and the diseases, it can penetrate users’ privacy if ML algorithms are 
used for the wrong reasons. The intelligence of the machine can prove critical 
in overfitting data that can penetrate the users’ privacy as their behaviour is 
closely modelled. This can break the trust of users and push them to behave 
differently. Privacy can push people to behave differently to what is expected of 
them. An example is where between 15% to 17% of US adults have changed 
their behaviour in order to protect their privacy by eliminating information from 
being disclosed to their medical professionals (Malin, Emam, & O'Keefe, 2013). 
Such change in behaviour range from paying out of pocket to avoid disclosure 
to not seeking treatment and asking the healthcare professionals to record less 
serious health problems (Malin et al., 2013). This can lead to inaccurate, 
mismatch in data that impacts the integrity of the information produced because 
of this. Evidence suggests that privacy is of concern to people using information 
systems (IS) for medical reasons, particularly the use of websites as it impacted 
their behaviour (Sampat & Prabhakar, 2017). Those with higher privacy 
concerns view IS systems to be more risky and develop concerns about them 
(Sampat & Prabhakar, 2017). Another case of protecting users’ privacy is with 
the implementation of EHR systems, where the content of the structured and 
free-text data means that privacy and security are essential for managing the 
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systems (Huang, Sharaf & Huang 2013). A modern example of this challenge 
is in the implementation of Smart health (s-health), where context-aware 
augmentation of mobile health in smart cities provides an opportunity for 
accurate and efficient prevention of various diseases and accidents (Zhang, 
Zheng, & Deng, 2018). The main concern for users of s-heath is who has 
access to their health data, as the expectation of users of the systems is such 
that only professional healthcare givers should have access to them, which 
presents a limitation in the way access control is granted to people accessing 
the systems that can potentially harm the data security (Zhang et al., 2018). 
 
Chapter Summary: 
The research was addressed using the J48 Algorithm in Weka Tool. However, 
with the use of such technique, data accuracy must be defined and given a 
context in order to understand the causes of inaccurate data. The human 
behaviour is another factor that must be taken into consideration when 
modelling an algorithm to achieve a certain level of data accuracy and to 
accurately predict when or not data is accurate. This gives metadata another 
important role in helping researchers and people understand what the data 
means and how it affects the modelling. With more metadata, the data can be 
become more contextualized thus providing a deeper understanding of the 
phenomenon under study, which in this instance, would be how the patient 
managed their chronic disease (diabetes). However, with data becoming more 
contextualized and machine learning performance of predicting accurately, the 
privacy of the users and the security of the data become critical to ensure that 
users’ privacy is not exploited, and their data misused.  
 
Chapter 6 : Conclusion 
This chapter presents an overview of the study and provides a review of how 
the research question was addressed. mHealth presents an opportunity in 
expanding health services and delivering more care through both self-
management and other technologies. This makes data a fundamental part of 
mHealth as data is produced by users of the systems (patients, health 
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professionals, and analytical data) and it is then transformed into information 
that can lead to decision making. The delivery of accurate mHealth solutions 
can be achieved through the implementation of Machine Learning algorithms 
that can be trained to detect inaccurate data. 
 
The research question was addressed using a qualitative approach where 
patients’ data were examined in depth and themes were generated that help 
understanding how data inaccuracy occurs. The findings revealed that a 
classification algorithm (J48) can be implemented in mHealth solutions to 
address the issue of data inaccuracy and information integrity.  
 
The following is a summary of the how the research question was addressed, 
the contribution to both theory and practice, the limitations presented in the 
study and the future research directions.  
6.1 Answering the research question 
The purpose of this study was to find ways (the ‘How’ part of the research 
question) through which Machine learning can detect inaccurate data to prevent 
erroneous data from being used in decision making, deliver information with 
Integrity and preventing medical errors. The research question posed in the 
study was ‘How can Machine Learning be applied in mHealth solutions to 
address data accuracy and Information Integrity?’. The research question was 
addressed when data was modelled using a classification algorithm that 
detected which instances of patients’ data were accurate or inaccurate. This 
was accomplished after the manual labelling of the data which resulted in a 
model that checked for the quality of data. The Machine Learning model means 
that that mHealth can use this model to enhance the element of data quality in 
mHealth solutions to further develop the quality of mHealth solutions, remove 
the risk of harming patients from false or inaccurate data that could be used in 
decision making, and continue to deliver solutions. As the number of chronic 
diseases rises and an increasing number of people seeks self-management to 
improve their health, this Machine Learning model can help in assisting that the 
information generated by mHealth technology is accurate and can be relied 
upon for turning the data into information that can be used to help make a great 
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impact on peoples’ health status and continue to improve the management of 
their diseases. In Table 6.1.1., it illustrates how each element of the data quality 
was addressed in this study as they played a role in generating the Machine 
Learning Model.  
Table 6.1.1: Addressing the Element of Data Quality in this study. 
Data Quality Element How this element is addressed in this study 
Completeness This element is critical in checking the accuracy of the 
data. This element was addressed in this study as it 
served as the first check for data accuracy by examing if 
the datasets contained complete values (data and time 
stamps, code, and the reading). This then allowed the data 
to be progressed to the next stage of checking the 
Currency and Timelinesss of the data. 
Currency & Timeliness This element of time was of high importance too. The time 
stamps and the timeliness of the data demonstrated the 
human behaviour and the patients’ way of managing 
diabetes through the day. This was addressed by 
checking the timestamps of each reading, then compared 
on hourly, daily and weekly basis. This provided an idea 
of when data is generated and at what frequency.  
Legibility This element did not require much attention as almost all 
of the data were readable, except in cases where random 
values were present within datasets that could be 
translated or used in the analysis of the data. 
Consistency This element provided an insight of how and when data 
was generated, providing a pattern of consistent and 
inconsistent data. The patterns assisted in modelling the 
data and the human behaviour (patients taking their 
gluocose readings), which were then used to flag accurate 
and inaccurate data.  
Reliability While some of the data were complete, and legible, yet, 
they were not reliable as they did not provide readings that 
could be relied upon for decision making. An example of 
this included a single reading with no further explanation 
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of before or after reading decision making (ie: no 
continuation of the action taken by patients). 
Meaning and 
Usefulness 
Data that were complete, current, legible, consistent and 
can be relied upon, meant that the data provided a 
meaning to what the patients were doing and could be 
used for further analysis. 
Accuracy and Validity After each dataset was examined against all previous 
elements, this element provided the final check that 
ensured that data were completed, current & timely, 
legible, consistent, reliable, meaningful and useful.  
Accessbility This element was not applicable in this study as all data 
were accessible. 
Confidentiality and 
Security 
This element could not be addressed as the case used in 
this study was secondary and did not included a solution 
where data can be monitored right from when the data is 
generated to when it is delivered to its destination (medical 
professional or automated mHealth solution). Hence, this 
element was not tested.  
6.2 Contribution to Theory and Practice 
This study made contributions to both Theory and Practice. The following 
highlights the contributions from the study. 
 
6.2.1 Contribution to Theory 
The first contribution to theory is within the IoT domain, where the approach 
applied in the analysis of the data can be applied to areas of IoT, such as those 
demonsteated by Laplante & Laplante (2016). A second area of contribution 
within mHealth is Adherence, where Levensky & O’Donohue (2006) stated that, 
despite the advancements in the medical field, adherence is still a problem. The 
Algorithm used in this study can be applied to a case study of medical 
adherence, whereby the algorithm can detect if a patient is adhering to their 
medication by analysing if patients’ data is accurate, that is yielding the 
expected outcome. This can in turn enhance the patient-clinician interaction by 
providing an efficient way of analysing the patients data to deliver effective 
solutions (Kelly-Irving et al., 2009). A third area is health promotion, where the 
pg. 141 
 
use of Mobile Apps and SMS (lupton 2012) resulted in Big Data, and the 
algorithms used in this study can be applied to filter through the data to provide 
an overview of the the health promotion program 
 
Another 2 areas where this study contributely largely to, are Big Data, and Data 
Quality. Big Data now includes the veracity variable (Sebaa et al., 2018), that 
states the reliability and quality of the data. This contribution to the theory of Big 
Data, is by demonstrating how veracity can be achieved through the use of 
algorithms that can detect the level of data accuracy. This extends to Data 
Quality, where errors in data (Olson, 2003) can now be detected through the 
use of algorithms, which enhance the quality of data, leading to better outcomes 
and results.  
 
6.2.2 Contribution to Practice 
In terms of practice, this study can serve as a guide in impelementing data 
quality controls to improve areas mentioned by (Olson, 2003) and (Magrabi et 
al., 2016). This can in turn improve the quality of care delivered through 
mHealth such as those stated by (Mirza, Norris, & Stockdale, 2008). The study 
also contributes to the area of Machine Learning and how it can be implemented 
in new emerging technology by analysing the human behaviour and 
demonstrating the steps in modelling the data. This includes implementing the 
algorithms for chronic disease based solutions such as diabetes (Karan et al., 
2012). The contributions are not limited to this study, as the algorithms can be 
adopted by researchers and other interested stakeholders to use within their 
solutions. 
 
6.3 Limitations 
With the findings and the contributions this study made to the fields of theory 
and practice, there were limitations present in the study. The study did not have 
access to a medical professional who could contribute to establishing an 
understanding of how diabetes works and what the reason for the way humans 
behaved, or whether the data were accurate (in the context of the diseases). 
However, this study did rely on the supplied metadata that explained diabetes 
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and provided background information about the codes in the datasets that 
explained what was happening with the patients. Access to patients was of 
limitation as there were no patients involved in this study which meant the study 
lacked information that helped understand how or why the data was sent and 
what the patients thought of mHealth. Also, the labelling of the data was based 
on the definitions listed in the literature review that helped in forming an 
understanding of the characters of each element of the data quality. 
 
6.4 Future research directions 
Future research direction from this study is to perform similar studies on 
different mHealth technologies such as wearable, implantable, text messaging 
and other technologies that are considered as mHealth solution. The future 
studies should be conducted based on examining the data from the moment 
they are generated (ie: typed by the patient) all the way to when it reaches the 
medical professional or the intended destination and compare the original data 
with the final data that’s used by medical professionals. The studies should also 
be extended to the communication component of mHealth solution and 
examine the element of timeliness as delays caused by network outages and 
drops in packets can also affect the quality of the data. Other studies are also 
needed for examining the security aspects of mHealth solutions and how 
metadata can affect the privacy of users transmitting data for analysis using the 
Cloud technology. 
6.5 Lessons Learnt 
Accomplishing the original purpose of this study is a major satisfaction. 
However, the study brought some lessons for the research including: 
• The research methodology needs to be more thorough and should illustrate 
the process of the analysis in greater depth. 
• As themes emerged during the literature review, the researcher should 
attempt at publishing in academic journals to help in highlighting some more 
areas that need to be investigated and studied 
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• Time management is critical to completing the study on time and a more 
realistic milestones should be set with expected outcomes pinned against 
real deadlines to ensure the study is moving forward.  
The above points were crucial to this study and they were revised multiple times 
during the research. Upon revision, they helped move the study forward and at 
the end accomplish what was set out to be done, by answering the research 
question. 
 
Chapter Summary: 
The purpose of the study was to accomplish a way in which Machine Learning 
can be applied in mHealth solutions that can detect inaccurate data and achieve 
information integrity. The research question was addressed using a J48 
classification Algorithm. The results from the study contributed to both Theory 
and Practice areas of Information Systems. The research however, did have 
some limitations which were highlighted, and lessons were learnt during the 
study.  
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Appendix A 
To view the results and the algorithms from this study, please navigate to the 
folder containing the data by copying the below URL and pasting it into a web 
browser to view the folders containing the data.  
https://1drv.ms/f/s!AhpMjZqGve6kkFyjtvtezY4W-_eQ  
 
Once the URL is opened, you’ll be presented with 4 numbered folders (See 
below Screenshot). Folder 1 contains the original data, Folder 2 contains the 
new data format, Folder 3 is the folder containing the Weka .ARFF format which 
can be imported into WEKA Tool to run the algorithms against, and Folder 4 
cotains the actual results from the Algorithms.  
 
 
 
The following list of attachments shows how to load data into Weka and using 
the J48 Algorithm to classify the data. Note, Folder 3 which contains both 
training and testing datasets in the WEKA ARFF Format. They can be loaded 
into WEKA without any editing required.  
 
Step 1: Open WEKA and click on Explorer.  
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Step 2: Once Explorer is opened, click on ‘Open file’ 
 
Step 3: After clicking ‘Open file’, navigate to the folder containing the training 
and testing datasets in the WEKA ARFF and select a file.  
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Step 4: Once a file is selected, browse to the next tab ‘Classify’ and under 
‘Classifier’ select ‘trees’ and then ‘J48’. Afte the algorithm is selected, press 
‘Start’. 
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as part of this study. 
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International Publishing. 
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